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ABSTRACT 
Elizabeth Mathias Garrett: Characterization of a phase variable regulatory system and 
its impacts on Clostridioides difficile physiology (Under the direction of Rita Tamayo) 
  
Clostridioides difficile is a Gram-positive, spore-forming, obligate anaerobic 
bacterium that causes gastrointestinal disease and is the leading cause of nosocomial 
infections in the U.S. Despite its significant public health burden, key aspects of 
pathogenesis including the regulatory strategies that benefit C. difficile fitness during 
infection are not well understood. In this work, we identify and characterize a two-
component regulatory system with significant impacts on C. difficile physiology as well 
as elucidate the complex regulatory networks that govern its expression. We find that 
expression of cmrRST, a highly conserved operon that encodes two response 
regulators (CmrR and CmrT) and a histidine kinase (CmrS), is subject to phase 
variation. Phase variation is a regulatory mechanism used by many bacterial pathogens 
to introduce phenotypic heterogeneity in a population as a bet-hedging strategy to help 
ensure the survival of the overall population. cmrRST is phase variably regulated by 
conservative site-specific recombination, which involves the reversible inversion of a 
DNA element containing regulatory information, termed the cmr switch, by the site-
specific recombinase RecV. The phase variable production of CmrRST results in two 
distinct C. difficile subpopulations distinguishable by colony morphology. CmrRST alters 
cell morphology, promotes a novel form of surface migration, and inhibits swimming
iv 
 motility. Additionally, we provide evidence that CmrRST has a role in virulence and that 
phase variation occurs in vivo. In addition to phase variable regulation by the cmr 
switch, cmrRST expression is regulated by c-di-GMP, an intracellular signaling 
molecule, through a riboswitch. Furthermore, cmrRST is subject to autoregulation by 
CmrR. We find that regulation by CmrR and c-di-GMP supersede the effects of the cmr 
switch orientation. Finally, we begin to identify and characterize the CmrRST regulon 
and provide evidence that CmrT is the primary regulator of gene expression that results 
in changes in motility and cell morphology, while CmrR appears to be dedicated to 
autoregulation of cmrRST transcription. This work identifies an important regulatory 
system with significant implications for our understanding of C. difficile population 
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CHAPTER 1. INTRODUCTION 
CLOSTRIDIOIDES DIFFICILE EPIDEMIOLOGY, RISK FACTORS, AND TREATMENT 
 Clostridioides difficile is a Gram-positive, opportunistic bacterial pathogen. C. 
difficile infection (CDI) causes mild to severe diarrhea, with a risk of complications 
including pseudomembranous colitis, toxic megacolon, and sepsis [1-3]. The CDC 
estimates that there were 233,900 cases of CDI with nearly 13,000 fatalities in 2017 in 
the U.S [4]. C. difficile causes an estimated 20-30% of antibiotic-associated diarrhea 
cases [5]. Furthermore, C. difficile is the leading cause of nosocomial infections in the 
U.S. One study of a hospital over an 11-month period found that 21% of patients 
acquired C. difficile during their hospital stay, illustrating the extent of this problem [6]. 
Additionally, community-acquired CDI (CA-CDI) incidence has increased over the last 
decade, constituting about a third of cases in the U.S [7-9]. 
 C. difficile is a sporulating bacterium and an obligate anaerobe [2, 3]. Because C. 
difficile dies in environmental oxygen conditions, the transmission of the spore is the 
primary means of infection through the fecal-oral route [10]. The spore is a metabolically 
inactive form of the bacterium in which the genetic material is protected by thick 
glycoprotein walls. When the spore is ingested by an individual, it passes through 
gastrointestinal tract until it encounters primary bile acids such as cholate in the 
intestine. These primary bile acids bind receptors on the spore and cause the spore to 
germinate into a replicative “vegetative” cell. In this form, the bacterium can colonize the 
colon and cause disease. 
2 
 The normal gut microbiota in healthy individuals is very protective against CDI. 
However, antibiotic use can disturb the gut microbiome, making the individual more 
susceptible to CDI [11-14]. Much research in recent years has been focused on 
elucidating the relationship between the gut microbiota and CDI. Antibiotic treatment 
reduces the number and the diversity of commensal bacteria that appear to prevent CDI 
[13, 14]. One mechanism by which commensal gut microbes protect against CDI is 
through the conversion of primary bile acids necessary for spore germination into 
secondary bile acids [15, 16]. These secondary bile acids do not stimulate C. difficile 
spore germination and instead inhibit vegetative cell growth. Mice that have been 
treated with the antibiotic clindamycin produce more of the primary bile acid 
taurocholate and less secondary bile acids [11, 15]. Many commensal bacterial families 
including Lachnospiraceae and Ruminococcaceae are associated with transformation of 
primary to secondary bile acids [15, 17]. Members of these families have been shown to 
provide protection from CDI in animal models. Other Clostridia such as Clostridium 
scindens also can convert primary bile acids into secondary bile acids and are 
associated with providing resistance to C. difficile colonization [18]. Gut microbes 
additionally may prevent CDI by direct bacterial competition. A human intestinal derived 
strain of Bacillus thuringiensis was found to produce a bacteriocin, named Thuricin CD, 
that specifically targets spore-forming Gram-positive bacteria including C. difficile [19].  
 Commensal gut bacteria may also protect against C. difficile colonization by 
competing for resources needed for C. difficile growth. C. difficile has been shown to 
utilize components of mucin including sialic acid as an energy source [20]. Bacterial 
communities grown from the cecums of hamsters outcompeted C. difficile when grown 
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with limited nutrient availability; however, this effect was lost when the medium was 
supplemented with additional carbon sources including components of mucins [21]. 
Additionally, Ng et al. demonstrated that antibiotic treatment increased free sialic acid in 
a murine model and that this nutrient source benefitted C. difficile expansion [20]. These 
studies suggest that commensal microbes prevent C. difficile colonization by limiting 
nutrient availability. Not all commensal bacteria are protective against CDI. Bacterioides 
thetaiotamicron is a common gut microbe that produces an enzyme that cleaves mucin, 
therefore increasing the availability of sialic acid for C. difficile [20]. B. thetaiotamicron 
also produces high levels of succinate, which C. difficile can utilize for energy through 
fermentation [22]. In an animal model, co-infection of C. difficile and B. thetaiotamicron 
increased C. difficile bacterial burden as compared to C. difficile infection alone [20]. 
Additionally, in a study surveying the effect of clindamycin treatment on the gut flora of 
healthy individuals over two years, B. thetaiotamicron was much more highly 
represented than non-antibiotic treated controls [23]. Together, these data suggest that 
the ability of C. difficile to colonize the gut and cause infection is intimately tied to the 
commensal gut microbiome and that disruption of the gut microbiome increases the risk 
of CDI. 
 The incidence of C. difficile increased significantly across the world in the last 20 
years [1]. This increased incidence is associated with outbreaks of epidemic ribotypes 
of C. difficile, including ribotype (RT) 027. RT 027 is a hypervirulent RT first recognized 
in 2002 [24, 25]. It quickly became the most prevalent RT isolated from outbreaks, and 
outbreaks caused by RT 027 strains have been associated with increased morbidity and 
mortality [26, 27]. Characterization of 027 strains shows that they produce more of the 
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toxins TcdA and TcdB than non-epidemic isolates and are also able to produce the 
binary toxin CDT [28]. Additionally, 027 strains are more antibiotic resistant. More 
recently, the number of cases associated with 027 strains has decreased, and it has 
been replaced as the most prevalent RT by 012-020 in the U.S., with 002 also 
becoming more common [29]. In addition to the public health burden of nosocomial 
cases of CDI, the incidence of CA-CDI has increased over the last decade [7-9]. CA-
CDI is more prevalent among females and affects many patient populations previously 
considered to be low risk, including children and young adults [30]. In Europe, CA-CDI 
is commonly caused by RT 027 and 014-020, while RT 027 is the most common cause 
in the U.S [31, 32]. Additionally, new RT are being identified regularly as the cause of 
both CA-CDI and nosocomial cases. Surveillance in the U.S. has led to 49 unique RT 
designations from 2010-2014 [29]. An outbreak of severe and recurrent cases of CDI in 
2018 was shown to be caused by a new RT, 826 [33]. Therefore, continued surveillance 
is important to our understanding and control of CDI. 
The antibiotics metronidazole, vancomycin, and fidoxomicin are commonly used 
to treat symptomatic CDI [34]. However, CDI has a high rate of recurrent infection after 
conventional antibiotic treatment; about 20-30% of patients experience a second 
episode of CDI, with the chance of subsequent infection increasing with each occurence 
[8, 9, 35]. The mechanisms underlying recurrent infection are unclear. More than 80% of 
first recurrences are caused by the same strain as the initial infection; one explanation 
for this result is that relapse is occurring [36, 37]. Therefore, alternate mechanisms of 
treatment are being explored. One strategy under investigation is the use of antibiotics 
in conjunction with a microbe to repopulate the gut, potentially preventing C. difficile re-
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colonization. For example, several studies in human patients showed that treatment 
with antibiotic as well as Saccharomyces boulardii, a species of yeast that colonizes the 
colon but is not maintained for long, increased the efficacy of treatment versus antibiotic 
treatment alone [38, 39]. Similar studies have shown mixed results [40]. Several studies 
have shown that the administration of Lactobacillus strains with antibiotic treatment 
reduced CDI incidence in patients  [41, 42]. Additionally, treatment with C. difficile 
spores from non-toxigenic strains has been shown to reduce CDI [43]. Other studies 
investigating the administration of microbes with antibiotcs have shown no effect or 
inconclusive results [44]. Fecal microbiota transplantation has also been an effective 
strategy for the treatment of recurrent CDI [34, 45]. In this method, patients with CDI are 
given a fecal sample from a healthy donor. The microbiota from the donor repopulate 
the gut, reestablishing microbial diversity and preventing relapse or reinfection. Grehan 
et al. showed that recipients of fecal transplants were stably colonized by the donor 
microbiota [46]. Multiple studies have shown the efficacy of this treatment in resolving 
infection and preventing recurrence, with success rates around 80-90% [47-49]. 
However, the use of FMT is not without risk, is not well regulated, and there are few 
rigorous clinical studies [50]. Further efforts have been made towards preventing CDI 
through the use of probiotics. In vitro studies have identified several bacteria, including 
Lactobacillus, Bifidobacterium and Clostridium strains, as potential probiotics that inhibit 
C. difficile growth or spore germination [51, 52]. Probiotic therapies have shown mixed 
results in human patients. In summary, improved therapies for the treatment and 
prevention of CDI, especially recurrent, are required. 
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C. DIFFICILE TOXINS 
C. difficile produces toxins TcdA and TcdB during colonization of the colon [53]. 
Both TcdA and TcdB target factors in the host cell that result in disassembly of the 
cytoskeleton, cell lysis, and a robust immune response [54]. While not all strains 
produce both, symptomatic CDI is associated with the production of at least one of 
these toxins [43, 55]. Therefore, their role in disease has been thoroughly studied both 
in vitro and in vivo. 
The genes encoding TcdA and TcdB are within the 19.6 kb pathogenicity locus 
(PaLoc) of the genome along with tcdE, tcdR, and tcdC [2]. TcdE is suggested to 
function as a holin for the secretion of toxins TcdA and TcdB [56, 57].TcdR is an RNA 
polymerase sigma factor that positively regulates the transcription of tcdA and tcdB [58]. 
TcdR also has additional regulatory targets that promote sporulation [59]. TcdC is an 
anti-sigma factor that antagonizes TcdR to negatively regulate expression of tcdA and 
tcdB [60, 61]. RT 027 strains, which are associated with large outbreaks of CDI and 
hypervirulence, produce high amounts of toxin which has been attributed to an 
inactivating mutation in tcdC [28]. In vitro data to support this has been inconclusive. 
Overexpression of tcdC in 027 strain M7404 reduced toxin production as well as 
virulence in a mouse model of infection [62]. In contrast, restoration of a functional tcdC 
allele into 027 strain R20291 was not sufficient to reduce toxin levels or cytotoxicity [63]. 
Therefore, role of TcdC in infection is unclear.  
TcdA and TcdB are glucosylating toxins with four domains: ACDB [54]. The A 
domain contains glucosyltransferase activity. This domain is required for the cytotoxic 
effects of these toxins. TcdA and TcdB glucosylate host Rho GTPases, preventing their 
activation. Rho proteins have a wide range of functions in the cell. Therefore, the loss of 
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their activity results in many cytopathic and cytotoxic effects. Rho inactivation causes a 
redistribution of the cytoskeleton, resulting in cell rounding [64, 65]. Tight junctions are 
also disrupted, which alters cell-to-cell contact and causes permeabilization of the 
epithelial cell layer [66, 67]. TcdA and TcdB also induce apoptosis, activate the 
inflammasome, and trigger pyroptosis [53, 68]. Together, these cytotoxic effects result 
in a massive inflammatory response, causing diarrhea and colitis [53, 69]. These toxins 
are highly potent, and administration of these toxins alone is sufficient to cause disease 
in an animal model [70].  
The B domain is important for the binding of the toxins to host receptors [54]. The 
B domains of TcdA and TcdB differ in structure, and data suggest that they have 
different receptors as well. While many receptors for TcdA and TcdB have been 
identified, the receptors important for pathogenesis in a human host are still unclear. 
TcdA has been shown to bind host cell glycans [71, 72]. TcdA also binds gp96, a 
glycoprotein that is found on human colonocytes [73]. However, loss of gp96 binding 
only partially protects from TcdA cytotoxicity, suggesting other factors are at play. 
Chondroitin sulfate proteoglycan 4 and the Wnt receptor FZD have been shown to bind 
TcdB and promote internalization of the toxin, but their role in pathogenesis is unclear 
[74, 75].  
Once bound to host epithelial cells, TcdA and TcdB enter the cell by endocytosis 
mediated by the D domain [76]. The C domain has autoproteolytic activity and cleaves 
the toxin, releasing the glucosyltransferase domain [77]. This proteolytic activity is 
stimulated by inositol hexakisphosphate, which is produced by host cells. After 
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cleavage, the glucosyltransferase domain of TcdA or TcdB is free to modify target Rho 
proteins. 
There has been much investigation into the individual roles of TcdA and TcdB in 
pathogenesis. Several studies have presented data suggesting that while both toxins 
can cause disease, TcdB is more potent and associated with increased virulence in 
animal models [78-81]. For example, Carter et al. demonstrated using three different 
mouse models of CDI that a mutation in tcdB, but not tcdA, caused severe attenuation 
of a C. difficile RT 027 strain [78]. A study in a hamster model of CDI showed similar 
data that hamsters infected with a strain of C. difficile only producing TcdA had 
significantly higher survival than those infected with wild-type or a tcdA mutant strain 
[79]. Characterization of clinical isolates from patients with CDI seem to support these 
results. Only one disease-causing isolate that does not produce TcdB has been 
identified [82]. In contrast, virulent strains that do not produce TcdA are far more 
common [83-85].  
Some C. difficile RT including epidemic RT 027 produce a third toxin called 
binary toxin or CDT [86-88]. CDT consists of two subunits, CDTa and CDTb [54]. CDTb 
binds an unknown receptor on host cells to mediate uptake while CDTa functions as an 
actin specific ADP-ribosyltransferase. This toxin prevents actin polymerization, causing 
severe disruptions in the cell cytoskeleton. Treatment of epithelial cells with CDT 
causes the formation of microtubule-based protrusions which may increase the ability of 
C. difficile to adhere to the cell surface [89]. It is estimated that less than a quarter of 
toxigenic strains produce CDT [90, 91]. While CDT is not required for virulences, 
9 
several studies have found that CDT production is associated with increased CDI 
mortality [91]. However, the role of CDT in pathogenesis is still undefined. 
MOTILITY AND SURFACE BEHAVIORS OF C. DIFFICILE 
Flagella 
Flagella serve as important virulence factors in many bacterial pathogens [92]. In 
other gastrointestinal pathogens including Campylobacter jejuni and Vibrio cholerae, 
flagella contribute motility, adherence, and colonization of the host [92-94]. Flagellar-
mediated swimming motility occurs when the flagellar motor rotates the flagellar filament 
in a propeller-like manner. C. difficile produces peritrichous flagella that are essential for 
swimming motility in vitro [95, 96]. Flagellar biosynthetic genes are organized into three 
major operons called F1, F2, and F3 [97]. F3, also called the early stage flagellar 
operon, is the largest of these operons with 29 genes. This operon encodes many of the 
motor and structural components necessary for flagellar assembly. F1, also called the 
late stage operon, is not expressed until the proteins encoded by F3 have assembled. 
F1 encodes proteins including the flagellin, FliC, and the cap protein, FliD. F2 encodes 
proteins that function in glycosylation of the flagellar filament. The F2 operon is the most 
divergent of the flagellar operons between C. difficile strains, leading to differences in 
glycosylation patterns [98-100].  
In addition to encoding structural components of the flagella, the early stage 
flagellar operon encodes the alternate sigma factor SigD [97]. SigD is necessary for the 
expression of the other flagellar operons, and sigD mutants are non-motile [101-103]. 
Furthermore, SigD promotes the expression of tcdR [101, 104]. Because TcdR is a 
positive regulator of tcdA and tcdB expression, SigD promotes toxin production and 
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links this to flagellar biosynthesis. SigD has additional regulatory targets outside the 
flagellar operon and the PaLoc including genes involved in sporulation [101]. 
The role of flagella in virulence is still not well defined. Many virulent ribotypes 
are missing one or more of the flagellar operons, suggesting that they are dispensable 
for virulence [105]. Flagella contribute to multiple phenotypes in C. difficile in addition to 
motility. For example, flagella contribute to agglutination. The degree of agglutination is 
strain dependent; even within the same ribotype, strains have different agglutination 
habits, which may be due to differences in glycosylation of the flagellar filament [98-
100]. Flagella also affect adherence and colonization in a strain dependent manner. 
Loss of the flagellar filament through a mutation in fliC in RT 027 strain R20291 resulted 
in reduced adherence to mammalian cell lines as well as reduced colonization in a 
mouse model [95, 96]. Interestingly, RT 027 strain R20291 in which a gene encoding 
the flagellar motor, motB, had been mutated showed no difference in colonization, 
suggesting that motility is not required for colonization but the flagellum may function as 
an adhesin [95]. In contrast, a fliC mutation in the RT 012 strain 630Δerm increased 
adherence to mammalian cell lines and had no difference in colonization in a mouse 
model. Two studies in 630Δerm showed that mutant fliC and fliD strains were more 
virulent in a hamster model of CDI, possibly because flagella are immunogenic or 
because loss of these genes increased toxin production [96, 102]. In summary, flagella 
are an important component of C. difficile physiology and have a complex and multi-
faceted role in the interaction between the bacterium and the host. 
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Type IV pili 
Type IV pili (TFP) are extracellular appendages produced by a wide range of 
both Gram-positive and Gram-negative bacteria [106, 107]. Smaller and thinner than 
flagella, TFP similarly can function in motility and adherence. TFP-mediated motility 
occurs by a grappling hook mechanism in which TFP extend, attach to a surface, and 
retract, pulling the bacterium along [108]. TFP are a key virulence factor in many 
bacteria including Clostridium perfringens, where they contribute to a surface motility 
termed gliding motility, adhesion to host tissues, and biofilm formation [109-112]. 
Genes encoding components for TFP are considered core genes and are found 
in all sequenced C. difficile strains [105, 106]. In C. difficile, TFP contribute to surface 
motility and autoaggregation in vitro [113, 114]. TFP also promote adherence to host 
cells. McKee et al. showed that TFP-deficient mutants had reduced adherence to 
mammalian cell lines at 24 hours post inoculation but not at 1 hour, suggesting that TFP 
are not required for initial attachment but contribute to long term adherence [115]. 
Similarly, in a mouse model of CDI, TFP mutants behaved similarly to WT at early 
stages of infection but were cleared more rapidly, indicating a role for TFP not in initial 
colonization but in persistence. In a hamster model of infection, C. difficile was shown to 
express TFP genes, and microscopy showed the attachment of bacteria to the host 
epithelia by structures resembling TFP [116]. However, the significance of TFP-
mediated motility versus adherence during infection is unknown.  
Biofilm formation 
Biofilms are complex bacterial communities that form both in the environment 
and during infection [117]. Biofilms consist of bacterial aggregates adhered and 
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surrounded by a protective matrix composed of polysaccharides, proteins, and 
extracellular DNA. For many bacterial pathogens, biofilm formation is a key virulence 
strategy [117, 118]. Biofilms are highly protective against antimicrobials, environmental 
stresses, and the host immune response. Additionally, they contribute to bacterial 
persistence and the recurrence of infection.  
C. difficile biofilms were first described in 2012 [119], and the ability of C. difficile 
to form biofilms in vitro is now well documented [120-123]. Several factors have been 
shown to contribute to biofilm formation in vitro. Multiple studies have shown using 
different models of biofilm formation that TFP contribute to biofilm formation in C. 
difficile [113, 121, 122]. Additionally, genes encoding TFP components are more highly 
expressed during biofilm growth than planktonic growth [122]. Like that of other 
bacteria, the C. difficile biofilm matrix consists of DNA, protein, and polysaccharides 
[123-125]. Treatment of biofilms with proteinase K or DNAse I prevents biofilm formation 
and disperses established biofilms, suggesting that these molecules are important 
structural components of the matrix [123, 124]. Furthermore, flagella and components of 
the S-layer have been shown to contribute to biofilm formation as well [123, 126, 127].  
Less is understood about the importance of C. difficile biofilms in vivo. In a 
mouse model of infection, Lawley et al. described large aggregates of C. difficile 
associated with the host epithelium that corresponded to sites of intense inflammation 
and tissue damage [128]. Similarly, Soavelomandroso et al. showed that some, but not 
all, C. difficile strains form aggregates on the surface of the mucus layer in the cecum 
and colon of mice [129]. These aggregates contained polysaccharides and extracellular 
DNA consistent with a biofilm matrix. Similar aggregates have been seen in the cecums 
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and colons of hamsters [125]. Further studies have suggested that C. difficile can form 
polymicrobial biofilms with gut microbiota [130]. While these studies suggest that C. 
difficile forms biofilms in vivo, their role in infection remains unclear. 
Biofilms are linked to recurrent infection in many bacterial pathogens [117, 118]. 
Therefore, whether C. difficile biofilms contribute to recurrent infection is of great 
interest. Semenyuk et al. showed that mature biofilms contain a dense concentration of 
spores [125]. As spores are highly resistant to antimicrobials, biofilms might serve as a 
reservoir of spores for reinfection. However, other studies have shown conflicting 
results, possibly due to differences in growth conditions and strains tested [123, 129]. C. 
difficile in biofilms are more resistant than planktonic cells to metronidazole and 
vancomycin, antibiotics commonly used to treat CDI [123-125, 131]. This observation 
suggests that biofilms protect vegetative cells from antibiotics, and these cells could 
reestablish infection once antibiotic treatment has ceased. Further study on the role of 
biofilms in recurrent CDI is necessary. 
PHENOTYPIC HETEROGENEITY AND PHASE VARIATION 
Even within the same environmental conditions, populations of clonal bacteria 
can display diverse phenotypes [132, 133]. This phenotypic heterogeneity is an 
important survival strategy for bacteria. If environmental conditions change quickly, 
bacteria may not be able to sense and develop a response rapidly enough to ensure 
survival. Phenotypic heterogeneity works as a bet-hedging strategy to help ensure that 
at least one of a number of phenotypically distinct subpopulations of bacteria have a 
fitness or survival advantage.  
14 
Many bacterial pathogens have been demonstrated to generate phenotypic 
heterogeneity, which can contribute to virulence as a survival strategy that promotes 
persistence during infection. One well characterized example of phenotypic 
heterogeneity as a virulence strategy is the development of persisters [132, 134]. Many 
pathogens including Staphylococcus aureus, Mycobacterium tuberculosis, and 
Escherichia coli produce a small subpopulation of slow-growing or dormant cells called 
persisters. Under favorable conditions, this subpopulation may go unnoticed. However, 
persisters are highly resistant to antibiotic treatment as well as many host immune 
responses. Thus, they have a fitness advantage compared to vegetative cells during 
these stressful conditions. Once in more favorable conditions (such as the cessation of 
antibiotic treatment), persisters can resume normal growth. Persister cells have been 
shown to perpetuate chronic and recurrent infections and serve as an important 
example of how phenotypic heterogeneity can aid pathogens in infection. 
Phenotypic heterogeneity can be introduced into a population through many 
mechanisms including phase variation [135-137]. Phase variation is a reversible 
change, often a recombination event, which happens stochastically at a low rate per 
bacterial generation. This reversible change results in a change in gene expression and 
an ON/OFF phenotypic switch. The subpopulation with the switch in the state that 
confers the greatest fitness advantage, ON or OFF, may become the dominant 
subpopulation as a result of selective pressure. Phase variable factors are typically 
surface components including pili, flagella, and capsule. These factors often provide 
distinct advantages under specific conditions but may be costly due to energy 
requirements or immunogenicity, for example. Phase variation is widespread throughout 
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the bacterial kingdom, including commensal and pathogenic bacteria, and can occur 
through multiple mechanisms [136, 138, 139].  
Slipped strand mispairing 
Small, repetitive DNA sequences are highly mutagenic due to the tendency for 
slippage during DNA replication [140, 141]. One mechanism of phase variation called 
slipped strand mispairing (SSM) has evolved to utilize these “mistakes” in order to 
regulate gene expression in an ON/OFF manner. Repetitive sequences can cause a 
misalignment between daughter and parent strands during replication, resulting in an 
expansion or contraction of the repeated sequence. If SSM occurs in a promoter region, 
transcription of the downstream may be affected. Alternately, SSM in a coding region 
can alter the open reading frame, affecting translation. However, because either 
expansion or contraction can occur in these repetitive sequences, the sequence change 
is reversible. Sequences involved in SSM have been shown to occur with 1 to 7 
nucleotide repeats, though tetrameric repeats are most common [136, 142-144]. 
SSM has been demonstrated in multiple pathogens including Neisseria 
meningitidis, Haemophilus influenzae, and Campylobacter jejuni [136]. In H. influenzae, 
hifA, encoding the major pilin, is phase variably regulated by SSM of nine to eleven 
dinucleotide repeats [145]. These repeats are found between the -10 and -35 regions of 
the promoter. Therefore, expansion or contraction of this region allows RNA polymerase 
to only bind and drive transcription with a permissive number of repeats. HifA pili are a 
virulence factor that contribute to adherence; therefore, phase variation of this factor 
could be significant for pathogenesis [146]. 
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Methylation 
 Reversible changes in the DNA methylation can alter gene expression in a phase 
variable manner [136, 137]. Methylation of important regulatory elements can affect the 
binding of transcription factors or other DNA-binding proteins. In contrast to other 
mechanisms of phase variation, this mechanism does not alter the DNA sequence but 
rather is epigenetic.  
 Phase variable methylation has been identified in Salmonella enterica 
Typhimurium and E. coli [136]. Several loci in E. coli are phase variably regulated by the 
activity of Dam methyltransferase including pap, which encodes pili that are a key 
virulence factor contributing to pyelonephritis during urinary tract infections (UTI), and 
agn43, which encodes the outer membrane protein Ag43. Ag43 promotes 
autoaggregation as well as biofilm formation, contributing to bacterial virulence, 
persistence, and recurrent UTI [147-150]. Dam methyltransferase globally recognizes 
GATC sequences in the E. coli genome and methylates the adenine [151]. When three 
GATC sequences near the -10 site of the ag43 promoter are methylated, the 
transcriptional regulator OxyR is unable to bind [152, 153]. Upon DNA replication, the 
genome becomes hemimethylated, allowing OxyR to bind and repress expression of 
ag43. Both Dam and OxyR are constitutively expressed [151]. Therefore, both compete 
for the ag43 promoter sequence in its hemi- or nonmethylated state, leading to ON and 
OFF phase cells within the bacterial population. Importantly, the methyltransferase itself 
is not phase variably regulated; only the methylation state and therefore downstream 
gene expression is phase variable. 
 In contrast, phase variable methylation in Streptococcus pneumoniae occurs 
through phase variation of a methyltransferase. Methyltransferases contain an S subunit 
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that is responsible for recognition of DNA sequences and the specificity of binding [154]. 
S. pneumoniae has three genes encoding S subunits. Only one of these genes encodes 
a functional protein; however, extensive recombination by inversion occurs between 
these three genes, altering the sequence of the S subunit and therefore the recognized 
binding sequences of the methyltransferse [155-157]. Altered methylation patterns 
result in differential production of many factors including capsular exopolysaccharides, 
causing phase variable opaque and transparent colonies. Studies using animal models 
of infection indicate that the transparent variant has improved colonization while the 
opaque is better adapted for later stages of infection [154]. 
Site-specific recombination 
Another mechanism of phase variation involves site-specific DNA recombination 
[136, 137]. In contrast to homologous recombination, which typically requires more than 
50 base pair (bp) of sequence homology, site-specific recombination can occur with 
cognate sequences of less than 30 bp. Site-specific recombination includes inversion, 
excision, and insertion [158]. While excision and insertion events have been shown to 
mediate phase variation, inversion of DNA elements is more common. During inversion, 
also called conservative site-specific recombination, DNA sequences flanked by 
inverted repeats can undergo strand exchange mediated by a recombinase, resulting in 
“flipping” of the region between the inverted repeats. Crucially, no sequence is lost 
during this event, and the sequence can repeatedly invert without sequence 
degradation. If the invertible element contains regulatory information, its inversion can 
regulate expression of surrounding genes. Invertible DNA elements are widespread 
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through bacteria, and advances in the field continue to elucidate the extent to which 
they are present [138, 139]. 
One well-characterized example of phase variation mediated by an invertible 
element occurs in E. coli [136, 159]. The fimS invertible element consists of a 296 bp 
sequence flanked by 9 bp inverted repeats. Within the invertible element is a promoter. 
One orientation of the invertible element, called the ON orientation, contains the 
promoter in the proper orientation to promote transcription of the downstream gene, 
fimA; in the OFF orientation, the promoter is divergently positioned, and fimA is not 
transcribed. FimA is a major component of type 1 fimbriae. Type 1 fimbriae are a key 
virulence factor in UTIs. Strains lacking type 1 fimbriae are highly attenuated in an 
animal model as well as in human patients with UTI [160]. Additionally, the ability to 
phase vary the production of type 1 fimbriae is an important virulence strategy. E. coli in 
which the fimS is locked in the OFF orientation was shown to be significantly attenuated 
in a mouse model of UTI [161]. Further studies have shown that during infection of the 
lower urinary tract, fimS is found predominantly in the ON orientation [162, 163]. The 
invertible element is predominantly OFF in bacteria recovered from the urine, 
suggesting that type 1 fimbriae are important for adherence to uroepithelia during 
infection of the bladder [164]. However, non-fimbriated bacteria become predominant 
over time during infection of the kidney, possibly because fimbriae are immunogenic; 
therefore, there may be selection against fimS ON cell in this environment [163, 165, 
166]. Together, these studies suggest that phase variable regulation of type I fimbriae is 
important to virulence and pathogenesis. 
19 
Site-specific recombination requires the activity of recombinases [158]. Nearly all 
of these recombinases are either in the tyrosine or serine recombinase families. While 
these two families of recombinases act through different mechanisms, the end result is 
the same. Recombinases bind the inverted repeats flanking the invertible DNA 
sequence. After the DNA-protein complex has been formed, the recombinase cleaves, 
rearranges, and rejoins the DNA strands such the intervening sequence has been 
inverted. In the case of the fim system, the tyrosine recombinases FimB and FimE are 
encoded directly upstream of fimS [136, 159]. FimB mediates inversion of fimS 
bidirectionally (i.e., ON to OFF and OFF to ON) [167]. In contrast, FimE predominantly 
inverts this sequence from ON to OFF, and only acts in the opposite direction at a very 
low rate. This selectivity occurs due to binding affinity of FimE to the left inverted repeat 
with fimS in the OFF orientation, impeding inversion from this orientation [167, 168]. 
The amount of a recombinase within the cell affects the rate of inversion [138, 
169]. Therefore, factors that regulate FimB and FimE production affect the proportion of 
ON/OFF cells within a population. The DNA binding protein H-NS represses expression 
of both recombinase genes by blocking the promoter of each [170, 171]. Additionally, 
the orientation of fimS affects fimE expression. In the OFF orientation, the fimE 
transcript is destabilized by the formation of a Rho-dependent terminator at the 3’ end of 
the coding sequence [172, 173]. Multiple factors called recombination directionality 
factors have been shown to affect inversion by changing the interaction of the 
recombinases with fimS [136, 159, 169]. IHF and Lrp bind the DNA around the invertible 
element, bending it in such a way that it increases the ability of the recombinase to 
interact with the inverted repeats [159]. Studies have found that the rate of inversion is 
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decreased in Lrp-deficient cells, while fimS is unable to invert without IHF [174-177]. 
The expression of the recombination directionality factors can be regulated by 
environmental factors. For example, the expression of lrp is regulated by nutrient 
availability [178]. While phase variation is canonically stochastic, the dynamics of 
inversion are subject to a network of interactions and multiple levels of regulation. The 
well-characterized fimS invertible element serves as an important model for further 
understanding of phase variation through conservative site-specific recombination. 
Phase variation in C. difficile 
  Recent work by our lab and others has revealed that C. difficile has the potential 
to generate extensive phenotypic heterogeneity through phase variation. Several 
invertible DNA elements have been identified in C. difficile. The first invertible element 
to be identified, Cdi1, was found by Emerson et al. in a 2009 study that investigated the 
cell wall protein CwpV [179]. This study found that within a clonal population of bacteria 
only 5-10% of cells expressed cwpV. They identified a putative invertible element 
flanked by inverted repeats directly upstream of cwpV and confirmed that this sequence 
undergoes inversion. Transcriptional analysis revealed that transcription was initiated 
upstream of the invertible element. The ON orientation permits transcription to continue 
through the invertible element, allowing cwpV expression. In contrast, in the OFF 
orientation, the nascent mRNA forms an intrinsic transcriptional terminator that 
prematurely halts transcription 5’ of the cwpV coding sequence. This post-transcription 
initiation mechanism of regulation by an invertible element was the first of its kind to be 
described. 
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 The significance of the phase variable regulation of cwpV is unclear. CwpV is a 
cell wall protein that is antigenically distinct among C. difficile strains [180]. Despite the 
differences in protein structure, its phase variable regulation seems to be conserved. 
Overexpression of cwpV results in autoaggregation of cells in vitro, and CwpV also 
confers resistance to phage predation by allowing adsorption of phage but preventing 
DNA injection [181]. Based on these results, Sekulovic et al. speculated that CwpV 
functions as a superinfection exclusion (SIE) system, a mechanism of phage defense 
[181, 182]. If so, a subpopulation of CwpV-producing cells may provide protection to 
neighbor cells by binding and disarming phage. However, the significance of this 
phenomenon to infection remains unknown.  
 Stabler et al. compared whole genomes of a three C. difficile strains [183]. In 
addition to multiple mutations, insertions, and excisions, they identified three sequences 
found in inverted orientations between strains and flanked by inverted repeats. One of 
these was the previously identified Cdi1 invertible element, regulating cwpV. The other 
two were named Cdi2 and Cdi3. Both are upstream of genes encoding c-di-GMP 
phosphodiesterases. They speculated that these sequences are also invertible 
elements with a role in phase variation but did not characterize them further. 
 Anjuwon-Foster et al. identified the Cdi4 invertible element, also called the “flg 
switch”, upstream of the early stage flagellar operon [103]. They verified that the 
sequence flanked by inverted repeats inverts and regulates expression of the 
downstream flagellar genes in a phase variable manner. The mechanism of regulation 
by this invertible element is unknown. The use of transcriptional reporters indicated that 
the flg invertible element does not contain promoter, nor does it contain an intrinsic 
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terminator as observed for the cwpV invertible element. However, this sequence does 
stop transcription from the promoter found directly upstream of the flg invertible 
element, PflgB, suggesting another mechanism of transcriptional termination.  
 The flg switch regulates the expression of the early stage flagellar operon [103]. 
As a result, flg ON cells are flagellated while flg OFF cells are aflagellate and do not 
undergo swimming motility. The early stage flagellar operon encodes SigD, an alternate 
sigma factor that promotes the expression of the toxin genes tcdA and tcdB. Therefore, 
the production of toxins is phase variable as well through regulation by SigD. flg ON 
bacteria produce significantly more toxin than flg OFF bacteria and are more cytotoxic 
to mammalian cell lines. Together, these results indicate that C. difficile populations 
consist of motile/toxigenic and non-motile/non-toxigenic subpopulations. Because of the 
significance of these factors to virulence, the phase variable production of flagella and 
toxins likely has significant ramifications for infection, though this has not been 
experimentally supported.  
The initial characterization of flg phase variation was done in RT 027 strain 
R20291, an epidemic and hypervirulent isolate. RT 012 strain 630, isolated from a 
patient in 1982, was found to have the invertible element only in the ON orientation 
[184]. Additionally, Anjuwon-Foster et al. investigated the flg invertible element in RT 
012 clinical and environmental isolates and found that it was only in the OFF orientation. 
These data suggest that in contrast to RT 027 strains, RT 012 strains may only invert at 
an extremely low rate. The underlying reason is unknown but may be related to 
differences in the sequence of the inverted repeats. Whether that lack of ability to 
readily invert the flg invertible element affects virulence is unclear. Further investigation 
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of the dynamics of phase variation in vivo might provide important information about C. 
difficile pathogenesis.  
 Sekulovic et al. utilized a new method for detecting invertible elements using 
deep sequencing of whole bacteria genomes [138]. Analysis of the reads from pair-end 
sequencing shows specific patterns in regions of inversion. Pairs of reads are typically 
of opposing orientations and at a certain inner-mate distance. In regions of inversion, 
these read-pairs are in the same orientation and at a longer inner-mate distance. These 
atypical reads are typically trimmed or discarded during mapping, but they can predict 
the location of invertible elements. When accounting for such atypical reads in whole 
genome sequencing of C. difficile strain R20291, the four previously recognized 
invertible elements were detected and three additional elements were identified. 
Sekulovic et al. demonstrated that these predicted invertible elements undergo 
inversion and at least one of them regulates downstream genes in a manner consistent 
with phase variation. Application of this method in C. difficile RT 078 and 017 identified 
one additional invertible element not found in RT 027 [185]. Additionally, Sekulovic et al. 
found that some invertible elements are widely conserved with a high degree of 
sequence homology among C. difficile strains, while others are limited to specific 
lineages. In summary, eight invertible DNA elements have been identified in C. difficile, 
seven of which are found in strain R20291. To this point, only two (cwpV and flg) have 
been characterized, and the study of a third invertible element is contained within this 
dissertation. Together these data indicate that C. difficile is capable of considerable 
phenotypic heterogeneity through phase variation. 
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 Additional work has been focused on the identification of the recombinases 
responsible for inversion. Emerson et al. investigated the ability of seven conserved 
recombinases to invert the Cdi1 invertible element and found that only one, designated 
RecV, had this ability [179]. RecV was able to invert Cdi1 in a heterologous organism, 
suggesting that no additional C. difficile-specific factors are required. Deletion of the 
gene encoding this recombinase locked the invertible element, indicating that RecV is 
required for inversion [180]. Anjuwon-Foster et al. similarly found that RecV was both 
sufficient and required for inversion of the flg switch [103]. Further study found that 
RecV affected the orientation frequency of five of the seven invertible elements in 
R20291 [138].  Typically, invertible elements have a dedicated recombinase encoded in 
their vicinity, but the regulation of multiple invertible elements by one recombinase has 
been described [158, 159]. The Mpi recombinase in Bacteroides fragilis regulates the 
inversion of at least 13 sequences throughout the genome. Most of these loci are 
associated with the regulation of polysaccharide production, allowing for a high degree 
of antigenic variability [186]. Similarly, regulation of multiple invertible elements by RecV 
may suggest some coordination or common function between the regulated loci or that 
high phenotypic diversity resulting from one recombinase is beneficial under some 
conditions. Whether RecV regulates these invertible elements in a hierarchical manner 
is unknown but may provide important insights into the dynamics of phase variation in 
C. difficile. 
C-DI-GMP SIGNALING 
3’-5’-Cyclic diguanylic acid (also cyclic diguanylate, c-di-GMP) is an intracellular 
dinucleotide signaling molecule. Enzymes for c-di-GMP metabolism have been 
25 
identified in all major bacterial phyla, evidencing the ubiquity of this molecule [187]. C-
di-GMP was first discovered in 1987 as a signal stimulating cellulose production in 
Gluconacetobacter xylinus [188]. Since then, c-di-GMP has been shown to have roles in 
the regulation of many types of motility, polysaccharide production, biofilm formation, 
toxin production, attachment and adherence, and many other phenotypes. 
Most bacteria exist in a surface-associated state [189, 190]. However, the ability 
to move is important for nutrient acquisition, the avoidance of detrimental conditions, 
and other essential functions. C-di-GMP has an important role in many bacteria in the 
transition between sessile, community-associated and motile, free-living lifestyles. 
Broadly, c-di-GMP is a negative regulator of factors that promote motility, such as 
flagella, and is a positive regulator of factors that promote surface attachment, including 
extracellular matrix components, pili, and other adhesins [189, 191, 192]. C-di-GMP is 
well-noted as a positive regulator of biofilm formation. C-di-GMP also plays a role in 
sensing and responding to surface contact. Several studies have shown that 
intracellular c-di-GMP levels increase with surface contact in several bacteria [113, 193-
195]. Additionally, c-di-GMP regulated factors like flagella and TFP have a role in 
surface sensing in many bacteria. For example, flagella can mediate transient 
attachment to a surface in many species including Pseudomonas aeruginosa [196]. This 
contact via flagella can begin a signal cascade involving c-di-GMP that results in the 
production of factors including TFP and exopolysaccharides that tether the cell to the 
surface [193, 197]. Caulobacter crescentus utilizes a similar mechanism of reinforcing 
transient, flagellar surface attachment with adhesins through a signal cascade involving 
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c-di-GMP [198]. Attachment to a surface is a key step in colonization, tissue invasion, 
and biofilm formation.  
Numerous bacterial pathogens utilize c-di-GMP signaling pathways to control the 
production of virulence factors [192, 199]. In P. aeruginosa, c-di-GMP is a negative 
regulator of the type III secretion system (T3SS), a major virulence determinant that 
delivers toxic effector proteins to host cells [200, 201]. Furthermore, c-di-GMP positively 
regulates the type VI secretion system (T6SS). The T6SS contributes to interbacterial 
killing and is associated with chronic infection [202-204]. C-di-GMP also regulates the 
production of cholera toxin by Vibrio cholerae, which drives pathogenesis [205]; the 
production of the Dot/ICM type IV secretion system in Legionella pneumophila, which is 
required for intracellular growth of the bacteria [206]; and T3SS effector production in S. 
enterica serovar Typhimurium, which contributes to host cell invasion [207, 208]. 
Together, these examples convey the important role that c-di-GMP plays in the 
virulence of many bacterial pathogens. 
Not only is c-di-GMP a regulator of virulence factors in bacteria, but it can also 
modulate the host immune response. Karaolis et al. found that the administration of c-
di-GMP to mice before infection with Staphylococcus aureus significantly reduced 
bacterial burden but did not affect bacterial growth in vitro [209]. Administration of c-di-
GMP in the absence of bacteria increased monocyte and granulocyte recruitment and 
activated proinflammatory signals in dendritic cells and macrophages. McWhirter et al. 
demonstrated that c-di-GMP is sensed via a cytosolic surveillance pathway [210]. Two 
host proteins have been shown to bind c-di-GMP and initiate an inflammatory response 
[211]. STING, a protein found on the endoplasmic reticulum, binds c-di-GMP and 
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initiates a type 1 interferon (IFN) response. The host protein DDX41 also binds c-di-
GMP and contributes to an IFN response, though this role may be dependent on 
STING. Binding of c-di-GMP to DDX41 promotes the interaction of DDX41 with STING, 
potentially increasing the affinity of STING for c-di-GMP and potentiating the 
inflammatory response. While the pro-inflammatory effects of c-di-GMP are well 
established, it is unclear how c-di-GMP becomes extracellular to the bacterium. It is 
possible that c-di-GMP exits bacteria through non-specific transporters [212]. 
Alternatively, it may be released as a consequence of bacterial cell death and lysis. The 
conditions under which this is relevant for infection are unclear. 
 C-di-GMP is synthesized from two GTP molecules by diguanylate cyclases 
(DGCs), which often act as homodimers. DGCs contain a GGDEF domain containing 
the active site necessary for c-di-GMP synthesis. C-di-GMP is degraded by 
phosphodiesterases (PDEs), which contain either EAL or HD-GYP domains for 
hydrolysis. The activity of these enzymes is often regulated through signal input 
domains, such as PAS or REC response regulator domains. Through these domains, c-
di-GMP metabolic enzymes can respond to environmental signals, and the opposing 
activities of these enzymes modulate intracellular c-di-GMP concentrations [213-216]. 
For example, the DGC WspR in Pseudomonas aeruginosa becomes phosphorylated at 
its REC domain in response to surface contact [217]. As a result, phosphorylated WspR 
oligomerizes at the cell poles and synthesizes c-di-GMP [218]. Proteins can also 
contain both GGDEF and EAL domains [216, 219]. Often, one of these domains is 
degraded such that it has lost catalytic activity but can still bind c-di-GMP and regulate 
activity of the enzyme.  
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 C-di-GMP receptors include both proteins and RNA riboswitches. Several c-di-
GMP binding protein domains have been identified [220, 221]. This includes degenerate 
GGDEF and EAL domains as previously mentioned, which can regulate the activity of 
the c-di-GMP receptor. PilZ domains are a well-characterized c-di-GMP binding domain 
found in many bacteria [222]. PilZ domains canonically contain two conserved motifs: 
an arginine rich motif (RXXXR) and a (D/N)XSXXG motif within a β-barrel. This domain 
can be found alone or in conjunction with other domains. Single-domain PilZ proteins 
are thought to function as adaptor proteins, interacting with and regulating the function 
of proteins that don’t directly bind c-di-GMP. PilZ domains can also be found alongside 
a multitude of domains with diverse functions, regulating their function through c-di-
GMP. For example, YcgR-like proteins, found in diverse bacteria including E. coli and 
Bacillus subtilis, contain an N-terminal β-barrel domain and C-terminal PilZ domain 
[222-225]. In response to c-di-GMP binding, the N-terminal domain interacts with 
flagellar motor or stator proteins, resulting in the modulation of motility. In several 
proteins, a binding site for another nucleotide has evolved to bind c-di-GMP, such as 
FleQ in P. aeruginosa and Clp in E. coli [220]. 
 C-di-GMP can also bind riboswitches, which are secondary structures that 
form in the 5’ untranslated region (5’UTR) of RNA transcripts [226, 227]. Riboswitches 
consist of an aptamer domain, which binds a ligand, and an expression platform, which 
regulates transcription or translation of the mRNA. Ligand binding to the aptamer 
causes a change in conformation, leading to regulatory changes through the expression 
platform. For example, in the absence of a ligand, the expression platform can form a 
transcriptional terminator. Binding of the ligand to the aptamer can cause a 
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conformational change, abolishing the terminator and allowing transcription to continue. 
Alternatively, the expression platform may permit transcription in the absence of ligand, 
and binding results in the formation of a transcriptional terminator. Riboswitches can 
also regulate translation by altering the availability of the ribosomal binding site (RBS) 
through conformational changes in the RNA secondary structure. Lee et al. 
demonstrated that a c-di-GMP riboswitch regulated the spliced products of an allosteric 
ribozyme [228]. In the presence of c-di-GMP, the ribozyme splices such that the product 
contains an RBS and start codon, allowing translation. In the absence of c-di-GMP, an 
alternate secondary structure forms such that the spliced product is lacking an RBS. 
These examples demonstrate that riboswitches can function in many different ways. As 
detailed in the next section, riboswitches appear to be the primary receptors of c-di-
GMP leading to transcriptional and physiological changes in C. difficile. 
The specificity of c-di-GMP signaling is an area of great interest within the field. 
Many bacteria that utilize c-di-GMP signaling encode multiple DGCs and PDEs, and 
these proteins can have specific roles in the regulation of individual factors, even within 
bacteria encoding multiple c-di-GMP effectors [229]. One mechanism underlying this is 
differences in effector c-di-GMP binding affinity. C-di-GMP effectors can have vastly 
different binding affinities such that they effectively become activated at different 
thresholds of c-di-GMP concentrations. For example, Pultz et al. demonstrated that 
PilZ-domain proteins within both S. enterica serovar Typhimurium and P. aeruginosa 
had vastly different binding affinities, and altering this binding affinity changed the 
phenotypic response to c-di-GMP [230]. Another mechanism that contributes to c-di-
GMP signaling specificity includes interactions between the DGC or PDE and the 
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effector. For example, a DGC can cause a local increase in c-di-GMP concentrations 
such that a co-localized effector, but not a distal effector, can respond. For example, the 
P. fluorescens DGC GcbC directly binds the effector LapD [231, 232]. LapD contains a 
degenerate EAL domain that binds c-di-GMP, activating the protein and contributing to 
biofilm formation [233, 234]. Furthermore, this interaction occurs regardless of c-di-GMP 
production by GcbC, suggesting that c-di-GMP can be quickly produced and sensed 
within this preformed complex [231, 232]. These studies indicate that c-di-GMP 
signaling is dynamic with both global and specific regulatory roles. 
C-di-GMP signaling in C. difficile 
C-di-GMP is a key regulator in C. difficile [235]. Transcriptome analysis of a 
strain overexpressing a DGC revealed 166 genes that are differentially regulated in 
response to elevated c-di-GMP levels [236]. C-di-GMP promotes aggregation, biofilm 
formation, adherence to mammalian cells, and surface motility in C. difficile [113-115, 
237]. These phenotypes may in part be due to the regulation of TFP, which contribute to 
these behaviors as discussed above. However, TFP-deficient mutants still exhibit 
increased biofilm formation and adherence, suggesting other c-di-GMP-regulated 
factors at play [113, 115]. C-di-GMP regulates multiple known or putative adhesins, and 
several of these have been demonstrated to increase biofilm formation when 
overexpressed [236]. Additionally, c-di-GMP is a negative regulator of the flagellar 
biosynthetic operons [101, 104, 237]. Overexpression of a DGC inhibits swimming 
motility. Because toxin gene expression is linked to flagellar gene expression through 
the alternate sigma factor SigD, c-di-GMP also negatively regulates the expression of 
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tcdA and tcdB [101, 104]. Therefore, c-di-GMP is an important regulator of known and 
putative virulence factors of C. difficile. 
C. difficile has a large c-di-GMP network including 37 genes encoding predicted 
DGCs and PDEs, consisting of nearly 1% of its total genome [238, 239]. Based on two 
separate studies expressing these genes in heterologous bacteria, 28 DGCs and PDEs 
have been demonstrated to be enzymatically active. Several of these proteins, including 
some not found to be active, contain both GGDEF and EAL domains, suggesting that 
they may be c-di-GMP receptors. However, the regulation and function of specific DGCs 
and PDEs is largely unknown. The exception is PdcA, an EAL-domain PDE that also 
contains a PAS domain and a degenerate GGDEF domain [120]. Removal of the PAS 
and GGDEF domains decreased enzyme activity, suggesting that these domains 
regulate the EAL domain activity. Expression of pdcA is regulated by CodY, a global 
transcription factor that represses gene expression during nutrient-rich conditions such 
as exponential phase. Consistent with this, pdcA is expressed during the stationary 
phase of growth. Additionally, PdcA activity is regulated by GTP, which is more 
abundant during stationary phase. A pdcA mutant strain had decreased toxin production 
and cytotoxicity against a mammalian cell line as well as increased biofilm formation. 
However, loss of PdcA had no effect on swimming motility or on total intracellular c-di-
GMP levels. These data indicate that PdcA has a specific role in c-di-GMP signaling, 
modulating only a subset of c-di-GMP regulated processes through an unknown 
mechanism. PdcA is only one of many c-di-GMP metabolizing proteins in C. difficile 
which likely also have specific signaling roles and patterns of activation. 
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No c-di-GMP binding protein effectors have been demonstrated in C. difficile, 
though TFP ATPase PilB1 has a predicted c-di-GMP binding MshEN domain [240]. 
However, Soutourina et al. identified and confirmed the expression of 16 c-di-GMP 
riboswitches in strain 630Δerm [241]. Mckee et al. confirmed that 11 of these are 
functional and differentially regulate downstream genes in response to altered c-di-GMP 
levels [236]. Seven riboswitches are class I and negatively regulate gene expression 
while four are class II and positively regulation expression. Therefore, it seems that 
riboswitches are the primary mechanism by which c-di-GMP signals in C. difficile. 
Several of these riboswitches have been characterized. One riboswitch, Cdi-2-4, 
regulates the major pilin gene pilA1 and is therefore responsible for the regulation of 
TFP by c-di-GMP. Cdi-2-4 positively regulates pilA1; binding of c-di-GMP to this 
riboswitch abrogates the formation of a transcriptional terminator [113, 114]. The Cdi-1-
3 riboswitch is directly upstream of flgB and the early stage flagellar operon. This 
riboswitch, when bound to c-di-GMP, negatively regulates expression of flagellar genes 
as well as toxin genes through SigD. The early stage flagellar operon is also phase 
variably regulated by an invertible element. Under basal c-di-GMP levels, the Cdi-1-3 
riboswitch permits transcription and therefore the invertible element is the determinant 
of flagellar gene expression. However, when the riboswitch binds c-di-GMP, 
transcription is prematurely terminated regardless of the orientation of the invertible 
element. Therefore, the production of flagella and toxins are regulated by both c-di-GMP 
and phase variation. 
33 
SUMMARY 
 Many aspects of C. difficile biology and pathogenesis remain poorly understood. 
Several factors contribute to this lack of information. C. difficile has only emerged as a 
major public health threat in recent decades [1]. Additionally, as suggested by its name, 
C. difficile can be difficult to culture as an obligate anaerobe, and many techniques 
utilized with oxygen-tolerant microbes do not function in anaerobic environments [242, 
243]. C. difficile is not naturally competent and was considered to be genetically 
intractable until recent years; the first plasmids were not conjugated into this organism 
until 2002 and the first targeted gene disruption was not created until 2006 [244-247]. 
Advances in the field have allowed new insights into C. difficile physiology, but large 
gaps in our understanding remain, including many key aspects of virulence and the 
regulatory strategies that allow adaptation and persistence in infection.  
Recent studies have identified that with multiple invertible DNA elements, C. 
difficile is capable of considerable phenotypic heterogeneity, but the extent and impact 
of this heterogeneity is unclear [138, 185]. This work began with the goal of 
characterizing one visible sign of phenotypic heterogeneity, colony morphology. We 
observed that C. difficile strains from multiple ribotypes form two distinct colony 
morphologies, the cause and significance of which were unknown. In this work, we 
characterized the operon colony morphology regulator cmrRST, its role in multiple 
aspects of C. difficile physiology, and its regulation. This operon encodes a putative two 
component regulatory system including a sensor kinase (CmrS) and two DNA-binding 
response regulators (CmrR and CmrT). We show that cmrRST is subject to a complex 
and hierarchical network of regulation including phase variable regulation by an 
invertible DNA element as well as regulation c-di-GMP signaling through a riboswitch. 
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We describe the role of CmrRST in colony morphology, swimming motility, biofilm 
formation, and a previously unknown mechanism of cellular migration. In an animal 
model of CDI, we find that CmrRST has a role in virulence and that cmrRST undergoes 
phase variation in vivo. Finally, we present data describing the transcriptional profiles of 
CmrR and CmrT, allowing further investigation into the unique roles of each response 
regulator and the novel mechanisms by which they regulate motility. cmrRST as well as 
its upstream regulatory elements are highly conserved across C. difficile strains and 
ribotypes. Therefore, understanding the important role that this phase variable operon 
plays in C. difficile physiology may provide crucial information about the factors and 
regulatory strategies that contribute to pathogenesis. 
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CHAPTER 2: PHASE VARIATION OF A SIGNAL TRANSDUCTION SYSTEM 




Phenotypic heterogeneity within bacterial populations is a widely established 
phenomenon that allows the population to survive sudden environmental changes [248-
250]. Heterogeneity serves as a “bet-hedging” strategy such that a subpopulation can 
persist and propagate an advantageous phenotype. Phase variation is one mechanism 
that imparts phenotypic heterogeneity, typically by controlling the ON/OFF production of 
a surface-exposed factor that directly interfaces with the environment [136, 158]. Many 
human pathogens, including pathogenic Escherichia coli, Neisseria meningitidis, and 
Streptococcus pneumoniae, employ phase variation to evade the host immune system 
and increase host colonization, persistence, and virulence [136, 164, 251-257]. Phase 
variable phenotypes are heritable yet reversible, allowing the surviving subpopulation to 
regenerate heterogeneity. In phase variation by conservative site-specific 
recombination, a serine or tyrosine recombinase mediates the inversion of a DNA 
sequence adjacent to the regulated gene(s) [158]. The invertible DNA sequences are 
 
1 This chapter previously appeared as an article in the journal PLoS Biology. Figure numbers have been 
modified. The original citation is as follows: Garrett EM, Sekulovic O, Wetzel D, Jones JB, Edwards AN, 
Vargas-Cuebas G, McBride SM, Tamayo R. (2019) Phase variation of a signal transduction system 
controls Clostridioides difficile colony morphology, motility, and virulence. PLoS Biol 17(10): e3000379. I 
generated all data with the exception of those found in Fig. 2.13A-B and Fig. S2.14A-B. I wrote and edited 
the original manuscript with feedback from Rita Tamayo as well revised it in response to reviewer 
comments. 
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flanked by inverted repeats and contain the regulatory information, such as a promoter, 
that when properly oriented controls gene expression in cis. 
Clostridioides difficile (formerly Clostridium difficile) is a gram-positive, spore-
forming, obligate anaerobe and a significant public health burden globally, causing 
gastrointestinal disease ranging from diarrhea to potentially fatal complications such as 
pseudomembranous colitis, toxic megacolon, bowel perforation, and sepsis. C. difficile 
pathogenesis is primarily driven by the toxins TcdA and TcdB, which inactivate host 
Rho-family GTPases resulting in actin cytoskeleton dysregulation, tight junction 
disruption, and host cell death; consequently, TcdA and TcdB compromise the epithelial 
barrier and elicit diarrheal symptoms and inflammation [78, 258, 259]. Many aspects of 
C. difficile physiology and pathogenesis remain poorly understood. For example, some 
Clostridioides species, including C. difficile, are capable of forming two distinct colony 
morphologies; one is smooth and circular, and the other is rough and filamentous [103, 
260-262]. However, the underlying mechanisms and physiological relevance of this 
dimorphism are unknown. Many bacterial species develop multiple colony morphologies 
as a result of the regulated production of surface factors, which can impact diverse 
physiological traits and behaviors [263-268]. In multiple species, the production of 
surface factors is subject to phase variation, leading to changes in gross colony 
morphology. In S. pneumoniae and Acinetobacter baumannii, phase variation of 
capsule polysaccharides leads to the formation of either opaque or translucent colonies 
that differ in a multitude of phenotypes including cell morphology, biofilm formation, 
antibiotic sensitivity, host colonization, and virulence [251, 253, 256, 266, 268, 269]. 
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Phase variation of colony morphology is therefore an important adaptive strategy during 
infection for multiple pathogens.  
The biological significance and mechanisms underlying colony morphology 
development of C. difficile have not been reported. C. difficile encodes multiple factors 
that are regulated through phase variation. In C. difficile, eight invertible DNA 
sequences, or “switches”, have been identified, seven of which are present in the 
epidemic strain R20291 [138, 185]. Two have been characterized: one controlling phase 
variation of the cell wall protein CwpV and the other controlling flagellar phase variation 
[103, 181, 184, 270]. The phase variable flgB flagellar operon encodes the sigma factor 
SigD, which coordinates flagellar gene expression and positively regulates the tcdA and 
tcdB toxin genes [101, 102, 237]. Consequently, the flagellar switch mediates phase 
variation of flagella and toxin production, highlighting the potential impact of phase 
variation on C. difficile physiology and virulence.  
As in many bacteria, the intracellular signaling molecule c-di-GMP regulates the 
transition between community-associated and planktonic, motile lifestyles of C. difficile 
[113, 114, 120, 235, 237]. This regulation occurs in part through direct control of gene 
expression by c-di-GMP via riboswitches [236, 241, 271, 272]. For example, a c-di-GMP 
riboswitch lies in the 5’ leader sequence of the flgB operon and causes transcription 
termination when c-di-GMP is bound, thus inhibiting swimming motility [104, 236, 271]. 
Because flagellum and toxin gene expression is linked through SigD, c-di-GMP also 
inhibits toxin production [101, 104]. Conversely, a c-di-GMP riboswitch upstream of the 
Type IV pilus (TFP) locus allows c-di-GMP to positively regulate gene expression and 
promote TFP-dependent behaviors such as autoaggregation, surface motility, biofilm 
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formation, and colonization of host tissues [104, 113-115, 120, 237]. Additionally, c-di-
GMP regulates the expression and cell wall anchoring of surface proteins and adhesins 
[228, 241, 273]. Therefore, c-di-GMP coordinates the expression of multiple surface 
factors with implications for pathogenesis.  
In this study, we characterized rough and smooth colony isolates of C. difficile 
R20291 and determined that they exhibit distinct motility behaviors in vitro. Colony 
morphology and associated motility phenotypes are controlled by both phase variation 
and c-di-GMP, and colony morphology is independent of TFP and flagella. We identified 
the c-di-GMP regulated, phase-variable signal transduction system, consisting of a 
putative histidine kinase and two DNA-binding response regulators, that modulates 
colony morphology, surface migration, and swimming motility. Finally, we provide 
evidence using a hamster model of infection for phase variation and a role for the 
CmrRST system in virulence. The link between phase variation and c-di-GMP signaling 
to control CmrRST production suggests a mechanism for switching a global expression 
program during infection, which appear to have critical implications for disease 
development.  
 
MATERIALS AND METHODS 
Growth and maintenance of bacterial strains 
C. difficile strains were maintained in an anaerobic environment of 85% N2, 5% CO2, 
and 10% H2. C. difficile strains were cultured in Tryptone Yeast (TY; 30 g/liter Bacto 
tryptone, 20 g/liter yeast extract, 1 g/liter thioglycolate) broth or Brain Heart Infusion plus 
yeast (BHIS; 37 g/liter Bacto brain heart infusion, 5 g/liter yeast extract) media at 37 °C 
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with static growth. Escherichia coli strains were grown in Luria Bertani medium at 37 °C 
with aeration. Antibiotics were used where indicated at the following concentrations: 
chloramphenicol (Cm), 10 µg/mL; thiamphenicol (Tm), 10 µg/mL; kanamycin (Kan), 100 
µg/mL; ampicillin (Amp), 100 µg/mL. Table S1 lists descriptions of the strains and 
plasmids used in this study. 
 
Differentiation of rough and smooth colonies 
To differentiate rough and smooth colonies from wild-type C. difficile strains, 5 µL of 
liquid cultures were spotted onto BHIS agar plates and grown for 48-72 hours. For 
rough and smooth colonies, all growth was collected and plated in dilutions on BHIS 
agar. For predominantly rough colonies, growth was collected from the filamentous 
edges [237, 261]. For predominantly smooth colonies, growth was collected from the 
center of the spot (our stock of C. difficile R20291 consists primarily of bacteria yielding 
smooth colonies, so the spot center represents the inoculum). For enumeration of rough 
and smooth colonies, serial dilutions were plated, rough and total colony forming units 
(CFU) were counted, and data were expressed as percent rough CFU.  
 
Microscopy 
For whole colony imaging, colonies were grown on BHIS plates for 24 hours prior to 
imaging. For strains containing plasmids, the BHIS agar medium contained 10 µg/mL 
Tm. For strains carrying pDccA, pDccAmut, pEAL, or pMC-Pcpr, 2 µg/mL nisin was 
included to induce gene expression. For strains with pCmrR, pCmrT, or mutant 
derivatives, anhydrotetracycline (ATc) was added at the indicated concentrations. 
40 
Colonies were imaged at 2-8x magnification using a Zeiss Stereo Discovery V8 
dissecting microscope with a glass stage and light from the top. 
 For imaging of motile spots, R20291 WT, ΔcmrR, ΔcmrT, and pilB1-null strains 
were grown overnight in BHIS and then spotted on BHIS 1.8% agar 1% glucose. After 
72 hours of growth, colonies were images using a Keyence BZ-X810 microscope. 
For Gram stain imaging, R20291 WT rough or smooth, ΔcmrR, or ΔcmrT 
colonies were differentiated as previously described and heat fixed on a glass slide. 
Cells were Gram-stained (BD Kit 212524) and visualized at 40-80x magnification using 
an Olympus BX60 compound microscope or a Keyence BZ-X810 microscope. For 
quantification of cell length, at least two images from two biological replicates were 
analyzed using ImageJ. 
For visualization by scanning electron microscopy, R20291 rough and smooth 
isolates and the sigD mutant were grown overnight in TY broth and washed once with 
phosphate buffered saline (PBS). For visualization of colony structure, R20291 was 
spotted on BHIS agar and grown for 3 days. The colony was excised on agar and fixed. 
All samples were fixed in 4% glutaraldehyde in 150 mM sodium phosphate buffer. The 
samples were dehydrated through increasing concentrations of ethanol and dried using 
carbon dioxide as the transition solvent in a Samdri-795 critical-point dryer (Tousimis 
Research Corporation, Rockville, MD). Coverslips were mounted on aluminum stubs 
with carbon adhesive tabs, followed by a 5-nm thickness platinum sputter in a Hummer 
X sputter coater (Anatech USA, Union City, CA). Images were taken with a working 
distance of 5 mm and a 130-μm aperture using a Zeiss Supra 25 field emission 
scanning electron microscope (FESEM) operating at 5 kV (Carl Zeiss SMT Inc., 
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Peabody, MA). For quantification of cell length, at least seven images from two 
biological replicates were analyzed using ImageJ. 
 
Quantitative PCR analysis of invertible element orientations 
Quantitative PCR (qPCR) was used to quantify the percent of the population with each 
of the seven invertible elements in a given orientation as described previously [138]. 
Rough and smooth colonies were collected from a BHIS plate, and genomic DNA was 
purified. qPCR was performed with SensiMix SYBR (BioLine). Twenty μL reactions with 
100 ng of genomic DNA and 100 nM primers were used. Reactions were run on 
Lightcycler 96 system (Roche) with the following three-step cycling conditions: 98°C for 
2 min, followed by 40 cycles of 98°C for 30 s, 60°C for 1 min, and 72°C for 30 sec. 
Quantification was done using the ΔΔCT method, with rpoA as the reference gene and 
the indicated reference condition [138]. All primers used in this and other experiments 
are listed in Table S2. 
 
Construction of ∆cmrR and ∆cmrT in C. difficile R20291 
Markerless deletions of cmrR (locus tag CDR20291_3128) and cmrT (locus tag 
CDR20291_3126) were done using a previously described codA-based allelic exchange 
method with minor modifications [63]. Briefly, approximately 1100-1300 bp genomic 
fragments were PCR-amplified upstream and downstream of cmrR and cmrT with the 
following primers sets: OS158 and OS266 (cmrR, upstream), OS163 and OS267 (cmrR, 
downstream); OS268 and OS269 (cmrT, upstream), OS271 and OS283 (cmrT, 
downstream). Complementary overlapping sequences were added to the 5-prime end of 
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primers to allow for accurate fusion of all PCR products into PmeI-linearized pMTL-
SC7215 vector using Gibson Assembly Master Mix (New England BioLabs). The 
resulting plasmids were then conjugated into C. difficile R20291 strain (GenBank 
accession: CBE06969.1) using the heat-stimulated conjugation method described 
elsewhere [274]. Mutants were selected as previously described and screened by 
colony-PCR for the presence of the correct left and right homology-chromosomal 
junction and the absence of respective cmrR and cmrT coding sequence [63]. All PCR 
products were Sanger-sequenced to confirm the correct genetic construct and the 
absence of any secondary mutations. 
 
Surface and swimming motility assays 
For surface motility assays, 5 µL of overnight (16-18hr) cultures were spotted onto 
BHIS-1.8% agar supplemented with 1% glucose [235]. For swimming motility assays, 1 
µL of overnight cultures was inoculated into 0.5x BHIS-0.3% agar [103]. For plasmid-
bearing strains in both assays, the medium was supplemented with 10 µg/mL Tm. 
Where indicated, ATc was included at the indicated concentrations to induce 
expression. At 24 hour intervals the diameters of growth were taken as the average of 
two perpendicular measurements. For measurements of surface colony diameters, the 
first measurement corresponds to the widest part of the colony including any tendrils, 
and a perpendicular measurement regardless of the presence of a tendril. These values 
were averaged and used as the colony diameter as described previously [113]. Data 
from at least 8 biologically independent cultures were analyzed using a one-way 
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ANOVA to determine statistical significance. The plates were photographed using a 
Syngene G:Box imager. 
 
Biofilm Assay 
Biofilm assays were done as previously described [120]. Overnight cultures of C. difficile 
were diluted 1:100 in BHIS 1% glucose 50 mM sodium phosphate buffer (pH 7.5) in 24-
well polystyrene plates. After 24 hours of growth, supernatants were removed, the 
biofilms were washed once with PBS and then stained for 30 minutes with 0.1% crystal 
violet. After 30 minutes, the biofilms were washed again with PBS, and the crystal violet 
was solubilized with ethanol. Absorbance was read at 570 nm. Four independent 
experiments were performed.  
 
RNA isolation and real-time PCR 
For quantitative real-time PCR (qRT-PCR) analysis of flagellar gene expression, C. 
difficile with vector or cmrR/cmrT expression plasmids was grown for 48 hours in 0.5x 
BHIS-0.3% agar to express flagellar genes. Bacteria were recovered and cultured in TY 
broth with 10 ng/mL ATc for vector and pCmrR; 2 ng/mL ATc for pCmrT. For qRT-PCR 
analysis of toxin gene expression, C. difficile with vector or cmrR/cmrT expression 
plasmids were grown overnight in TY broth and diluted into BHIS broth with 10 ng/mL 
ATc for vector and pCmrR; 2 ng/mL ATc for pCmrT. For both experiments, samples 
were collected at mid-exponential phase and preserved in 1:1 ethanol-acetate. For qRT-
PCR analysis of cmrR and cmrT transcript abundance in rough and smooth isolates, 
rough and smooth colonies were differentiated as described above and streaked on 
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BHIS agar. After 24 hours growth, colonies were collected and preserved in 1:1 ethanol-
acetate.  
 RNA was isolated, treated with DNase I, and reverse transcribed including a no-
reverse transcriptase control as previously described [184, 237]. Real-time PCRs were 
done using 2 ng of cDNA, primers at a final concentration of 500 nM, and SYBR Green 
Real-Time qPCR reagents (Thermo Fisher) with an annealing temperature of 55°C. 
Primers used were as follows: R856-R857, flgB; R858-R859, flgM; R1063-R1064, fliC; 
R930-R931, pilA1; R852-R853, tcdA; R2298-R2299, cmrR; and R2537-R2538, cmrT). 
The data were analyzed using the ΔΔCt method with rpoC (R850-R851) as the 
reference gene [103]. 
 
Animal experiments 
All animal experimentation was performed under the guidance of veterinarians and 
trained animal technicians within the Emory University Division of Animal Resources 
(DAR). Animal experiments were performed with prior approval from the Emory 
University Institutional Animal Care and Use Committee (IACUC). C. difficile spores 
were collected from 70:30 sporulation broth after 3 days of growth [275]. The spores 
were purified using a sucrose gradient and stored in PBS with 1% bovine serum 
albumin as described previously [115, 276]. Prior to inoculation, the spores were 
enumerated by plating serial dilutions on BHIS-agar containing 0.1% sodium 
taurocholate. 
Male and female Syrian golden hamsters (Mesocricetus auratus, Charles River 
Laboratories) were housed individually in sterile cages and given a standard rodent diet 
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and water ad libitum. To render the animals susceptible to C. difficile, one dose of 
clindamycin (30 mg kg−1 of body weight) was administered by oral gavage seven days 
prior to inoculation. Hamsters were inoculated with ~5000 spores of a single strain of C. 
difficile [276, 277]. Uninfected controls treated with clindamycin were included in each 
experiment. Hamsters were weighed at least daily and monitored for signs of disease 
(weight loss, lethargy, diarrhea and wet tail). Fecal samples were collected daily for 
determination of bacterial burden (see below). Hamsters were considered moribund if 
they lost 15% or more of their highest weight or if they showed disease symptoms of 
lethargy, diarrhea and wet tail. Animals meeting either criterion were euthanized by 
CO2 asphyxiation and thoracotomy. Immediately following euthanasia, animals were 
necropsied, and cecal contents were obtained for enumeration of total C. difficile CFU 
and for subsequent DNA isolation. To enumerate C. difficile CFU, fecal and cecal 
samples were weighed, suspended in 1X PBS, heated to 60°C for 20 min to minimize 
growth of other organisms, and plated on taurocholate cycloserine cefoxitin fructose 
agar (TCCFA; [278, 279]). C. difficile CFU were enumerated after 48 hours. Six animals 
(3 male, 3 female) per C. difficile strain were tested, and the data were analyzed using 
GraphPad Prism. 
 
Semi-quantitative PCR and qPCR analysis of DNA from hamster cecums 
Hamster cecal contents in PBS were treated with lysozyme and subjected to bead 
beating to lyse spores. DNA was purified by phenol:chloroform:isopropanol extraction 
and washed with ethanol. For semi-quantitative PCR, 0.5 ng DNA per 50 µL reaction 
was PCR amplified using 0.5 μM orientation-specific primers to detect the orientation of 
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the cmr switch (Cdi6): RT2378-RT2379 for the ON orientation; RT2378-RT2197 for the 
OFF orientation. For qPCR, 4 ng DNA per 20 µL reaction was used with 0.5 μM 
orientation-specific primers. 
 
Sporulation assays  
C. difficile cultures were grown in BHIS medium supplemented with 0.1% taurocholate 
and 0.2% fructose until mid-exponential phase (i.e., OD600 of 0.5), and 0.25 ml aliquots 
were plated onto 70:30 agar supplemented with 2 µg/ml thiamphenicol [275]. After 24 h 
growth, ethanol resistance assays were performed as previously described [280, 281]. 
Briefly, the cells were removed from plates after 24 h (H24) and suspended in BHIS 
medium to an OD600 of ~1.0. The number of vegetative cells per milliliter was 
determined by immediately serially diluting and plating the suspended cells onto BHIS. 
Simultaneously, a 0.5-ml aliquot was added to 0.3 ml of 95% ethanol and 0.2 ml of dH2O 
to achieve a final concentration of 28.5% ethanol, vortexed, and incubated for 15 min to 
eliminate all vegetative cells; ethanol-treated cells were subsequently serially diluted in 
1× PBS with 0.1% taurocholate and applied to BHIS plus 0.1% taurocholate plates to 
determine the total number of spores. After at least 24 h of growth, CFU were 
enumerated, and the sporulation frequency was calculated as the total number of 
spores divided by the total number of viable cells (spores plus vegetative cells). 
A nonsporulating mutant (MC310; spo0A::erm) was used as a negative control. 
Germination assays 
C. difficile strains were grown in 500-ml liquid 70:30 medium and spores were purified 
for germination studies as previously described, with some modifications [277, 282-
47 
284]. Cultures in sporulation medium were removed from the anaerobic chamber after 
120 h of anaerobic growth and kept outside of the chamber in atmospheric oxygen 
overnight. Spore cultures were collected by centrifugation, suspended in water, and 
frozen for 15 min at -80°C. After thawing, spore suspensions were centrifuged for 10 
min at ~3200 x g in a swing bucket rotor, and the supernatant was discarded. Spore 
pellets were washed two times with water then suspended in 1 ml of a 1x PBS + 1% 
BSA solution, applied to a 12 ml 50% sucrose bed volume, and centrifuged at ~3200 x g 
for 20 min. The supernatant was decanted and the spores were checked by phase-
contrast microscopy for purity. Sucrose gradients were repeated until the preparations 
reached a purity of greater than 95%. Spore pellets were then washed three times with 
1x PBS + 1% BSA and suspended to an OD600 = 3.0. Germination assays were carried 
out as previously described, with slight modifications [282, 283]. After treatment of 
spores for 30 min at 60°C, spore germination was analyzed in BHIS containing 10 mM 
taurocholate and 100 mM glycine. The OD600 was determined immediately and at 
various time points during incubation at room temperature. Results are presented as 
means and standard errors of the means of three independent biological replicates.  
 
Detection of TcdA by western blot 
Rough and smooth isolates as well as cmrR and cmrT mutants were grown for 24 hours 
in TY broth and normalized to OD600 ~ 1.8 prior to collection. Cells were pelleted, 
suspended in SDS-PAGE buffer, and boiled for 10 minutes. Samples were then run on 
4–20% Mini-PROTEAN TGX Precast Protein Gels (Bio Rad) and transferred to a 
nitrocellulose membrane. Membranes were stained with Ponceau S stain (Sigma 
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Aldrich) to assess sample loading. TcdA was detected as described previously using a 
mouse α-TcdA primary antibody (Novus Biologicals) and goat anti-mouse IgG 
conjugated with IR800 (Thermo Fisher) [42]. 
 
RESULTS 
C. difficile strains of diverse ribotypes develop two distinct, phase-variable 
colony morphotypes 
The C. difficile strain R20291, a ribotype 027 strain associated with epidemic 
infections, exhibits two distinct colony morphologies: a “smooth” colony that is round 
and circular, and a “rough” colony that is flatter and has filamentous edges [103, 261, 
262]. In addition to R20291, strains UK1 (ribotype 027), VPI10463 (ribotype 087), 630 
(ribotype 012), and ATCC 43598 (ribotype 017) yielded both rough and smooth colonies 
(Figure 2.1). Some of these strains (R20291 and UK1) showed both colony 
morphotypes through routine plating, while others (630) required extended incubation to 
allow the appearance of bacteria that develop rough colonies. ATCC BAA 1875 
(ribotype 078) did not develop smooth colonies under any conditions tested. Therefore, 
many strains are capable of generating two distinct colony morphologies in vitro. 
We and others previously observed that spotting a culture of C. difficile R20291 
on an agar surface results in expansion of the colony as dendritic, filamentous growth 
[237, 261]. We discovered that this culturing method allows the segregation of the two 
colony morphologies. Streaking from the center of the colony yielded a population of 
predominantly smooth colonies, while streaking from the edges yielded a population of 
predominantly rough colonies (Figure 2.2A). To evaluate the stability of the colony 
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phenotypes, we passaged rough and smooth colonies through multiple growth 
conditions. Streaking a rough or smooth colony again onto agar medium resulted in 
overall maintenance of the original morphology (Figure 2.2A,C), indicating that colony 
morphology is heritable and generally stable under specific growth conditions. Similarly, 
the starting morphology was maintained when the isolates were passaged in broth 
(Figure 2.2C). Because surface growth promoted the development of the rough 
morphotype, we speculated that conditions favoring swimming motility might yield 
smooth colonies. Rough and smooth colonies were inoculated into soft (0.3%) agar to 
allow for swimming motility over 48 hours (Figure 2.2B, panel 4). Growth recovered from 
the edges of the motile growth solely yielded smooth colonies, regardless of the starting 
morphology, indicating that colony morphology is reversible (Figure 2.2B,C). These data 
support that C. difficile colony morphology phase varies and reveal in vitro growth 
conditions that select for a specific phase variant: expansion of a colony on an agar 
surface favors bacteria that yield rough colonies, while swimming conditions select for 
bacteria that yield exclusively smooth colonies.  
Rough and smooth colony isolates exhibit distinct motility behaviors 
The observation that surface growth favors bacteria that develop rough colonies 
suggests that the rough morphotype has an advantage over smooth in this growth 
condition. Conversely, smooth morphotype bacteria may have an advantage over the 
rough in swimming motility. To test this, we assessed the motility behaviors of rough 
and smooth colony isolates. Expansion of colonies of “wild-type” (i.e. undifferentiated by 
colony morphology) R20291 on an agar surface is characterized by initial (~ 24 hours) 
growth restricted to the site of inoculation, then spreading tendrils of growth between 24 
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and 96 hours [113]. Type IV pili were previously shown to contribute to motility on an 
agar surface, so the non-piliated pilB1 mutant was included as a control [113, 114]. In 
this assay, bacteria isolated from rough colonies exhibited greater colony expansion 
after 48 hours compared to undifferentiated (wild type) R20291 (Figure 2.2D,E). 
Conversely, bacteria derived from smooth colonies were deficient in colony expansion 
compared to the rough isolates and more similar to the pilB1 control after 48 hours 
(Figure 2.2D,E), though the smooth isolates remained capable of colony expansion. 
Flagellum-dependent swimming motility was assayed by inoculating bacteria into 
0.3% agar and measuring migration through the medium. Undifferentiated R20291 and 
a non-motile sigD mutant served as controls [103]. Rough colony isolates showed 
significantly decreased swimming motility compared to smooth and undifferentiated 
populations (Figure 2.2F,G). Bacteria from smooth colonies showed swimming motility 
comparable to the undifferentiated parent (Figure 2.2F,G), likely because the parental 
isolate consisted primarily of bacteria that yield smooth colonies. These results indicate 
that rough and smooth colony morphotypes have distinct motility behaviors.  
Colony morphology is regulated by a phase variable signal transduction system 
and c-di-GMP 
Because colony morphology development exhibited characteristics suggestive of 
phase variation, we sought to identify the underlying mechanism. To date, the only 
known phase variation mechanism in C. difficile involves site-specific DNA 
recombination resulting in a reversible DNA inversion that is known or predicted to 
impact gene expression in cis [138]. We postulated that one of the seven known 
invertible sequences in R20291 regulates the expression of genes involved in colony 
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morphology development, which would be evident as a correlation between the 
orientation of the invertible sequence and colony morphology (Figure 2.3A). To test this 
idea, we differentiated rough and smooth populations and analyzed the orientation of 
the “switches” in these isolates using qPCR with orientation-specific primers. For six of 
the switches, no correlation between morphology and sequence orientation was 
observed (Figure 2.3B). However, the orientation of the invertible element Cdi6, which is 
upstream of the operon CDR20291_3128-3126, showed a strong correlation with colony 
morphology [138, 270]. Each of four independently isolated rough populations contained 
the sequence predominantly in the orientation previously suggested to favor gene 
expression, while each of the smooth populations contained the sequence 
predominantly in the inverse orientation [138]. CDR20291_3128-3126 encodes a 
putative phosphorelay system consisting of two predicted response regulators and a 
predicted histidine kinase [138]. Accordingly, we named the operon colony morphology 
regulators RST, where cmrR and cmrT encode the response regulators and cmrS 
encodes the histidine kinase, and we refer to the Cdi6 invertible element as the “cmr 
switch”.  
Previous work showed that expression of the cmrRST locus is heterogeneous in 
a population of C. difficile R20291, occurring in an on/off manner consistent with phase 
variation [138]. We therefore used qRT-PCR to examine the impact of the orientation of 
the cmr switch on downstream gene expression in rough and smooth isolates. 
Expression of cmrR and cmrT was significantly increased in rough isolates relative to 
smooth (Figure 2.3C). Combined with the results of orientation-specific PCR of these 
isolates, these results indicate that bacteria that yield rough colonies bear the cmr 
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switch in the “on” orientation, while the bacteria yielding smooth colonies contain the 
switch in the “off” orientation. The cmrRST locus and its upstream regulatory region 
containing the cmr switch are present in all 65 complete C. difficile genomes available 
on NCBI with > 96% identity at the nucleotide level. This high conservation across 
diverse ribotypes indicates that this regulatory system, as well as the ability to control its 
production through phase variation, is important for C. difficile fitness. 
A c-di-GMP binding riboswitch (Cdi-2-2) lies 5’ of cmrRST and the invertible 
sequence and positively regulates expression of the operon (Figure 2.3A) [236, 241]. 
Additionally, rough and smooth colony morphotypes exhibited inverse swimming and 
surface motility phenotypes, which is characteristic of c-di-GMP regulation [104, 113]. 
Therefore, we hypothesized that c-di-GMP regulates C. difficile colony morphology. 
Using a previously described strategy, intracellular c-di-GMP was increased or 
decreased by ectopically expressing genes encoding the diguanylate cyclase DccA or 
the EAL domain from PdcA, respectively [113, 237]. Expression of dccA led to the 
uniform development of rough colonies, while the expression of a catalytically inactive 
DccA (DccAmut) did not, indicating that increased c-di-GMP stimulates rough colony 
formation (Figure 2.3D). Reducing c-di-GMP through overproduction of the EAL domain 
did not impact colony morphology, possibly because basal c-di-GMP levels are already 
low [237]. To determine whether the rough colony effect results from c-di-GMP-
mediated inhibition of flagellar motility or activation of TFP-dependent surface motility, 
dccA was expressed in TFP-null (pilB1::erm) or aflagellate (sigD::erm) backgrounds. 
The pilB1 and sigD mutants remained capable of forming both smooth and rough 
colonies in unmodified and increased c-di-GMP conditions (Figure 2.3E,F). Together, 
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these results indicate dual regulation of the cmrRST locus by both phase variation and 
c-di-GMP. Furthermore, c-di-GMP regulates colony morphology through a mechanism 
independent of TFP and flagella. To distinguish the spreading colonies developed by 
rough isolate bacteria from the surface motility imparted by TFP, we refer to the 
CmrRST-mediated phenomenon as “surface migration”.  
The response regulators CmrR and CmrT regulate colony morphology  
Because activation of cmrRST expression, whether by increased c-di-GMP 
and/or inversion of the switch to the “on” orientation, promotes the development of 
rough colonies, we examined the contributions of the response regulators CmrR and 
CmrT to this process. The cmrR and cmrT genes were individually expressed under the 
control of an ATc-inducible promoter in C. difficile R20291 during growth on BHIS-agar. 
Both CmrR and CmrT stimulated rough colony formation compared to non-induced 
controls (Figure 2.4). Expression of cmrT resulted in a rough phenotype at lower levels 
of induction than cmrR. Interestingly, some levels of induction of cmrT inhibited growth, 
suggesting that cmrT expression is toxic. Growth inhibition by CmrT, but not CmrR, was 
observed in broth culture as well (Figure 2.5A,B). 
Response regulators typically have a conserved aspartic acid residue in the 
phosphoreceiver domain that, when phosphorylated, leads to activation [285]. Mutation 
of this residue to a glutamic acid often mimics phosphorylation [286, 287]. Accordingly, 
compared to cmrR expression, lower levels of induction of cmrRD52E expression were 
required for formation of rough colonies (0.5 ng/ml versus 4 ng/ml ATc, respectively; 
Figure 2.4). Instead of a conserved aspartic acid residue, CmrT contains a glutamic acid 
at the expected phosphorylation site, precluding the need for a phosphomimic 
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substitution, and potentially explaining the lower level of inducer needed to yield rough 
colonies compared to cmrR. Substitution of the phosphorylation site of CmrT with 
alanine (CmrT-D53A) increased the concentration of inducer needed to obtain rough 
colonies. However, for the wild type and CmrR-D52A mutant, comparable levels of 
inducer (4 ng/mL ATc) resulted in rough colonies; this may be due to the need for an 
activating signal that is absent in these assay conditions. That the inactivating mutations 
did not abolish CmrR and CmrT function suggests that phosphorylation is not required 
for the activity of these response regulators if they are expressed at high levels.  
Because CmrR and CmrT promoted the rough colony morphotype, we examined 
the requirement of cmrR and cmrT in rough colony formation. Individual in-frame 
deletions of cmrR and cmrT were generated in C. difficile R20291. The mutants and 
undifferentiated wild-type R20291 parent were grown on BHIS-agar to allow selection of 
rough colony isolates from the edges (as in Figure 2.2). While the parent strain and 
cmrR mutant formed both rough and smooth colonies, the cmrT mutant did not form 
rough colonies under the given conditions (Figure 2.6A). Expression of cmrT in trans 
complemented the cmrT mutation, restoring the capacity to form rough colonies (Figure 
2.6B). Importantly, cmrR and cmrT mutants do not differ in growth rate from WT (Figure 
2.5C). Thus, while CmrR and CmrT both impact colony morphology development when 
overproduced, only CmrT is required for rough colony formation under the tested 
conditions. 
CmrR and CmrT inversely regulate swimming motility and surface migration 
Because bacteria isolated from rough and smooth colonies differed in surface 
migration and swimming motility (Figure 2.2), we assessed the roles of CmrR and CmrT 
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in these processes. Ectopic expression of cmrR or cmrT in R20291 significantly 
increased surface migration compared to uninduced and vector controls (Figures 2.7A, 
2.8A,B). Enhanced surface migration was also observed in a TFP-deficient (pilB1::erm) 
background, again indicating that CmrR and CmrT-mediated surface migration is 
independent of TFP (Figures 2.7A, 2.8A,B). Conversely, cmrR and cmrT expression 
inhibited swimming motility of R20291 (Figures 2.7D, 2.8C,D). These data are 
consistent with the increased surface migration and decreased swimming motility 
exhibited by rough colony isolates (cmrRST ON), which are the inverse of the motility 
phenotypes of the smooth colony isolates (cmrRST OFF). Expression of cmrR and 
cmrT alleles with inactivating alanine substitutions resembled the wild-type allele, 
suggesting again that high levels of expression overcome the need for phosphorylation 
(Figure 2.8). However, as seen with colony morphology (Figure 2.4), the cmrR-D52E 
allele increased surface migration and decreased swimming motility at lower levels of 
induction relative to the wild-type allele, suggesting that the amino acid substitution 
increased activity (Figure 2.8). Expression of cmrR or cmrT did not alter transcript levels 
of representative flagellum or TFP genes (Figure 2.9), suggesting that the observed 
differences in surface migration and swimming motility occur through post-
transcriptional regulation or through an alternative mechanism.  
To further define the role of cmrRST, the cmrR and cmrT mutants and relevant 
controls were evaluated for surface migration and swimming motility. In both assays, the 
cmrR mutant behaved comparably to the R20291 parent (Figure 2.7B,C,E,F), indicating 
that CmrR is dispensable for these processes. However, the cmrT mutant exhibited 
significantly reduced surface migration, a defect that was complemented by expressing 
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cmrT in trans. The opposite effect was observed for swimming motility; the cmrT mutant 
showed greater motility compared to the parent strain. CmrT thus appears to be the 
dominant response regulator of the CmrRST system for control of rough colony 
formation, surface migration, and swimming motility in vitro.  
CmrR and CmrT promote bacterial chaining 
 Phenotypic analysis of motility and quantification of flagellum and TFP transcripts 
indicates that CmrRST mediated colony morphology occurs independently of these 
surface structures. Cell morphology has also been shown to affect gross colony 
morphology [268, 288, 289], so we investigated whether cell morphology differs 
between rough and smooth morphotypes. Examination of C. difficile colonies by 
scanning electron microscopy (SEM) revealed the presence of the expected bacilli 
towards the center, as well as elongated cells particularly along the edge of the colony 
(Figure 2.10A). These elongated cells appeared as organized bundles corresponding to 
the tendrils apparent in the macrocolony, suggesting a role for the elongated bacteria in 
expansion of rough colonies. Consistent with this, SEM of bacteria derived from smooth 
and rough colonies revealed dichotomous cellular morphologies. Smooth colony-
derived bacteria appeared as standard bacilli (4.089 µm ± 1.207 in length), while rough 
colony-derived cells were longer (7.428 µm ± 4.130) and sometimes exhibited an 
extremely elongated shape, resembling a bacterial filament or chain (Figure 2.10B,C). 
To determine whether the elongated cells result from filamentation or cell chaining, cells 
from rough and smooth colonies were Gram stained. While cells from smooth colonies 
consisted of the expected single or double rods, cells from rough colonies more 
commonly appeared in bacterial chains of three or more cells (Figure 2.10E,F). Septa 
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separating cells within chains were clearly visible, differentiating this morphology from 
filamentation. Differences in processing may explain why cell chains were more 
common in Gram stained samples than in SEM imaged samples; processing of samples 
for SEM may have disrupted chains.  
Since cmrRST expression favors rough colony development, we examined the 
roles of CmrR and CmrT in the chaining phenotype. In contrast to uninduced and vector 
controls, bacteria over-expressing cmrR or cmrT also displayed cell chaining (Figure 
2.10G). Based on our surface motility data, we predicted that though CmrR and CmrT 
both contribute to cell chaining and elongation, only the ΔcmrT mutant would be 
deficient in these phenotypes. We imaged Gram stained WT, ΔcmrR, and ΔcmrT cells 
collected from the edges of motile spots (Figure 2.11A,B). The ΔcmrR mutant displayed 
a slight decrease in cell length as compared to the WT control but still appeared as 
elongated cells and cell chains. However, ΔcmrT cells were significantly shorter than 
WT and appeared only as single or double cells. Together, these results indicate that 
rough colonies contain bacterial chains whose formation is promoted by CmrRST. 
 To better understand the contribution of cell chaining to the expansion of a 
colony on a surface, we visualized WT, ΔcmrR, and ΔcmrT grown on agar. WT, ΔcmrR, 
and TFP-deficient strains displayed elongated cells in bundled cell chains, and these 
structures appeared to expand in an ordered manner away from the colony edge 
(Figure 2.11C). However, the ΔcmrT strain, which is defective in surface motility, did not 
display these long cell bundles. Together, these data suggest that CmrT-mediated 
changes in cell morphology and chaining contribute to the movement of C. difficile 
across a surface. 
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Bacterial motility, cell morphology, and adherent behaviors are central to biofilm 
development, and chaining and filamentation can also affect surface adhesion and 
biofilm formation [290-293]. We therefore examined the role of CmrRST in C. difficile 
biofilm formation. Bacteria isolated from rough and smooth colonies and the cmrR and 
cmrT mutants were assayed for biofilm production in rich medium on plastic as 
described previously [113, 120]. The cmrR mutant showed significantly increased 
biofilm formation compared to the rough isolate, while the cmrT mutant showed no 
significant difference (Figure 2.12), suggesting that CmrR negatively regulates biofilm 
formation. 
Phase variable colony morphology via CmrRST impacts C. difficile virulence 
Given the broad role of CmrRST in controlling C. difficile physiology and 
behaviors, we predicted that the cmrR or cmrT mutants would have altered virulence in 
a hamster model of C. difficile infection. Male and female Syrian golden hamsters were 
inoculated with spores of ΔcmrR or ΔcmrT, or smooth or rough isolates of R20291, 
which remain capable of phase varying cmrRST expression. Notably, the strains tested 
did not differ in sporulation or germination rates in vitro (Figure 2.13). The animals were 
monitored for disease symptoms and euthanized when moribund as described in the 
Materials and Methods. Hamsters infected with ΔcmrR showed increased survival 
compared to those infected with the rough isolate of the R20291 parent (P = 0.003, log-
rank test). Survival of hamsters infected with ΔcmrR was also greater than that of 
animals infected with the smooth isolate, but the difference did not reach statistical 
significance (P = 0.098, log-rank test). While the mean times to morbidity were 
comparable for the animals that did succumb (44.08 hours for cmrR, 48.15 ± 12.87 
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hours for rough, 54.69 ± 22.90 hours for smooth), most of the animals inoculated with 
ΔcmrR survived (Figure 2.14A). For animals infected with ΔcmrT, both time to morbidity 
and percent animal survival were equivalent to those infected with the rough and 
smooth isolates.  
To evaluate intestinal colonization, fecal samples were collected every 24 hours 
post-inoculation, and dilutions were plated on TCCFA medium (containing the spore 
germinant taurocholic acid) to enumerate C. difficile colony forming units (CFU). All 
animals infected with ΔcmrT, rough, and smooth isolates yielded detectable CFU at the 
time of collection preceding disease development and euthanasia (Figure 2.14B). 
However, we observed no correlation between bacterial load and disease onset or 
severity. The number of ΔcmrR CFU was never above the limit of detection in feces of 
infected animals (Figure 2.14B), though C. difficile was detected in the cecum of the 
ΔcmrR-infected hamster that became moribund (data not shown). These data indicate 
that CmrR, but not CmrT, is important for the ability of C. difficile to colonize the 
intestinal tract and cause disease in the hamster model.  
To determine whether the attenuation of the ΔcmrR mutant was due to reduced 
toxin levels, we evaluated the effect of CmrR and CmrT on TcdA production. Western 
blot analysis showed that ΔcmrR does not produce significantly lower levels of TcdA 
toxin than rough and smooth isolates in vitro, suggesting that the virulence defect of 
ΔcmrR occurs through a toxin-independent mechanism (Figure 2.13C,E). Interestingly, 
ΔcmrT produced slightly higher TcdA levels by western blot. However, overexpression 
of cmrR and cmrT in R20291 did not significantly alter tcdA transcript abundance, 
suggesting that CmrRST does not transcriptionally regulate toxin gene expression. 
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Because the ΔcmrR strain was attenuated in hamsters, we expected the smooth 
isolate (CmrRST “off”) to be attenuated compared to the rough isolate (CmrRST “on”). 
While hamsters infected with the rough isolate all succumbed to disease, 33% of 
hamsters inoculated with the smooth isolate survived, suggesting moderately lower 
virulence of the smooth isolate (Figure 2.14A). However, this difference did not reach 
statistical significance as the survival times of hamsters that became moribund were not 
significantly different (P = 0.112, log-rank test), and both isolates were able to colonize 
(Figure 2.14A, B).  
We considered the possibility that the rough and smooth isolates, though chosen 
based on distinct colony morphologies, are “wild-type” and capable of phase variation. 
Accordingly, selective pressures in the intestinal tract may have resulted in a phenotypic 
switch during infection, mitigating the observed differences in virulence. To test this, we 
determined the orientations of the cmrRST switch in the spore preparations and the 
contents of the cecums collected from infected animals immediately after sacrifice. DNA 
obtained from cecal contents was subjected to PCR with two primer sets that amplify 
from the cmrRST switch in a particular orientation. Analysis of the cmrRST switch 
orientation in the spore inoculums indicate that the rough isolate consisted of bacteria 
with the switch primarily in the ON orientation, while the smooth isolate contained those 
primarily in the OFF orientation, consistent with prior in vitro analyses (Figure 2.14C, D). 
In the cecal contents of hamsters inoculated with the smooth isolate, C. difficile retained 
the cmrRST switch predominantly in the OFF orientation (94.56 ± 2.52% OFF; Figure 
2.14D). In contrast, cecal contents from rough isolate-infected animals also contained 
the switch in a mixed or predominantly OFF orientation (75.71 ± 9.44% OFF), indicating 
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that that the rough (ON) isolate inoculum underwent phase variation during infection. 
These data suggest that either ON/OFF switch rates are altered in favor of the OFF 
orientation during acute, short-term infection, and/or there is a selective pressure for the 
cmrRST OFF state and corresponding phenotypes. 
 
DISCUSSION 
Phase variation provides a mechanism for generating phenotypic heterogeneity 
in bacterial populations to enhance the survival of the population as a whole when 
encountering detrimental environmental stresses. In this study, we characterized the 
phase variation of a signal transduction system, CmrRST, which we found broadly 
impacts C. difficile physiology and behavior. During growth in vitro, C. difficile 
populations consist of bacterial subpopulations that are CmrRST ON, yielding rough 
colonies, and CmrRST OFF, yielding smooth colonies. These subtypes display 
divergent motility phenotypes in vitro, with smooth colony isolates showing increased 
swimming motility and rough colony isolates displaying enhanced surface motility. The 
identification of growth conditions that segregate for the respective morphological 
variants, each with enhanced motility in the corresponding growth condition, indicates a 
selective advantage for that motility behavior.  
Although ectopic expression of either response regulator, CmrR or CmrT, 
increased surface motility, only CmrT is required for surface migration and rough colony 
development, suggesting that CmrT is the dominant regulator under these conditions. 
Alternatively, CmrR may also play a role but requires an activating signal through the 
histidine kinase CmrS to be functional. The latter possibility is supported by the 
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observation that a phosphomimic substitution at the predicted phosphorylation site in 
the receiver domain increases CmrR activity. In contrast, because CmrT contains a 
glutamic acid at this site, it likely does not require activation by a histidine kinase and 
instead acts constitutively. For this reason, the receiver domain of CmrT may be 
considered a pseudo-receiver domain [285, 294]. 
In the hamster model of acute infection, the cmrR mutant did not detectably 
colonize and exhibited reduced virulence, indicating a role for this signal transduction 
system during infection. In contrast with the in vitro motility phenotypes driven primarily 
by CmrT, the CmrR regulator appears to be critical for virulence. The divergent roles for 
the regulators suggest that an activating signal for CmrR is present in the host intestine, 
though it remains possible that CmrT activity is somehow inhibited during infection. A 
similar mechanistic distinction between the regulators may explain the role of CmrR, but 
not CmrT, in biofilm formation in vitro. Whether CmrR and CmrT control distinct 
regulons, act cooperatively, and/or antagonistically is unknown and currently under 
investigation.  
Compared to the strong attenuated virulence of the cmrR mutant, the rough and 
smooth isolates exhibited modest differences in virulence. The latter result may have 
arisen from the ability of the isolates to phase vary, resulting in convergent phenotypes 
due to selective pressures in the intestinal environment. Tracking of the cmr switch 
orientations in the inoculums and cecal contents at the experimental endpoint indicate 
that the rough variant (cmrRST ON) switched to populations with the cmr switch in a 
mixed or predominantly OFF orientation. That phase variation of CmrRST occurred 
during infection may have resulted in diminished differences in virulence between the 
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rough and smooth variants. In addition, these findings imply the presence of a selective 
pressure that favors the cmrRST OFF phase variant, at least in the later stages of 
infection. However, the high conservation of the cmrRST locus and the upstream 
regulatory region indicates that this regulatory system and its ability to phase vary 
confer a fitness advantage. The colonization defect of the cmrR mutant suggests that 
signaling through CmrR contributes to initial colonization, and therefore the ability to 
generate a CmrRST ON subpopulation may be important at an early stage of infection. 
In our study, cecal contents were harvested at the experimental endpoint when disease 
was fulminant, and the collection of samples after more frequent intervals is limited by 
the short duration of the infection and low bacterial load prior to 24 hours post-
inoculation. This sampling strategy may not capture transient changes in the cmr switch 
bias during different stages of infection, over a longer infection, or in a different location 
in the intestinal tract. Testing the impact of cmrR and cmrT mutations in a phase-locked 
ON background as well as a double cmrR cmrT mutant may better reveal the role of this 
system in C. difficile virulence.  
Unlike phase variation mechanisms that control the production of a specific 
surface factor, the phase variation of the CmrRST system is poised to coordinate the 
expression of multiple pathways. Previous studies have described phase variation of 
proteins with regulatory function resulting in broad changes in gene expression. A few 
transcriptional regulators have been reported to phase vary, including the global 
virulence gene regulators BvgAS in Bordetella and the response regulator FlgR in 
Campylobacter jejuni [295-297]. In C. difficile, phase variation of flagellar genes impacts 
the transcription of the alternative sigma factor gene sigD, which couples the expression 
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of flagellum and toxin genes, linking virulence factor production to the orientation of the 
flagellar switch [103, 298]. Coordinated regulation of genes resulting in global changes 
in transcription can also result from phase variation of DNA modification systems, as 
observed in Haemophilus influenza, Helicobacter pylori, Salmonella enterica, and 
Streptococcus strains [143, 299-303]. In Streptococcus pneumoniae, for example, DNA 
inversions within three genes encoding the sequence recognition factor of a Type I 
restriction-modification (RM) system allow for changes in genomic methylation patterns, 
resulting in phase variable regulation of virulence factors including capsule [154, 303]. 
The CmrR and CmrT response regulators each contain DNA binding domains and have 
the capacity to regulate gene transcription. Therefore, inversion of the cmr switch likely 
also indirectly controls the expression of multiple genes in a phase variable manner. 
The CmrRST system regulates multiple processes, but the basis for the 
phenotypic changes are unclear. Colony morphology and motility assays indicate TFP- 
and flagellum-independent mechanisms, and the transcription of TFP and flagellum 
genes is not affected by CmrR and CmrT. TFP-independent surface migration has not 
previously been described in C. difficile. Examination of cellular morphology indicates 
that CmrRST promotes bacterial chaining. Bacillus subtilis also exhibits cell chaining, 
and this chaining may contribute to bacterial migration as cells are pushed along the 
axis of growth and division [304-307]. In support of this hypothesis, the edges of C. 
difficile motile spots exhibit well-organized bundled chains of elongated cells that extend 
away from the center and are absent without cmrT. This mechanism appears similar to 
gliding motility in Clostridium perfringens, although that process requires TFP [110, 
308]. Bacterial chaining is observed in a number of bacterial species and can affect 
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flagellar motility, surface adhesion, biofilm formation, susceptibility to phagocytosis, and 
virulence [289-293, 304, 309-312]. Chaining of C. difficile through regulation by 
CmrRST may similarly alter motility behaviors and persistence in the intestine. How 
CmrRST mediates changes to cell chaining, colony morphology, and motility is 
unknown, and ongoing work to define the CmrRST regulon may reveal the underlying 
mechanisms. 
The complexity of cmrRST regulation not only alludes to the importance of 
controlling CmrRST activity, but also highlights the growing link between phase variation 
and c-di-GMP signaling in C. difficile. Expression of flagellar genes is also modulated by 
both a c-di-GMP binding riboswitch and an invertible element [103, 104, 271], as well as 
two additional phase variable genes in C. difficile that encode c-di-GMP 
phosphodiesterases [138]. In the case of flagellar gene regulation, c-di-GMP inhibits 
transcription through a riboswitch that induces transcription termination, and the 
invertible flagellar switch further controls expression through an uncharacterized post-
transcriptional mechanism. For cmrRST expression, c-di-GMP positively regulates 
transcription, and the cmr switch controls phase variation through an undefined 
mechanism [138, 236]. The hierarchy between these regulatory elements is unclear. A 
σA-dependent promoter lies 5’ of both the riboswitch and cmr switch [241]. The invertible 
sequence may contain an additional promoter to drive expression when properly 
oriented [136, 159]. Alternatively, the upstream σA-dependent promoter may be the only 
site of transcriptional initiation, and the invertible element may contain another 
regulatory sequence that modulates expression [179].  
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Finally, this and other recent work underscores that genetically clonal C. difficile 
strains, as well as isogenic mutants, may differ phenotypically due to phase variation. 
The seven sites of site-specific DNA recombination in the C. difficile genome can be 
inverted independently, and this study shows that in vitro culturing conditions can 
change the biases of switch orientations in the overall population. From a research 
standpoint, this can introduce significant variability into otherwise controlled 
experiments. This concern may be especially significant in infection studies, where 
differences in switch biases in inoculums may skew apparent outcomes. Caution should 
be taken in interpreting such data, as observed differences may be due to differences in 
expression of phase variable traits rather than the targeted mutations. 
Through phase variation, populations of bacterial pathogens can rapidly adapt to 
changing environmental pressures, balancing the need to move, adhere, and avoid 
immune recognition through the course of infection. The phase variation of CmrRST 
may allow alternating modes of surface or swimming motility in C. difficile as needed 
during infection –swimming motility (cmrRST OFF) may allow exploration and 
colonization of new sites, while bacterial chaining (cmrRST ON) may allow the spread of 
bacteria along the epithelial surface once contact has been made. Further work 
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FIGURES AND TABLES 
 
Figure 2.1. Formation of rough and smooth colonies by multiple C. difficile 
strains. C. difficile strains representing five different ribotypes (indicated in 
parentheses) were grown on BHIS-agar medium for 72 hours to allow differentiation of 
colony morphology. Growth was recovered and plated on BHIS-agar for visualization of 
individual colonies. Shown are representative images from two independent 
experiments. Black triangles indicate “smooth” colonies, and white triangles indicate 




Figure 2.2. Reversible selection of distinct colony morphotypes with opposing 
motility phenotypes. (A) C. difficile R20291 liquid culture was spotted on BHIS-1.8 % 
agar and grown for 48 hours to allow spreading growth (panel 1). Bacteria collected 
from the center of a spot yield mostly smooth colonies (panel 2), while bacteria from the 
edge yield almost exclusively rough colonies (panel 3). (B) Rough and smooth colony 
isolates obtained as in A were passaged in 0.5X BHIS-0.3% agar (panel 4), and 
samples were collected from the edge of motile growth. Both rough and smooth colony 
isolates only gave rise to smooth colonies (panels 5,6). Shown are representative 
images of colonies from four independent experiments. All images were taken at 2X 
magnification. (C) Quantification of colony morphology for rough and smooth colony 
isolates after passage on a BHIS-agar surface (surf) as in A or in motility medium 
(swim) as in B, with samples collected from the edges of growth. R, S indicate rough 
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and smooth starting inoculums, respectively. Rough and smooth isolates were also 
directly passaged through BHIS broth medium or struck on an BHIS agar plate and then 
enumerated. Symbols indicate individual values from 3-4 independent experiments, and 
bars indicate means and standard deviations. (D,E) C. difficile R20291, a TFP-null 
control (pilB1), and rough (R) and smooth (S) colony isolates were assayed for surface 
motility on BHIS-1.8 % agar. (D) A representative of four experiments is shown. (E) 
Surface motility was quantified by measuring the diameter of growth after 48 hours. 
(F,G) C. difficile R20291, a non-motile control (sigD), and rough (R) and smooth (S) 
colony isolates were assayed for swimming motility in 0.5x BHIS-0.3% agar. (F) A 
representative of four experiments is shown. (G) Swimming motility was quantified by 
measuring the diameter of growth after 48 hours. (E,G) **p < 0.01, ***p < 0.001, ****p < 
0.0001, one-way ANOVA and Tukey’s post-test  
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Figure 2.3. Expression of a c-di-GMP regulated phosphorelay system promotes 
rough colony formation in a TFP- and flagellum-independent manner. (A) Diagram 
of seven invertible DNA elements previously identified in C. difficile R20291. Gray 
triangles represent inverted repeats flanking invertible elements, which are named 
according to previously defined nomenclature [29]. Downstream regulated genes are 
shown. Blue rectangles denote c-di-GMP riboswitches, and direction of regulation is 
indicated with arrows. (B) qPCR analysis of the orientations of the seven invertible DNA 
sequences in rough (R) and smooth (S) colony isolates. Data are expressed as the 
percentage of the population with the sequence in the orientation present in the 
reference genome (FN545816). Symbols indicate values from individual isolates. (C) 
qRT-PCR analysis for expression of cmrR and cmrT in rough and smooth isolates 
grown on BHIS agar. Data from four biological replicates was analyzed using the ΔΔCt 
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method with rpoC as the reference gene and was normalized to the smooth condition. 
Shown are means with standard deviations. *p < 0.0001, Holm-Sidak multiple t-test. (D-
F) C. difficile R20291, a TFP-null (pilB1) mutant, and an aflagellate (sigD) mutant 
containing the indicated plasmids for manipulation of intracellular c-di-GMP were grown 
on BHIS-agar with or without inducer (2 µg/ml nisin). Shown are images representative 
of the most common morphology yielded by each strain. Values in each panel indicate 
the percentage of rough colonies of ≥ 100 total colonies from at least two independent 
experiments. All images were taken at 2X magnification  
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Figure 2.4. The putative response regulators CmrR and CmrT promote the 
development of rough colonies. C. difficile R20291 with plasmids for expression of 
cmrR, cmrT, or mutant alleles was evaluated for colony morphology on BHIS-1.8 % 
agar with ATc to induce expression (ATc concentrations indicated in ng/mL). Expression 




Figure 2.5. Growth of mutant and over-expression strains in vitro. C. difficile strains 
were grown in BHIS broth with ATc at 0, 2 or 10 ng/mL for induction. Optical densities 
(600 nm) over time for R20291 with plasmids for expression of (A) cmrR and mutant 
alleles or (B) cmrT and mutant alleles. (C) Optical densities over time for R20291 WT, 




Figure 2.6. CmrT is required for rough colony formation. (A) Colony morphology of 
C. difficile R20291, ΔcmrR, ΔcmrT with vector after 24 hours on BHIS-1.8% agar. (B) 
Complementation of ΔcmrR and ΔcmrT mutants with expression of the respective 
genes in trans induced with 2 ng/mL ATc, imaged after 24 hours. All images were taken 





Figure 2.7. CmrR and CmrT inversely regulate surface and swimming motility. C. 
difficile strains were assayed for surface motility on BHIS-1.8% agar 1% glucose after 
72 hours (A-C) and for swimming motility through 0.5X BHIS-0.3% agar after 48 hours 
(D-F). (A) C. difficile R20291 (WT) and a TFP-null (pilB1) mutant, each with plasmids for 
expression of cmrR, cmrT, or a vector control, assayed for surface motility with or 
without ATc (10 ng/µL for pCmrR, 2 ng/µL for pCmrT). (B) Surface motility of WT, 
ΔcmrR, ΔcmrT strains with vector or respective expression plasmids for 
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complementation. (C) Representative image of surface motility. (D) C. difficile R20291 
(WT) and a non-motile sigD mutant with pCmrR, pCmrT, or vector as indicated, 
assayed for swimming motility with or without ATc (10 ng/µL for pCmrR, 2 ng/µL for 
pCmrT). (E) Swimming motility of WT, ΔcmrR, ΔcmrT strains with vector or 
complementation plasmids, in the presence of 0.2 ng/µL. A non-motile sigD mutant was 
included as a control. (F) Representative image of swimming motility. Shown are the 
means and standard deviations of the diameters of motility growth. *p < 0.05, ****p < 
0.0001, two-way ANOVA and Tukey’s post-test comparing +/- ATc (A,D) or one-way 




Figure 2.8.  Amino acid substitutions of the phosphorylation sites in CmrR and 
CmrT alter activity. C. difficile with plasmids for expression of cmrR, cmrT, or mutant 
alleles, as well as a vector control, were assayed for surface migration on BHIS-1.8% 
agar 1% glucose (A,B) and for swimming motility through 0.5X BHIS-0.3% agar 
(C,D). TFP-null (pilB1) mutant with vector or cmrR/cmrT expression plasmids were 
included in the surface migration assay (A,B). A non-motile sigD mutant was used as a 
control for swimming motility experiments (C,D). The media contained ATc at 0, 2, or 10 
ng/ml (white, grey, and black bars, respectively) to induce gene expression. 
(B,D) Expression of cmrT inhibited growth at 10 ng/ml and was not included. Shown are 
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the means and standard deviations of the diameters of motile growth after 48 (C,D) or 
72 (A,B) hours. **p < 0.005,  # p < 0.0005, + p < 0.0001, two-way ANOVA 




Figure 2.9. CmrR and CmrT do not regulate flagellum or TFP gene expression. C. 
difficile with vector or cmrR/cmrT expression plasmids were grown for 48 hours in 0.5x 
BHIS-0.3% agar to express flagellar genes. Bacteria were recovered and cultured in TY 
broth with inducer (10 ng/mL ATc for vector and pCmrR; 2 ng/mL ATc for pCmrT). 
Samples were collected at mid-exponential phase for RNA extraction and qRT-PCR 
analysis. The data were analyzed using the ΔΔCt method with rpoC as the reference 
gene and no ATc as the control condition. Shown are the means and standard 






Figure 2.10. CmrR and CmrT promote bacterial chaining. A) SEM images of a whole 
R20291 colony after 3 days of growth on BHIS agar. (A) A colony excised on an agar 
slice, at 1 x 103 magnification. The arrow denotes the orientation of the image with 
respect to the colony. The dotted line marks the apparent transition from the colony 
edge and center. (B) 2.5 x 103 magnification images of cells at the colony center and 
edge. (C) 4.5 x 103 magnification of rough and smooth cell suspensions. Samples were 
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grown in broth culture prior to fixation. Shown are representative images from two 
biological replicates. (D) Quantification of cell lengths obtained from SEM images using 
ImageJ. Cells were measured from at least seven images from two biological replicates 
(rough n = 574, smooth n = 457). ****p < 0.0001 by unpaired t-test. (E, F) Gram stain of 
C. difficile samples taken directly from the center and edge of a colony (E) or from rough 
and smooth colonies (F) at 60X magnification. G) Gram stain of C. difficile with plasmids 
for expression of cmrR or cmrT, or a vector control were grown on BHIS-agar with and 
without inducer (10 ng/mL ATc for vector and pCmrR; 2 ng/mL ATc for pCmrT). 
Magnifications are indicated. Shown are representative images from two independent 
experiments.   
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Figure 2.11. The cmrT mutant is defective in cell elongation and chaining. (A) 
R20291 WT, cmrR, and cmrT cultures were spotted and grown on BHIS 1.8% agar 
1% glucose for 72 hours. Cells from the colony edge were collected, Gram stained, and 
imaged at 60x magnification. Shown are representative images. (B) Quantification of 
cell lengths in Gram stain images from (A). At least 2 images from 2 biological replicates 
were used. The lengths of more than 514 cells per strain were measured using ImageJ 
and normalized to the average WT cell length. Means and standard deviations are 
shown. *p < 0.0001, one-way ANOVA. (C) Representative images of the colony edges 
of WT, cmrR, cmrT, and pilB1::ermB. Cultures were spotted and grown on BHIS 





Figure 2.12. The cmrR mutant exhibits an increase in biofilm formation. 
R20291 smooth and rough isolates and the cmrR, and cmrT mutants were grown in 
BHIS 1% glucose- 50 mM sodium phosphate buffer for 24 hours in 24-well polystyrene 
plates. Adhered biofilms were washed and quantified using a crystal violet staining 
assay. The means of 4-5 technical replicates were normalized to values for the R20291 
rough isolate and combined from two independent experiments. * p < 0.05, one-way 






Figure 2.13. cmrR and cmrT mutants are not defective in sporulation, germination 
or toxin production. (A) Sporulation of R20291 rough and smooth isolates and the 
cmrR and cmrT mutants after 24 hours on 70:30 agar. Sporulation is expressed as a 
percentage of viable spores versus total cells, then normalized to values obtained for 
the rough isolate. (B) Germination of spores over time after addition of the germinants 
taurocholic acid and glycine. TAG = taurocholic acid and glycine germinants. (A,B) No 
statistically significant differences were observed using a one-way ANOVA, N = 3 
biological replicates. (C) TcdA levels in bacterial lysates were assessed after 24 hours 
of growth in TY medium by western blot. Ponceau S staining was used to determine 
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equal sample loading. (D) Quantification of TcdA western blots for 4 biological 
replicates. Intensity of the TcdA bands for each was normalized to intensity of Ponceau 
S staining per lane. Values were then normalized to the intensity for the smooth isolate. 
Shown is a representative image. *p < 0.05, one-way ANOVA with Tukey’s post-test. (E) 
qRT-PCR analysis tcdA mRNA levels in strains overexpressing cmrR, cmrT, or vector 
control. Bacteria were cultured in BHIS broth with inducer (10 ng/mL ATc for vector and 
pCmrR; 2 ng/mL ATc for pCmrT). The data were analyzed using the ΔΔCt method with 
rpoC as the reference gene and R20291 with vector as the control condition. Shown are 
the means and standard deviations of 4-6 biological replicates. No statistically 




Figure 2.14. Colony morphology and CmrR impact C. difficile virulence. Male and 
female Syrian golden hamsters with were inoculated with 5000 spores of the indicated 
C. difficile strains/isolates. (A) Kaplan-Meier survival data showing time of morbidity and 
euthanasia. Log-rank test: rough v. ΔcmrR, P = 0.003; smooth v. ΔcmrR, P = 0.098, log-
rank test. (B) CFU enumerated in feces collected at 24 hour intervals post-inoculation. 
Symbols indicate CFU from individual animals, and bars indicate the means. (C) 
Orientation of the cmr switch determined by PCR for the spore inoculums and cecal 
contents of moribund hamsters (rough R1-6, smooth S1-4) with detectable C. difficile.  
(D) Quantification of cmr switch orientation by qPCR in spore inoculums and cecal 
contents of moribund hamsters. Data are expressed as the percentage of the population 
with the sequence in the OFF orientation. Symbols indicate values from individual 
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hamsters, and horizontal bars indicate the median. Values of rough and smooth cecal 




Table 2.1. Strains and plasmids used in this study. 
Lab 
Notation 
Strain/Plasmid Name Description Reference 
 Escherichia coli DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
recA1 endA1 hsdR17(rκ -, mκ+) phoA 
supE44 thi-1 gyrA96 relA1 λ- tonA 
Invitrogen 
[313] 
RT270 Escherichia coli 
HB101(pRK24) 
E. coli used in conjugations with C. 
difficile, ApR, CmR 
[314] 
RT1124 C. difficile 630 Ribotype 012 strain (Genbank 
Accession # AM180355) 
 
RT273 C. difficile R20291 Ribotype 027 strain (Genbank 
Accession # FN545816) 
[99] 
RT1065 C. difficile UK1 Ribotype 027 strain [315, 316] 
RT1125 C. difficile VPI 10463 Ribotype 003 strain [317] 
RT1357 C. difficile ATCC BAA-
1875 
Ribotype 078 strain ATCC 
RT1358 C. difficile ATCC 43598 Ribotype 017 strain ATCC, 
[318] 
RT526 R20291 pMC-Pcpr R20291 with pMC-Pcpr, nisin inducible [113] 
RT527 R20291 pDccA R20291 with pMC-Pcpr::dccA, nisin 
inducible 
[113] 
RT528 R20291 pPdcA-EAL R20291 with pMC-Pcpr::EAL, nisin 
inducible 
[237] 
RT539 R20291 pDccAmut R20291 with pMC-Pcpr::dccAmut, nisin 
inducible 
[113] 
RT2196 R20291 pRPF185 R20291 with pRPF185, ATc inducible This work 
RT2085 R20291 pCmrR R20291 pRPF185::cmrR, ATc 
inducible 
This work 
RT2086 R20291 pCmrR-D52E R20291 pRPF185::cmrR-D52E, ATc 
inducible 
This work 
RT2087 R20291 pCmrR-D52A R20291 pRPF185::cmrR-D52A, ATc 
inducible 
This work 
RT2107 R20291 pCmrT R20291 pRPF185::cmrT, ATc inducible This work 
RT2201 R20291 pCmrT-D53A R20291 pRPF185::cmrT-D53A, ATc 
inducible 
This work 
RT1566 R20291 sigD  R20291 sigD::ermB, Targetron 
insertion  
[103] 
RT2111 R20291 sigD pMC-Pcpr R20291 sigD::ermB with pMC-Pcpr This work 
RT2112 R20291 sigD pMC-
pDccA 
R20291 sigD::ermB with pMC-
Pcpr::dccA 
This work 
RT2113 R20291 sigD pPdcA-EAL R20291 sigD::ermB with pMC-
Pcpr::EAL 
This work 
RT947 R20291 pilB  R20291 pilB::ermB, Targetron insertion [113] 
RT2177 R20291 pilB pMC-Pcpr R20291 pilB::ermB with pMC-Pcpr This work 
RT2178 R20291 pilB pDccA R20291 pilB::ermB with pMC-
Pcpr::dccA 
This work 




RT2180 R20291 pilB pCmrR R20291 pilB::ermB with 
pRPF185::cmrR 
This work 
RT2197 R20291 pilB pRPF185   R20291 pilB::ermB with pRPF185   This work 
RT2204 R20291 pilB pCmrT R20291 pilB::ermB with 
pRPF185::cmrT 
This work 
RT2256 R20291 ΔcmrR R20291 with in-frame deletion of cmrR This work 
RT2257 R20291 ΔcmrT R20291 with in-frame deletion of cmrT This work 
RT2267 R20291 ΔcmrR 
pRPF185 
R20291 ΔcmrR with pRPF185 This work 
RT2268 R20291 ΔcmrR pCmrR R20291 ΔcmrR with pRPF185::cmrR This work 
RT2269 R20291 ΔcmrT pRPF185 R20291 ΔcmrT with pRPF185 This work 
RT2270 R20291 ΔcmrT pCmrT R20291 ΔcmrT with pRPF185::cmrT This work 
MC310 R20291 spo0A R20291 spo0A::ermB [319] 
RT399 pMC-Pcpr pMC123 with nisin-inducible cpr 
promoter 
[237] 
RT402 pDccA pMC-Pcpr::dccA (CD630_14200), 
encodes DGC 
[237] 
RT529 pDccAmut pMC-Pcpr::dccAmut (AADEF), encodes 
inactive DGC 
[237] 
RT404 pPdcA-EAL pMC-Pcpr::pdcA-EAL [120] 
RT709 pRPF185 Contains ATc-inducible Ptet promoter [320] 
RT2073 pCmrR pRPF185::cmrR This work 
RT2074 pCmrR-D52E pRPF185::cmrR-D52E This work 
RT2075 pCmrR-D52A pRPF185::cmrR-D52A This work 
RT2106 pCmrT pRPF185::cmrT This work 




Table 2.2 Primers used in this study. 
Lab 
Notation 










R2213 LCF801 GGTAAGTTTGATTTTTATGTTAATGAATTG 
R2214 LCF714 CAGTTTGTGCACTAGCTATGCCTGC 
R2215 LCF796 CGCAATTATTTGTTTTTCATATGGATAAAATTGG 




























R2273 RpoAqF TCATTACCAGGTGTAGCAGTGAATGC 
R2274 RpoAqR GATAGAGCATGGTCCTTGAGCTTCT 
R2378 OS 196 GTACAGAAGTTACCCAGAAGCTTGT 
R2379 OS 197 TCCCCGCAATGGATGTTTTTTAATTCATC 
R2380 OS 198 TCCCAATTTAAATGTAGAGGTCATCAAT 
R2527 3128_F TACGAGCTCCTTGAGATTATGATTAAAATACCTTTG 
R2528 3128_R TACGGATCCCAGTATCTCACTTATGGTACAAACTTATAT 
R2529 3128pm_glu_F GTATAATTTTGGAAATTTCATTGCC 
R2530 3128pm_glu_R GGCAATGAAATTTCCAAAATTATAC 
R2531 3128pm_ala_F GTATAATTTTGGCTATTTCATTGCC 
R2532 3128pm_ala_R GGCAATGAAATAGCCAAAATTATAC 
R2533 3126_F TACGAGCTCTAATATAAAAGAATAATGATATTTGGGAGTG 
R2534 3126_R TACGGATCCCGTTAGCATTTCACATTTATAAC 
R2535 3126pm_ala_F TTTAGCAATAATTCTAACTGATGGTG 






 OS266 AGTATCTCACTACACCACTCCATTCAAAG 
 OS267 GAGTGGTGTAGTGAGATACTGTAATTAATAAATAGTTCTT
G 
 OS268 TTTTTTGTTACCCTAAGTTTGCCATCCATGTATCCTATC 
 OS269 TTAATATATTTATATAATCACTCCCAAATATCATTATTC 
 OS271 AGATTATCAAAAAGGAGTTTTGTCAAATCTTGTAACCAAC 
 OS283 AGTGATTATAGAAAATTATAACAATAAGAGGAGC 
R850 rpoCqF CTAGCTGCTCCTATGTCTCACATC 
R851 rpoCqR CCAGTCTCTCCTGGATCAACTA 
R856 CD0245qF GCAACTAATCTAAGAAGTCAGACAATAGC 
R857 CD0245qR AGGCATAGCATCATTTAGTGTTTCTTC 
R858 CD0229qF CAAGTGTATCAAATATGAGCGATGAA 
R859 CD0229qR TTATCCTCGCATCTCCTCTATCATT 
R1063 fliCqF TACAAGTTGGAGCAAGTTATGGAAC 
R1064 fliCqR GTTGTTATACCAGCTGAAGCCATTA 
R930 qRTpilA1F TGGCAGTTCCAGCTTTATTTAGTAAT 
R931 qRTpilA1R AAGATAATGCTGCACTCTTAACTGA 
R852 CD0663qF GGAGAAGTCAGTGATATTGCTCTTG 
R853 CD0663qR CAGTGGTAGAAGATTCAACTATAGCC 
R2298 CDR_3128qF1 AAGAAAAAGTTCGGGGATTTTTAGC 
R2299 CDR_3128qR1 CGCTGAAAACTTTAACACATTAGGA 
R2537 3126_qF GACAAGGATAATTGCC 
R2538 3126_qR CCATCACCATCAGTTAG 
a underlined sequences denotes restriction site 
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CHAPTER 3. MULTIPLE REGULATORY INPUTS CONTROL THE EXPRESSION OF 




The ability to adapt to environmental changes is critical to the survival of bacterial 
pathogens, which can face rapidly changing conditions and stresses during infection 
[321, 322]. Bacteria have therefore developed diverse strategies for adaptation [249, 
250, 323]. Sense-and-respond strategies often involve two-component systems (TCS) 
that consist of a sensor kinase and a cognate response regulator [324]. In response to 
an activating signal, such as binding of a ligand or a pH change, the sensor kinase 
autophosphorylates and activates a response regulator through transfer of the 
phosphoryl group [324, 325]. Response regulators have a wide range of functions, but 
many bind DNA to effect changes in transcription when activated [285]. These 
transcriptional changes contribute to adaptation of the bacterium to the environmental 
stimuli sensed by the sensor kinase. Signal transduction can also occur via signaling by 
intracellular small molecules such as cyclic diguanylate (c-di-GMP) [326, 327]. The 
intracellular level of c-di-GMP is modulated by the opposing activities of diguanylate 
cyclases and phosphodiesterases that synthesize and degrade c-di-GMP, respectively. 
 
2 This chapter is a manuscript in progress. Authors: Elizabeth M. Garrett, Ognjen Sekulovic, Anchal 
Mehra, John Shook, Rita Tamayo. I conducted the experiments in all figures except for Figure 3.7. I also 
wrote and revised the manuscript with feedback from Rita Tamayo. 
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The production and function of these enzymes is controlled by largely undefined 
environmental signals [120, 326]. C-di-GMP is recognized by specific protein or RNA 
receptors (riboswitches), which then mediate the adaptive response. Binding of c-di-
GMP to the riboswitch changes the RNA secondary structure to alter transcript stability, 
termination, or translation initiation, resulting in gene expression changes that contribute 
to bacterial adaptation [226, 328]. 
In contrast, generation of phenotypic heterogeneity in a bacterial population 
serves as a bet-hedging strategy to help ensure survival of the population as a whole. 
The development of phenotypically distinct variants improves the odds that a 
subpopulation survives a sudden stress [248, 249]. Phase variation, a mechanism of 
generating phenotypic heterogeneity, occurs through reversible genetic changes that 
typically cause an ON/OFF phenotypic “switch” [135, 329]. Several mechanisms of 
phase variation have been described including conservative site-specific recombination, 
in which a sequence-specific recombinase binds inverted repeats and mediates 
inversion of the intervening DNA [158]. The invertible DNA element contains regulatory 
information, such as a promoter, that impacts the expression of adjacent genes. In a 
well-characterized example in Escherichia coli, phase variation of fimbriae production is 
mediated by the fimS invertible element, which contains a promoter that drives 
transcription of the fimbrial genes when properly oriented [330-332]. In contrast, an 
invertible element in Clostridioides difficile results in the formation of an intrinsic 
terminator in the mRNA transcript when in the OFF orientation, preventing expression of 
the downstream gene cwpV; the intrinsic terminator does not form in the mRNA with the 
invertible element in the ON orientation [179]. 
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Clostridioides difficile is an intestinal pathogen and a leading cause of 
nosocomial infections in the U.S [3, 333]. C. difficile infection (CDI) can result in mild to 
severe diarrhea and potentially fatal complications such as pseudomembranous colitis, 
toxic megacolon, and sepsis. Recent work has shown that C. difficile contains multiple 
invertible DNA elements, indicating a considerable capacity for phenotypic 
heterogeneity through phase variation [138, 185]. Three of these invertible elements 
have been demonstrated to regulate downstream genes and related phenotypes in a 
phase variable manner. The Cdi4 invertible element modulates expression of the early 
stage flagellar operon resulting in phase variation of flagella [103]. This operon encodes 
the sigma factor SigD, which promotes the transcription of flagellar genes as well as 
transcription of tcdR, which encodes a direct activator of the C. difficile toxin genes tcdA 
and tcdB [101, 103, 104, 184, 262]. Accordingly, the production of these toxins is also 
phase variable. The Cdi1 invertible element mediates phase variation of CwpV, a cell 
wall protein that contributes to phage resistance [179-181, 270]. Finally, the Cdi6 
invertible element, here called the cmr switch, regulates the expression of cmrRST in a 
phase variable manner [138, 334]. The cmrRST operon encodes a putative non-
canonical TCS with two DNA-binding response regulators (CmrR and CmrT) and a 
sensor kinase (CmrS) [334]. Phase variation of CmrRST allows C. difficile to switch 
between two colony morphologies, termed rough and smooth, that differ in several 
physiological characteristics. Through unknown mechanisms, CmrRST positively 
regulates type IV pili-independent surface motility and cell elongation, and it negatively 
regulates swimming motility and biofilm formation. Furthermore, a cmrR mutant strain is 
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deficient for colonization and shows attenuated virulence in a hamster model of 
infection, indicating a role for this regulatory system in disease.  
In addition to regulation by the cmr switch, cmrRST expression is regulated by c-
di-GMP via a riboswitch [236, 241, 334]. C-di-GMP riboswitches are widespread in the 
C. difficile genome, with 11 functional riboswitches in strain 630Δerm [236, 241]. These 
riboswitches appear to be the primary mechanism of c-di-GMP regulation in C. difficile 
[236]. C-di-GMP riboswitches are classified as class I or class II; in C. difficile, the 
classes act as “off” and “on” switches, respectively [228, 271]. Upstream of the cmr 
switch are encoded a σA-dependent promoter followed by a class II c-di-GMP riboswitch 
that positively regulates cmrRST transcription (Figure 3.1A) [236, 241]. Accordingly, 
high c-di-GMP levels result in the formation of the rough colony morphology, consistent 
with increased cmrRST expression [334]. 
The respective contributions of the c-di-GMP riboswitch and the cmr switch to 
controlling expression of cmrRST, and therefore to the phenotypes controlled by this 
system, are unknown. One challenge to the study of phase variation is its stochastic 
nature, which adds uncontrolled variation into an otherwise controlled experiment. 
Phase locked strains in which the invertible element is prevented from inverting can be 
a useful tool with which to study phase variable systems [103, 184, 335]. Our previous 
work on CmrRST relied primarily on characterization of wild-type (WT) C. difficile rough 
and smooth colony isolates, which have a strong bias for the ON and OFF cmr switch 
orientations, respectively, but remain capable of switch inversion and phenotypic 
switching [334]. In this study, we characterized cmrRST regulation through the interplay 
of c-di-GMP and the invertible element by generating phase locked cmr OFF and cmr 
97 
ON strains. Through phenotypic characterization of these phase locked strains and 
analysis of the effects of c-di-GMP and cmr switch orientation, we found that that these 
regulatory features act independently. Moreover, c-di-GMP control through the 
riboswitch supersedes the effects of invertible element orientation. We determined that 
phase variable regulation occurs through inversion of a promoter encoded in the cmr 
switch. In addition, we demonstrate that CmrR positively autoregulates expression of 
cmrRST. The results of this study indicate that cmrRST expression is subject to 
regulation both through sense-and-respond mechanisms and phase variation, 
highlighting the potential importance of this system to C. difficile physiology through the 
variety of activating signals. 
MATERIALS AND METHODS 
Growth and maintenance of bacterial strains 
C. difficile R20291 (NCBI accession number FN545816.1) and derivative strains 
were maintained in an anaerobic environment of 85% N2, 5% CO2, and 10% H2. C. 
difficile strains were grown statically at 37 °C in BHIS (37 g/L Bacto brain heart infusion, 
5 g/L yeast extract) or in Tryptone Yeast (TY; 30 g/L Bacto tryptone, 20 g/L yeast 
extract, 1 g/L thioglycolate) broth as indicated. E. coli strains were grown in Luria 
Bertani medium at 37 °C with aeration. Antibiotics were used where indicated at the 
following concentrations: chloramphenicol (Cm), 10 μg/mL; thiamphenicol (Tm), 10 
μg/mL; kanamycin (Kan), 100 μg/mL; ampicillin (Amp), 100 μg/mL. Table 3.1 lists 




Construction of plasmids and strains  
Table 3.2 lists primers used in this study. To construct pPtet-DccA (pRT1587) and 
pPtet-EAL (pRT2444), dccA and the catalytic EAL domain of pdcA were PCR amplified 
from R20291 genomic DNA (dccA, primers R1907 and R1908; EAL, primers R2689 and 
R2690). Purified PCR products were digested with SacI and BamHI (New England 
Biolabs) and ligated into a similarly digested pRPF185 [320]. 
To construct pMC123::5'UTR-phoZ (pRT2497), pMC123::5'UTRcmrOFF-phoZ 
(pRT2514), pMC123::5'UTRcmrON-phoZ (pRT2515), inserts were PCR amplified from 
R20291 genomic DNA using the following primers: pRT2497, R2754 + R2342; pRT2514 
and pRT2515, R2337 + R2342. PCR products were digested with EcoRI and BamHI 
(New England Biolabs) and ligated into similarly digested pMC123::phoZ (pRT1343) to 
produce a transcriptional fusion with phoZ. Ligations were transformed into DH5α, and 
Cm-resistant colonies were screened by PCR with the above primers. Plasmids were 
confirmed by PCR and sequencing. Plasmids were transferred to C. difficile R20291 by 
conjugation using E. coli HB101(pRK24) as previously described [274, 314]. 
R20291 ΔcmrRΔcmrT (RT2296) was made by creating a markerless deletion of 
cmrT in R20291 ΔcmrR (RT2256) as previously described [334]. Regions up- and 
downstream of cmrT were PCR amplified (upstream, primers OS268 + OS269; 
downstream, primers OS271 + OS288) and joined by Gibson assembly (New England 
Biolabs) into PmeI-linearized pMTL-SC7215 [63]. The plasmid was introduced into 
R20291 ΔcmrR by conjugation with E. coli HB101(pRK24). Mutants were identified as 
described previously and verified by PCR and sequencing [63, 334]. 
99 
The cmr switch was locked either in the OFF or the ON configuration in C. 
difficile R20291 using a modified version of the previously described codA-based allelic 
exchange method [63]. Briefly, primer pairs OS383 + OS384 and OS385 + OS386 were 
used to PCR-amplify flanking homology regions in order to lock the Cdi6 switch in the 
OFF configuration. In addition, the primers were designed to delete three nucleotides at 
position 3,736,176 – 3,736,178 inclusively. The homology arms were then cloned by 
Gibson Assembly (New England BioLabs) into PmeI-linearized pMTL-SC7215 vector in 
which the codA negative-selection marker was replaced by the holin-endolysin module 
from a prophage in the C. difficile CD630 strain (locus tags CD630_28941 and 
CD630_28940, NCBI accession number CP010905.2) under the control of 
anhydrotetracycline (ATc)-inducible promoter from the pRPF185 plasmid [320]. The 
resulting plasmid was then conjugated into C. difficile R20291 strain as described 
previously [274]. The clones were selected on BHI agar containing 15 mg/ml Tm and 12 
mg/ml norfloxacin. Single-crossover integrant clones were purified by three rounds of 
streaking onto BHI agar with 15 mg/ml Tm and 12 mg/ml norfloxacin followed by 
double-crossover selection on BHI containing 100 ng/ml ATc. Colonies were screened 
for the desired mutation with primers OS387 + OS137. Genomic DNA from PCR-
positive clones was extracted, and the Cdi6 region was PCR-amplified using primers 
OS109 + OS111 following by Sanger-sequencing of the amplicon for verification. The 
same strategy was used to lock the Cdi6 switch in the ON configuration using primer 
pairs OS388 + OS383 and OS389 + OS386 to PCR-amplify homology arms and OS390 
+ OS391 for PCR-screening of presumed double-crossover clones. 
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R20291 recV cmr ON (RT2520) was derived from R20291 recV cmr OFF by 
ectopically expressing recV (pRecV) to stimulate cmr switch inversion, then screening 
resulting isolates for the cmr ON switch orientation. Specifically, RT1697 was grown in 
the presence of 20 ng/mL ATc to induce recV expression, then plated on BHIS without 
antibiotic selection to allow loss of pRecV. Tm-sensitive colonies, indicating loss of the 
plasmid pRecV, were identified by replica plating, and cmr ON isolates were identified 
by PCR with orientation-specific primers R2270 + R2271. 
  
Orientation specific PCR 
Orientation specific PCR was done as previously described [103, 138]. C. difficile 
strains were grown on BHIS-agar. Colonies were boiled to produce lysate for PCR  
using primers R2270 + R2271 to detect the ON orientation (140 bp product) and 
RT2271 + RT2272 to detect the OFF orientation (240 bp product). PCR products were 
separated on a TAE-1.5% agarose gel. 
 
Quantitative reverse-transcriptase PCR 
For analysis of cmrR and cmrT expression in C. difficile R20291 (WT), RIRmut cmr 
ON and cmr OFF, these strains were grown overnight (16 h) in TY medium, and 5 L 
were spotted on BHIS plates. After 24 hours, growth was collected, suspended in 1:1 
ethanol:acetone, and stored at -80 ºC for subsequent RNA isolation.  
For analysis of expression in R20291 strains carrying pCmrR, pCmrT or vector, 
these strains were grown overnight in TY-Tm medium. Cultures were diluted 1:30 in 
BHIS-Tm broth. After two hours growth, ATc was added to induce gene expression (WT 
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with vector and pCmrR, 10 ng/mL; WT with pCmrT, 2 ng/mL). Samples were collected 
at mid-exponential phase and saved in 1:1 ethanol:acetone at -80 ºC. 
After RNA was isolated and purified, samples were treated with TURBO  DNA-
free™  Kit (Life Technologies), and cDNA was synthesized using High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems)using the manufacturer’s protocols [184, 
237]. Real-time PCR was performed using SensiFAST SYBR & Fluorescein Kit (Bioline) 
as previously described. Data were analyzed using the ΔΔCt method, with rpoC as the 
reference gene and the indicated control condition [103]. Primers are as follows: rpoC, 
R850 + R851; cmrR, R2298 + R2299; cmrT, R2537 + R2538; cmrS, R2539 + 2540; 
TSS1, R2745 + R2746; TSS2/3, R2751 + R2804; TSS4, R2803 + R2716. 
Quantification of switch orientation by quantitative PCR 
WT pMC-Pcpr (RT526) and WT pDccA (RT527) were grown overnight in TY-Tm 
broth then diluted 1:30 in BHIS-Tm containing 1 µg/mL nisin  to induce dccA expression. 
After growth to late exponential phase, genomic DNA was purified by 
phenol:chloroform:isopropanol extraction and washed with ethanol. qPCR was 
performed as previously described with 100 ng of DNA per 20 µL reaction and 100 nM 
primers [334]. Data were analyzed using the ΔΔCt method, with rpoA as the reference 
gene and the indicated control condition [138]. Primers are as follows: ON orientation, 
R2270 + R2271; OFF orientation, R2271 + R2272; and rpoA, R2273 + R2274. 
Microscopy 
To image whole colonies, strains were grown on BHIS-Tm agar for 24 hours. For 
RIRmut cmr ON/OFF with pPtet-DccA, pPtet-EAL, or vector, ATc (20 ng/mL) was included 
in the agar. For WT, ΔcmrT, and ΔcmrRΔcmrT carrying pCmrR, pCmrT or vector 
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control, ATc was included at 10 ng/mL for strains with vector or pCmrR and at 2 ng/mL 
for pCmrT. Colonies were imaged using a Keyence BZ-X810 microscope or Zeiss 
Stereo Discovery V8 dissecting microscope with a glass stage. 
Fluorescence microscopy of SNAP-labelled strains was performed as previously 
described [138]. R20291 cmrR::SNAP pPtet-DccA or vector control were grown 
overnight in TY-Tm broth. Cultures were diluted 1:30 in BHIS-Tm. After two hours of 
growth, ATc (20 ng/mL) was added for induction. Mid-exponential phase samples were 
pelleted, washed, and incubated with SNAP-Cell TMR-Star (New England Biolabs) at 
37 ºC for 30 minutes. Samples were further washed and mounted on 1% agarose pads. 
Imaging was done using bright field and red channel on a Keyence BZ-X810 
microscope. Cells were counted on at least three fields from two biological replicates for 
each strain and condition. 
 
Motility assays 
Motility assays were done as previously described [103, 113, 334]. For surface 
motility, 5 µL of overnight culture was spotted onto BHIS-1% glucose-1.8% agar. For 
swimming motility, 1 µL was inoculated into 0.5x BHIS-0.3% agar. For strains carrying 
plasmids, Tm and ATc induction was included (10 ng/mL for vector and pCmrR; 2 
ng/mL for pCmrT). After 48 hours (swimming) or 72 hours (surface), the diameter of the 
motile spots were measured at the widest point and perpendicular to the first 
measurement. These measurements were averaged to reflect overall diameter. Surface 




Biofilm assays were done as described previously [120, 334]. Cultures were 
grown overnight in TY broth and diluted 1:100 in BHIS-1% glucose-50 mM sodium 
phosphate buffer in a 24-well polystyrene plate. Plates were grown statically for 24 
hours. Supernatant were removed from each well. The adherent biofilms were washed 
once with PBS then stained for 30 minutes with 0.1% crystal violet. After the crystal 
violet was removed, the biofilms were washed once more with PBS and the remaining 
crystal violet was solubilized with 1 mL ethanol. Absorbance at 570 nm was measured. 
 
Alkaline phosphatase assays 
Strains carrying phoZ reporters were grown in BHIS medium to OD600 ~ 1.0, then 
1.5 mL of culture was collected, pelleted and frozen. Samples were thawed, and 
alkaline phosphatase activity using the substrate p-nitrophenyl phosphate was 
measured as previously described [103, 336]. 
 
5’ rapid amplification of cDNA ends (RACE) 
R20291 recV cmr OFF (RT1693), recV cmr OFF pDccA (RT2184), and recV cmr ON (RT2520) 
were grown in BHIS to mid-exponential phase. RT2184 was grown with Tm and induced with 1 
µg/mL nisin. Samples were collected and frozen in 1:1 ethanol:acetone. RNA was extracted and 
purified as described above. cDNA was synthesized with the 5' RACE System for Rapid 
Amplification of cDNA Ends kit (Thermofisher) using the manufacturer’s protocol. Briefly, cDNA 
was synthesized using primer R2792 and SuperScript II reverse transcriptase. The samples 
were treated with RNase Mix then column purified and treated with TdT. The products were 
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then PCR amplified with the provided anchor primer and primer R2793, then subjected to 
Sanger sequencing.  
 
RESULTS 
Generation and phenotypic characterization of phase locked cmr ON and cmr 
OFF strains 
To characterize the dual regulation of the cmrRST system by phase variation and 
c-di-GMP, we first generated strains phase locked with the cmr invertible element 
irreversibly in the ON and OFF orientations. Phase locking can be achieved in multiple 
ways. One strategy is to delete the site-specific recombinase responsible for inversion. 
In C. difficile R20291, the RecV recombinase is required for inversion of the cmr switch 
[138]. However, RecV mediates inversion of multiple sequences, thus a mutation in 
recV has pleiotropic effects [103, 138, 179]. Instead, we chose to phase lock the cmr 
switch by mutating an inverted repeat, preventing site-specific recombination from 
occurring [158]. The exact nucleotides at which recombination and inversion of the cmr 
switch occurs were previously identified [138]. We used allelic exchange to delete the 
nucleotide at the site of inversion in the right inverted repeat (RIR) (position 3,736,177) 
in the R20291 genome, as well as one additional nucleotide on each side (Figure 3.1B). 
We recovered independent mutants with the cmr switch in either orientation and 
designated them RIRmut cmr ON and RIRmut cmr OFF. These mutants were subjected to 
orientation specific PCR to confirm that they are genotypically phase locked. In contrast 
to the WT parent that yielded both cmr ON and OFF products, RIRmut cmr ON 
exclusively yielded a PCR product corresponding to the ON orientation, and RIRmut cmr 
OFF only yielded the OFF orientation product (Figure 3.1C).  
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Previous work showed that R20291 rough and smooth colony variants correlate 
with cmr ON and OFF gene expression and phenotypes, respectively [334]. Specifically, 
the cmr ON, rough colony variant exhibits greater surface growth and reduced 
swimming motility compared to the cmr OFF, smooth colony variant. Furthermore, 
ectopic expression of cmrR and cmrT individually stimulated rough colony formation and 
surface motility while inhibiting flagellum-mediated swimming motility, although only 
cmrT was required for rough colony development and surface motility. To conclusively 
determine the effect of cmr switch orientation on gene expression, we measured the 
abundance of the cmrR and cmrT transcripts in the RIRmut cmr ON and RIRmut cmr OFF 
mutants. Non-locked rough and smooth isolates were included as controls [334]. Both 
cmrR and cmrT transcripts were 7- to 10-fold more abundant in C. difficile with the cmr 
switch in the ON orientation, whether in the naturally arising rough colony variant or in 
RIRmut cmr ON (Figure 3.1D). Therefore, the three nucleotides at the site of RecV-
mediated recombination are required for cmr switch inversion, and the ON orientation of 
the invertible element is sufficient to promote expression of cmrRST.  
The RIRmut phase-locked mutants were then evaluated for the phenotypes 
previously associated with cmrRST expression. As a control we included WT R20291, 
which is capable of CmrRST phase variation and generation of both rough and smooth 
colonies, as well as a ΔcmrRΔcmrT double mutant that forms only smooth colonies 
(Figure 3.2A). The RIRmut cmr OFF mutant formed exclusively smooth colonies, similar 
to ΔcmrRΔcmrT. RIRmut cmr ON formed rough colonies that resemble those in WT, 
though they appeared to have less defined topology (Figure 3.2A). Also consistent with 
increased cmrRST expression, RIRmut cmr ON displayed greater surface motility than 
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WT, while RIRmut cmr OFF had decreased surface motility more similar to that of 
ΔcmrRΔcmrT (Figure 3.2B, C). Finally, RIRmut cmr ON showed decreased swimming 
motility and biofilm formation compared to all other strains (Figure 3.2D, E). Together, 
these results reinforce the model that the cmr switch orientation modulates expression 
of cmrRST and therefore regulates colony morphology, motility, and biofilm formation. 
C-di-GMP regulates cmrRST expression independently of the invertible element 
Upstream of the cmr switch is a σA-dependent promoter followed by a c-di-GMP 
riboswitch sequence, adding another regulatory layer to the transcription of cmrRST 
[236, 241, 334]. The two regulatory features could act independently with one regulatory 
element dominant over the other, or act coordinately such that both the riboswitch and 
cmr switch must be in the “on” state to allow cmrRST transcription. To distinguish 
between these possibilities, we modulated c-di-GMP levels in the phase-locked RIRmut 
cmr ON and OFF strains by overexpressing the diguanylate cyclase dccA (pPtet-DccA) to 
increase intracellular c-di-GMP or the catalytic EAL domain of the phosphodiesterase 
pdcA, which hydrolyzes c-di-GMP, to reduce c-di-GMP (pPtet-EAL) [113, 120, 237]. 
Increasing c-di-GMP through overexpression of dccA resulted in rough colony formation 
in RIRmut cmr OFF, which normally forms smooth colonies (Figure 3.3A). Additionally, 
increasing c-di-GMP enhanced the rough colony appearance of RIRmut cmr ON. In 
contrast, reduction of c-di-GMP through overexpression of the EAL domain did not 
visibly affect the morphology of RIRmut cmr ON or OFF, suggesting that c-di-GMP levels 
are insufficient to drive expression of cmrRST under these conditions. Overexpression 
of dccA led to a significant 2- to 3-fold increase in the abundance of the cmrS transcript, 
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which served as a marker for cmrRST expression, in both RIRmut cmr ON and OFF, 
consistent with the colony morphology phenotypes observed (Figure 3.3B).  
These methods reflect changes in cmrRST expression as a population average. 
To assess the effects of the c-di-GMP riboswitch and the cmr switch on the 
heterogeneity of cmrRST expression among individual bacteria, we used a strain in 
which cmrR was replaced by a codon-optimized SNAP-tag gene reporter [138]. The 
pDccA plasmid and vector control were introduced into this strain. In the ΔcmrR::SNAP 
strain with vector and in the uninduced control, approximately 1% of the population 
fluoresced (Figure 3.3C). This result is similar to prior analyses showing that a minority 
of WT cells express cmrRST [138]. Induction of dccA increased fluorescence-positive 
cells to > 95%. This result is not due to a shift in cmr switch orientation. By qPCR, the 
orientation of the cmr switch was not significantly different between WT overexpressing 
dccA and the vector control (Figure 3.4). Therefore, the higher percentage of 
fluorescent cells reflects cmrRST expression in response to c-di-GMP. Together, these 
data indicate that expression of cmrRST from the upstream σA-dependent promoter and 
c-di-GMP riboswitch is not dependent on orientation of the cmr switch. Rather, high c-di-
GMP levels increase cmrRST expression regardless of orientation. 
The cmr switch contains a promoter in the ON orientation 
 The best characterized phase variation regulatory mechanisms involve a 
promoter encoded within the invertible element that drives expression of adjacent genes 
when in the proper orientation [139, 332]. Our data suggest that cmrRST transcription 
may originate from multiple sites in a manner dependent on internal c-di-GMP 
concentrations and the orientation of the cmr switch. Therefore, we sought to map the 
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transcriptional start sites (TSS) in strains reflecting these different states. Instead of 
using RIRmut phase locked strains, which are missing three nucleotides of unknown 
significance to transcription, we used strains in which the cmr switch is locked by a 
mutation in recV, designated recV cmr ON and recV cmr OFF (Figure 3.5). Additionally, 
dccA was overexpressed in recV cmr OFF to identify any TSS associated with 
increased c-di-GMP. Using 5’ RACE, four total TSS were identified in recV cmr ON, 
recV cmr OFF, and recV cmr OFF pDccA. In recV cmr OFF with and without dccA 
expression, a TSS designated TSS1 was identified 699 nt upstream of the cmrR start 
codon, upstream of the c-di-GMP riboswitch (Figure 3.6A, Figure 3.7). TSS1 was not 
detected in recV cmr ON, but this may be due to lower relative abundance of the TSS1 
transcript compared to transcripts from other initiation sites. Another TSS, designated 
TSS2, was found in recV cmr ON, located 336 nt upstream of cmrR and mapping within 
cmr switch in the ON orientation. A third TSS, designated TSS3, was identified 343 nt 
upstream of the cmrR start codon in both recV cmr OFF strains. This position maps 
TSS3 to within the cmr switch, appearing only in transcripts from the cmr OFF strains. In 
all three strains, TSS4 was identified 90 nt upstream from the cmrR start codon.  
These results suggest that expression of cmrRST can originate from multiple 
sites and confirm an expected TSS upstream of the c-di-GMP riboswitch. TSS2 within 
the cmr switch in the ON orientation was identified; however, we unexpectedly identified 
TSS3 within the cmr switch in the OFF orientation. To elucidate how phase variable 
cmrRST expression is mediated, we examined the functionality of these newly identified 
TSS. We created a series of transcriptional reporter fusions of the alkaline phosphatase 
(AP) gene phoZ to regions immediately upstream of cmrRST (Figure 3.6B) [336]. Two 
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of the fusions contain the upstream region from the LIR to the start of the cmrR coding 
sequence. These fusions differ in the orientation of the invertible element: ON 
(pMC123::5'UTRcmrON-phoZ) encompasses TSS2, and OFF 
(pMC123::5'UTRcmrOFF-phoZ) encompasses TSS3. Both fusions also include TSS4. 
Additionally, we included a reporter with the region from the 3’ end of the RIR to the 
start of the cmrR coding sequence (pMC123::5'UTR-phoZ), which contains TSS4, as 
well as a promoterless control (vector). To prevent inversion of the invertible element 
present in the reporters once in C. difficile, we assayed AP activity in a recV mutant 
lacking the recombinase necessary for inversion [138]. C. difficile with pMC123::5'UTR-
phoZ (Figure 3.6B, construct 1) or pMC123::5'UTRcmrOFF-phoZ (construct 2) showed 
no significant difference in activity compared to the promoterless control (Figure 3.6C). 
In contrast, C. difficile with pMC123::5'UTRcmrON-phoZ (construct 3) exhibited more 
than 30-fold higher AP activity (Figure 3.6C). These results indicate the presence of a 
functional promoter in the ON orientation of the cmr switch that leads to the TSS2 
transcript and suggest that the TSS3 and TSS4 transcripts are minor products. 
CmrR positively autoregulates expression of cmrRST 
Response regulators often have the property of autoregulating their expression 
[337]. To determine whether CmrR and/or CmrT have the ability to transcriptionally 
regulate cmrRST, we overexpressed cmrR (pCmrR) and cmrT (pCmrT) in C. difficile 
and analyzed cmrRST expression by qRT-PCR. Overexpression of cmrR resulted in a 
significant 7-fold increase in transcript abundance of cmrS and cmrT as compared to 
the vector control (Figure 3.8A). In contrast, overexpression of cmrT had no effect on 
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cmrR or cmrS transcript abundance. These results indicate the CmrR, but not CmrT, 
transcriptionally regulates the cmrRST operon.  
To assess whether CmrR-mediated regulation is dependent on the orientation of 
the invertible element, we overexpressed cmrR in the phase-locked recV mutants. 
Overexpression of cmrR significantly increased cmrS transcript abundance compared to 
the respective vector control in both recV cmr OFF and cmr ON strains (Figure 3.8B). 
While overexpression of cmrR in recV cmr OFF resulted in over a 20-fold increase in 
cmrS transcript abundance relative to vector control, cmrS transcript increased only 
about 2-fold in recV cmr ON pCmrR relative to vector control. We considered the 
possibility that CmrR regulates cmrRST expression from one of the previously identified 
TSS. To address this possibility, we used qRT-PCR to assess the transcript abundance 
of sequences immediately downstream of TSS1, the cmr switch containing TSS2 and 
TSS3, and TSS4 (Figure 3.8C). Transcript abundance did not increase following TSS1 
but did increase following the cmr switch with cmrR overexpression in both recV cmr 
OFF and cmr ON relative to the respective vector controls (Figure 3.8D). This result 
suggests that CmrR autoregulates cmrRST expression from either orientation of the cmr 
switch, though most strongly from the OFF orientation.  
cmrRST and its upstream regulatory elements are well conserved in C. difficile 
C. difficile strains from multiple ribotypes form rough and smooth colonies 
associated with phase variable cmrRST expression [334]. To examine the potential 
scope of CmrRST phase variation and function in C. difficile, we used NCBI BLAST to 
determine the extent of conservation of cmrRST and its upstream regulatory region 
using R20291 as the reference sequence. The analysis examined the 895 bases 5’ of 
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cmrR, which contains a c-di-GMP riboswitch and the cmr switch (Figure 3.1A), and the 
cmrRST coding sequences. Among the 71 available C. difficile whole genome 
sequences available in NCBI (taxonomic ID 1496), C. difficile strains shared high 
percent sequence identity to the reference for both the riboswitch (98.9% ± 1.2) and the 
cmr invertible element (98.1% ± 1.4) (Figure 3.9). This similarity is comparable to the 
average percent sequence identity for the cmrRST operon (98.7% ± 1.1). These results 
indicate that the c-di-GMP riboswitch and invertible element upstream of cmrRST are 
highly conserved across many C. difficile strains from divergent ribotypes and 
underlines the importance of this operon and its regulation to C. difficile physiology. 
 
DISCUSSION 
In this study, we demonstrate that the regulatory systems controlling the 
expression of cmrRST are complicated and multilayered. Our data support a model in 
which under basal c-di-GMP conditions, the orientation of the invertible element 
determines the expression level of cmrRST. However, under high c-di-GMP conditions, 
cmrRST is expressed and the orientation of the invertible element is secondary. Our 
data also suggest that the expression of cmrRST is subject to autoregulation through 
CmrR. Therefore, cmrRST expression may be influenced by multiple environmental 
signals through c-di-GMP, phase variation, and the response regulator CmrR. Because 
CmrRST has important roles in C. difficile motility, biofilm formation, and virulence, 
these results suggest there are multiple environmental criteria that need to be integrated 
to appropriately control cmrRST expression. 
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 To disentangle the roles of c-di-GMP and phase variation in cmrRST 
transcription, we phase locked the cmr switch by deleting only three nucleotides out of 
28 in the RIR, one of which was identified as the exact site of recombination during 
inversion of the invertible element by using pair-end sequencing [138]. Phenotypic 
analysis of phase locked R20291 RIRmut cmr ON and cmr OFF strains showed that they 
behave similarly to WT rough and smooth populations, respectively. cmrRST 
expression in the locked ON strain was equivalent to that of a WT rough population, as 
was the expression in RIRmut cmr OFF compared to WT smooth population. Consistent 
with these results, RIRmut cmr ON exhibited rough colonies, increased surface motility 
and decreased swimming motility and biofilm formation as compared to smooth WT, 
locked OFF, and ΔcmrRΔcmrT strains. These data indicate that orientation of the cmr 
switch is sufficient to drive expression of cmrRST and further confirms the role of 
cmrRST in these phenotypes. Interestingly, while RIRmut cmr ON forms rough colonies, 
they are not identical to those formed in WT populations, and there is still some 
heterogeneity of colony morphology. This observation may reflect differences in activity 
of CmrR or CmrT or that other factors contribute to colony morphology.  
We found that c-di-GMP regulates cmrRST expression regardless of the 
orientation of the invertible element. This suggests that the OFF orientation does not 
contain a terminator sufficient to completely prevent transcription from an upstream 
promoter as described for other invertible DNA elements in C. difficile [103, 179]. RIRmut 
cmr OFF exhibited surface motility intermediate between WT and ΔcmrRΔcmrT. This 
may be because in the locked OFF strain, cmrRST can still be expressed from the 
promoter upstream of the invertible element if c-di-GMP levels are permissive. C-di-
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GMP levels increase in C. difficile with growth on a surface [113]. Therefore, c-di-GMP 
likely promotes CmrRST-mediated surface motility regardless of switch orientation. 
Multiple TSS were identified upstream of cmrRST including TSS in the ON and 
OFF orientations of the cmr switch (TSS2 and TSS3, respectively) and between the 
switch and the translational start of cmrR (TSS4). However, only the ON orientation of 
the switch showed significant promoter activity through transcriptional reporters. This 
suggests that a promoter in the ON orientation of the cmr switch is responsible for the 
phase variable expression of cmrRST. The physiological significance of TSS3 and 
TSS4 is unclear. These may represent the start sites of low abundance transcripts that 
do not significantly contribute to cmrRST transcription under the tested conditions. 
In other bacteria, the inversion of a promoter is common mechanism by which 
invertible elements regulated downstream genes [139]. Interestingly, the cmr switch is 
the first invertible element shown to use this mechanism of regulation in C. difficile. The 
Cdi1 invertible element, which regulates the expression of downstream gene cwpV, 
forms an intrinsic transcriptional terminator in the OFF orientation [179]. In the ON 
orientation, the Cdi1 invertible element simply permits expression originating from an 
upstream promoter. While the mechanism by which mechanism by which the flg (Cdi-4) 
invertible element regulates expression is unknown, evidence suggests that there is not 
a promoter in the ON orientation and that the OFF orientation terminates transcription 
through an undefined mechanism [103]. Like the cmr switch, there is a promoter with a 
c-di-GMP riboswitch upstream of the flg invertible element [103, 104, 236]. However, 
this riboswitch inhibits transcription in response c-di-GMP binding. Therefore, in spite of 
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having similar regulatory elements, the flg and cmr operons are regulated by those 
elements in opposing manners. 
 We found that CmrR positively regulates expression of cmrRST. It is not 
uncommon for response regulators to regulate their own expression [337]. For example, 
in Salmonella enterica, the response regulator PhoP autoregulates expression of 
phoPQ, which regulates the composition of the bacterial enveloped and contributes to 
pathogenesis [338]. Further examples of autoregulation by response regulators include 
the BvgAS system in Bordetella pertussis and the VanRS system in Enterococcus 
faecium, both of which are key virulence determinants [339, 340]. Interestingly, CmrT 
does not regulate the expression of cmrRST, suggesting that despite significant 
homology between CmrR and CmrT, they may not share DNA binding motifs and 
therefore may have distinct regulons. We found that CmrR positively regulates 
expression of cmrRST with the cmr switch in both orientations and that CmrR-promoted 
transcription may originate from the cmr switch, possibly corresponding to the TSS2 and 
TSS3 sites. This suggests that cmrRST transcription may be subject to a positive 
feedback loop independent of switch orientation through CmrR. 
In summary, this work demonstrates that cmrRST expression is subject to 
multilayered regulation with multiple potential inputs from environmental signals. The 
complexity of this regulatory network suggests that cmrRST expression, and therefore 
its transcriptional targets, requires careful control. Further work that defines the signals 
which promote cmrRST expression will provide important insights into the role of this 
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FIGURES AND TABLES 
 
Figure 3.1. Generation of genetically phase-locked strains. A) Sequence of the right 
inverted repeat (RIR) of the cmr switch. Gray shading indicates sequence identity 
between the imperfect inverted repeats of the RIR in each orientation. Three 
nucleotides (shown in red) were deleted from the RIR to lock the cmr switch in the ON 
and OFF orientations. The asterisk (*) indicates the nucleotide at the site of 
recombination. B) Orientation-specific PCR to detect each orientation of the cmr switch 
in WT, RIRmut cmr OFF, and RIRmut cmr ON strains. C) qRT-PCR analysis for the cmrR 
and cmrT transcripts in WT rough and smooth isolates, RIRmut cmr OFF and RIRmut cmr 
ON. Data from four biological replicates were analyzed using the ΔΔCt method with 
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rpoC as the reference gene and normalization to the WT smooth samples . Shown are 





Figure 3.2. Phase-locked cmr ON strain phenocopies the WT rough morphotype. 
A) Colony morphology of WT rough and smooth isolates, RIRmut cmr OFF, RIRmut cmr 
ON, and ΔcmrRΔcmrT. Shown are representative images after 24 hours growth on 
BHIS agar. B) Surface motility of WT, RIRmut cmr OFF, RIRmut cmr ON, and 
ΔcmrRΔcmrT. Surface motility was quantified by measuring the diameter of growth after 
72 hours. Shown are means with standard deviations of eight biological replicates. C) 
Representative images of surface motility after 72 hours of growth. D) Swimming 
motility of WT, RIRmut cmr OFF, RIRmut cmr ON, and ΔcmrRΔcmrT mutant. Motility was 
quantified by measuring the diameter of growth in 0.5x BHIS 0.3% agar after 48 hours. 
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Shown are means with standard deviations of eight biological replicates from two 
independent experiments. E) Biofilm formation after 24 h in BHIS-1% glucose-50 mM 
sodium phosphate, quantified by crystal violet staining. Shown are means and standard 
deviations of 5-6 biological replicates normalized to values of WT. * p < 0.05, **** p < 





Figure 3.3. Regulation of cmrRST by c-di-GMP occurs independent of cmr switch 
orientation. A) Colony morphology of RIRmut cmr OFF and RIRmut cmr ON containing 
either vector, pPtet-DccA, or pPtet-EAL manipulation of intracellular c-di-GMP. Strains 
were grown on BHIS-agar with or without ATc to induce DGC and EAL gene 
expression. B) qRT-PCR analysis for expression of cmrR in RIRmut cmr OFF and RIRmut 
cmr ON strains carrying pDccA or vector control. Strains were grown in BHIS broth with 
ATc induction. Data were analyzed using the ΔΔCt method with rpoC as the reference 
gene and normalization to cmr OFF-vector. Shown are means with standard deviations 
of 6 biological replicates from two experiments.  * p < 0.05, *** p < 0.001, one-way 
ANOVA with Tukey’s multiple comparisons post-test. C) ∆cmrR::SNAP carrying pPtet-
DccA or vector control was grown in BHIS broth with 20 ng/ml ATc. Samples were 
imaged at 60x magnification by light and fluorescence microscopy following staining 
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with SNAP-Cell TMR-Star substrate. Shown are representative images with 
percentages of cells that are fluorescence-positive. Cells from at least three fields each 
from two biological replicates were counted. Numbers indicate the means and standard 




Figure 3.4. C-di-GMP does not cause inversion of the cmr invertible element. WT 
pDccA and vector control were grown in BHIS with nisin induction until late exponential 
phase, and gDNA was collected for qPCR analysis of cmr switch orientation. Data are 
expressed as the percent OFF orientation. Shown are the means and standard 
deviations of six biological replicates from two independent experiments. n.s. not 




Figure 3.5. The cmr switch is phase locked in recV-deficient strains. Orientation-
specific PCR to detect each orientation of the cmr switch in WT, recV cmr OFF and 




Figure 3.6. The cmr switch contains a promoter in the ON orientation. A) Diagram 
of TSS identified by 5' RACE B) Representation of the alkaline phosphatase reporters 
used in this experiment. Brackets indicate the regions from the native cmr locus that 
were used to make transcriptional reporters. Construct 1 contains the region between 
the 3’ end of the right inverted repeat and the 5’ end of cmrR coding sequence 
(pMC123::5'UTR-phoZ). Construct 2 includes the region in in construct 1 plus the cmr 
switch in the OFF orientation (pMC123::5'UTRcmrOFF-phoZ). Construct 3 is identical to 
construct 2 but with the cmr switch in the ON orientation (pMC123::5'UTRcmrON-phoZ). 
B) Activity of constructs 1, 2, and 3 as well as promoterless control, in the recV cmr OFF 
strain background. Shown are the means and standard deviations data from nine 
biological replicates from three independent experiments. ****p < 0.0001, one-way 





Figure 3.7. Identification of multiple transcriptional start sites upstream of 
cmrRST. Map of TSS identified by 5’ RACE in recV cmr ON, recV cmr OFF and recV 
cmr OFF pDccA. Gray highlight indicates the riboswitch sequence. Red and blue text 
denote the OFF and ON orientations of the cmr switch, respectively. Bold text indicates 
the inverted repeats. Green highlight mark TSS. Underline text indicates predicated -








Figure 3.8. CmrR positively regulates cmrRST expression. qRT-PCR measurement 
of cmrRST transcript abundance. Strains were grown with ATc induction (10 ng/mL for 
vector and pCmrR, 2 ng/mL for pCmrT) prior to RNA isolation. A) WT with pCmrR, 
pCmrT, and vector control. n.d., not determined; cmrR and cmrT were not measured in 
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strains overexpressing those genes. Shown are means and standard deviations of 4-6 
biological replicates. For cmrS measurements, ****p < 0.0001, one-way ANOVA with 
Tukey’s multiple comparisons post-test. B) qRT-PCR analysis of cmrS transcript 
abundance of recV cmr OFF and cmr ON, each with pCmrR or vector control. cmr OFF 
vector serves as the reference condition for ΔΔCt analysis. Shown are means and 
standard deviations of 4 biological replicates. ****p < 0.0001 relative to respective vector 
control, one-way ANOVA with Sidak’s multiple comparisons post-test. C-D) qRT-PCR 
analysis of sequence immediately downstream of the indicated TSS (shown in C). cmrS 
transcript abundance data is also shown in B. cmr OFF vector serves as the reference 
condition for ΔΔCt analysis. ***p < 0.001, ****p < 0.0001 relative to respective vector 





Figure 3.9. cmrRST and regulatory element sequences are highly conserved 
across C. difficile strains and ribotypes. Heat map showing percent sequence 
identity of 71 sequenced C. difficile strains in the NCBI database compared to R20291 
reference sequence (NCBI accession number FN545816.1). If the strain has been 
ribotyped, the ribotype is indicated on the left. For the cmr switch, both orientations were 
used as the reference and the highest percent sequence identity is shown. The 
following nucleotides were used as the reference sequence from R20291: riboswitch, 
3736512-3736863; cmr switch, 3735969-3736513; cmrRST, 3732474-3735968. 
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Table 3.1. Strains and plasmids used in this study. 
Lab 
Notation Strain/Plasmid Name Description Reference 
AC472 Escherichia coli DH5a F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
recA1 endA1 hsdR17(rκ -, mκ+) phoA 
supE44 thi-1 gyrA96 relA1 λ- tonA 
Invitrogen 
[313] 
RT270 Escherichia coli 
HB101(pRK24) 
E. coli used in conjugations with C. difficile, 
ApR, CmR 
[314] 
RT273 C. difficile R20291 Ribotype 027 strain (Genbank Accession # 
FN545816) 
[99] 
RT2395 R20291 RIRmut cmr OFF R20291 with the cmr invertible element 
locked in the OFF orientation due to the 
deletion of three nucleotides in the right 
inverted repeat 
This work 
RT2406 R20291 RIRmut cmr ON R20291 with the cmr invertible element 
locked in the ON orientation due to the 
deletion of three nucleotides in the right 
inverted repeat 
This work 
RT2256 R20291 ΔcmrR R20291 with in-frame deletion of cmrR [334] 
RT2296  R20291 ΔcmrRΔcmrT R20291 with in-frame deletions of cmrR 
and cmrT  
This work 
RT2435 R20291 RIRmut cmr ON 
vector 
R20291 cmr locked ON with pRT1611 This work 
RT2436 R20291 RIRmut cmr ON 
pPtet-DccA 
R20291 cmr locked ON with pRT1587 This work 
RT2437 R20291 RIRmut cmr ON 
pPtet-EAL 
R20291 cmr locked ON with pRT2444 This work 
RT2438 R20291 RIRmut cmr OFF 
vector 
R20291 cmr  locked OFF with pRT1611 This work 
RT2439 R20291 RIRmut cmr OFF 
pPtet-DccA 
R20291 cmr  locked OFF with pRT1587 This work 
RT2440 R20291 RIRmut cmr OFF 
pPtet-EAL 
R20291 cmr  locked OFF with pRT2444 This work 
RT2187 R20291 cmrR::SNAP R20291 with cmrR replaced by allelic 
exchange with a SNAP-tag coding 
sequence 
[138] 
RT2500 R20291 cmrR::SNAP 
vector 
R20291 cmrR::SNAP with pRT1611 This work 
RT2501 R20291 cmrR::SNAP 
pPtet-DccA 
R20291 cmrR::SNAP with  pRT1587 This work 
RT1693 R20291 recV cmr OFF R20291 with an insertional mutation in 
recV (recV::ermB); cmr locked OFF 
[181] 
RT2502 R20291 recV  
pMC123::phoZ 
R20291 recV::ermB cmr OFF with 
pMC123::phoZ 
This work 
RT2507 R20291 recV 
pMC123::5'UTR-phoZ 
R20291 recV::ermB cmr OFF with 
pRT2497 
This work 
RT2516 R20291 recV  
pMC123::5'UTRcmrOFF
-phoZ 




RT2517 R20291 recV 
pMC123::5'UTRcmrON-
phoZ 
R20291 recV::ermB cmr OFF with 
pRT2515 
This work 
RT1615 R20291 vector R20291 with pRT1611 [103] 
RT2085 R20291 pCmrR R20291 with pCmrR (pRT2073) [334] 
RT2107 R20291 pCmrT R20291 with pCmrT (pRT2106) [334] 
RT2463 R20291 RIRmut cmr OFF 
pCmrR 
R20291 cmr locked OFF pCmrR This work 
RT2465 R20291 RIRmut cmr ON 
pCmrR 
R20291 cmr locked ON pCmrT This work 
RT526 R20291 pMC-Pcpr R20291 with pMC-Pcpr containing a nisin 
inducible promoter 
[113] 
RT527 R20291 pDccA R20291 with pMC-Pcpr::dccA [113] 
RT2269 R20291 ΔcmrT vector R20291 ΔcmrT with pRT1611 [334] 
RT2402 R20291 ΔcmrT pCmrR R20291 ΔcmrT with pRT2073 This work 
RT2270 R20291 ΔcmrT pCmrT R20291 ΔcmrT with pRT2106 [334] 
RT2183 R20291 recV cmr OFF 
pMC-Pcpr 
R20291 recV::ermB cmr OFF with pMC-
Pcpr 
This work 
RT2184 R20291 recV cmr OFF 
pDccA 
R20291 recV::ermB cmr OFF with pMC-
Pcpr::dccA 
This work 
RT1697 R20291 recV cmr OFF 
pRecV 
R20291 recV::ermB cmr OFF with pPtet-
RecV 
[262] 
RT2520 R20291 recV cmr ON R20291 recV::ermB cmr locked ON This work 
RT2198 R20291 recV cmr OFF 
vector 
R20291 recV::ermB cmr OFF with 
pRT1611 
This work 
RT2543 R20291 recV cmr OFF 
pCmrR 
R20291 recV::ermB cmr OFF with 
pRT2073 
This work 
RT2544 R20291 recV cmr ON 
vector 
R20291 recV::ermB cmr ON with pRT1611 This work 
RT2545 R20291 recV cmr ON 
pCmrR 
R20291 recV::ermB cmr ON with pRT2073 This work 
RT1077 pMTL-SC7215 Vector for allelic exchange in C. difficile 
R20291 
[63] 
RT709 pRPF185 Contains ATc-inducible Ptet promoter with 
gusA 
[320] 
RT1611 pRT1611 Derivative of pRPF185 with gusA removed [103] 
RT1587 pPtet-DccA pRPF185 with gusA replaced by dccA This work 
RT2444 pPtet-EAL pRPF185 with gusA replaced by pdcA-EAL This work 
RT2073 pCmrR pRPF185 with gusA replaced by cmrR [334] 
RT2106 pCmrT pRPF185 with gusA replaced by cmrT [334] 
RT1343 pMC123::phoZ pMC123 with Enterococcus faecalis phoZ [103] 
RT2497 pMC123::5'UTR-phoZ phoZ transcriptional reporter including the 
region between cmrR and right inverted 




phoZ transcriptional reporter including the 
region from the cmr invertible element 





phoZ transcriptional reporter including the 
region from the cmr invertible element 





Table 3.2. Primers used in this study. 
Primer 









































CHAPTER 4. TRANSCRIPTOME ANALYSIS OF THE PHASE VARIABLE SIGNAL 
TRANSDUCTION SYSTEM CmrRST IN CLOSTRIDIOIDES DIFFICILE3
 
INTRODUCTION 
 The ability to sense and respond to environmental signals is key to bacterial 
adaptation and survival. Two component systems (TCS) are an important mechanism 
by which bacteria sense environmental signals and respond in order to adapt to quickly 
changing environments and survive environmental stresses. TCS consist of a sensor 
kinase, typically a histidine kinase found in the bacterial membrane, and a cognate 
response regulator [341, 342]. In response to an environmental signal, the sensor 
kinase autophosphorylates and transfers the phosphoryl group to the receiver domain of 
the response regulator. Histidine kinases can also have phosphatase activity and 
dephosphorylate the response regulator when its signal is not sensed [343, 344]. When 
phosphorylated, the response regulator becomes active and mediates the intracellular 
response to the extracellular signal through its effector domain [341, 342, 345]. 
Response regulators can have a variety of effector domains. The majority of known 
response regulators contain a DNA binding domain, allowing the response regulator to 
alter gene transcription through direct binding of a consensus DNA sequence [341]. 
 
3 This chapter is a manuscript in progress. Authors: Elizabeth M. Garrett, Derrick K. Cooper, Jilarie A. 
Santos-Santiago, John Shook, Rita Tamayo. I contributed data to all figures except for Figures 4.3B and 
4.5B,C, and experiments in those figures were done by students under my supervision. I also wrote and 
revised the manuscript with feedback from Rita Tamayo. 
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Therefore, TCS allow the bacterium to couple a discrete environmental signal to 
changes in gene expression. 
Many bacteria produce multiple TCS, allowing the bacterium to sense and 
respond to many diverse environmental signals [341, 342]. For example, Escherichia 
coli encodes 62 conserved TCS genes while Myxococcus xanthus encodes 263 [346]. 
The number of TCS genes correlates not only with genome size but also the diversity of 
the bacterium’s natural environment, indicating the importance of TCS for adaptation 
[347]. TCS play an important role in virulence by affecting bacterial survival within the 
host. TCS have been described as key virulence determinants in multiple bacterial 
pathogens including Escherichia coli, Bordetella pertussis, Pseudomonas aeruginosa, 
and Staphylococcus aureus [348-351]. For example, the SaeRS system in S. aureus 
regulates toxin production as well as innate immune evasion [352-354]. In P. 
aeruginosa, a leading cause of chronic infection in patients with cystic fibrosis, the 
GacAS system regulates the production of factors associated with chronic infection 
such as the type VI secretion system and biofilm formation [201, 350, 355]. The 
EnvZ/OmpR system is produced by multiple intestinal pathogens, including E. coli and 
Salmonella Typhimurium, and is important for survival under osmotic and acid stress as 
encountered during growth in the host gastrointestinal system [356, 357]. Several TCS 
contribute to antibiotic resistance as well. For example, VanSR is a TCS produced by 
multiple pathogens including S. aureus and Enterococcus faecium that provides 
vancomycin resistance by regulating the production of factors that result in cell wall 
remodeling [358]. Because of their significance to pathogenesis and antibiotic 
resistance, efforts have been made to target TCS as an antimicrobial therapy [359]. 
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Clostridioides difficile is an intestinal pathogen and a leading cause of 
nosocomial infections in the U.S., Europe, and Australia [1-3]. C. difficile infection 
causes mild to severe diarrheal symptoms with potentially fatal complications including 
pseudomembranous colitis, toxic megacolon, and sepsis. C. difficile produces many 
TCS; strain CD196 (ribotype 027) encodes 53 putative histidine kinases and 54 
response regulators [360]. Many of these TCS remain uncharacterized. Recent work 
has identified a TCS, CmrRST, with an important role in C. difficile physiology [334]. 
CmrRST consists of two response regulators (CmrR and CmrT) and a histidine kinase 
(CmrS). CmrRST promotes type IV pilus-independent surface motility and the formation 
of cell chains while inhibiting flagella-dependent swimming motility and biofilm 
formation. High cmrRST expression also results in rough colony morphology, while low 
cmrRST expression results in smooth colonies. In a hamster model of infection, a 
ΔcmrR strain was attenuated, indicating a role for CmrRST in virulence. Expression of 
cmrRST is regulated by c-di-GMP and by phase variation by site-specific recombination.  
The mechanisms by which CmrRST exerts its effects on colony morphology, 
surface motility, swimming motility, cell chaining, and virulence are unknown. CmrR and 
CmrT are both OmpR-family response regulators with winged helix-turn-helix (wHTH) 
domains, indicating that they likely function as transcription factors. Consistent with this 
role, CmrR promotes cmrRST transcription (Chapter 3). However, other targets of CmrR 
and CmrT regulation are unknown. The goal of this study was to define the 
transcriptional regulon of CmrRST. We determined that CmrR and CmrT regulate 
transcription of numerous genes encoding products of varied functions including cell 
wall proteins and proteins with functions in metabolism. We have begun to evaluate 
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CmrR- and CmrT-regulated genes for roles in CmrRST-regulated phenotypes. One 
CmrR- and CmrT-regulated locus, CDR20291_1689-1690, was found to impact C. 
difficile colony morphology and swimming motility, but not surface motility. 
 
MATERIALS AND METHODS 
Growth and maintenance of bacterial strains 
C. difficile R20291 (NCBI accession number FN545816.1) and derivative strains 
were grown statically at 37 °C in BHIS (37 g/L Bacto brain heart infusion, 5 g/L yeast 
extract) or in TY (30 g/L Bacto tryptone, 20 g/L yeast extract, 1 g/L thioglycolate) broth 
as indicated and were maintained in an anaerobic environment of 85% N2, 5% CO2, and 
10% H2. E. coli strains were grown with aeration in Luria Bertani medium at 37 °C. 
Antibiotics were used where indicated at the following concentrations: chloramphenicol 
(Cm), 10 μg/mL; thiamphenicol (Tm). Table 4.1 lists strains and plasmids used in this 
study. 
 
Construction of plasmids and strains  
Table 4.2 lists primers used in this study. To construct p1689-1690, 
CDR20291_1689-1690 were PCR amplified from R20291 using primers R2755 + 
R2756, then spliced into SacI and BamHI-digested pRPF185 by Gibson Assembly (New 
England Biolabs) [320]. Plasmids were confirmed by PCR and sequencing. p1689-1690 
was transferred to C. difficile R20291 by conjugation using E. coli HB101(pRK24) as 




 R20291 (WT) with plasmids pRPF185 (vector; RT1615), pCmrR (RT2085), or 
pCmrT (RT2107) were grown overnight in TY-Tm [334]. Cultures were then diluted in 
BHIS-Tm10, and anhydrotetracline (ATc; 2 ng/µL for vector and pCmrT; 10 ng/µL for 
vector and pCmrR) was added after two hours of growth. Cultures were grown to mid-
exponential phase, collected, and stored at -80 °C in 1:1 ethanol:acetone. RNA was 
extracted by phenol-chloroform as previously described and purified using the RNeasy 
kit (Qiagen) [184, 237]. The samples were treated RNase-Free DNase Set (Qiagen). 
RNA sample QC, additional DNase treatment, library preparations and 
sequencing reactions were conducted at GENEWIZ, LLC. (South Plainfield, NJ, USA). 
RNA samples were quantified using a Qubit 2.0 Fluorometer (Life Technologies), and 
RNA integrity was assessed with a 4200 TapeStation (Agilent Technologies). rRNA 
depletion was performed using the Ribozero rRNA Removal Kit (Illumina). RNA 
sequencing library preparation used the NEBNext Ultra RNA Library Prep Kit for 
Illumina by following the manufacturer’s recommendations (New England Biolabs). 
Briefly, enriched RNAs were fragmented for 15 minutes at 94 °C. First strand and 
second strand cDNA were subsequently synthesized. cDNA fragments were end 
repaired and adenylated at 3’ends, and a universal adapter was ligated to the cDNA 
fragments, followed by index addition and library enrichment with limited cycle PCR. 
Sequencing libraries were validated using the Agilent Tapestation 4200 and quantified 
by using a Qubit 2.0 Fluorometer as well as by quantitative PCR (qPCR; Applied 
Biosystems).The sequencing libraries were multiplexed and clustered on one lane of a 
flowcell and loaded on the Illumina HiSeq instrument according to manufacturer’s 
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instructions. The samples were sequenced using a 2x150 Paired End (PE) 
configuration. Image analysis and base calling were conducted by the HiSeq Control 
Software (HCS). Raw sequence data (.bcl files) generated from Illumina HiSeq were 
converted into FASTQ files and de-multiplexed using Illumina's bcl2fastq 2.17 software. 
One mismatch was allowed for index sequence identification. 
Data was analyzed using CLC Genomics Workbench v. 11 (Qiagen). Reads 
were mapped to the C. difficile R20291 genome (FN545816.1) using the software’s 
default scoring penalties for mismatch, deletion, and insertion differences. Principle 
component analysis (PCA) indicated that WT vector treated with ATc 2 ng/mL was not 
significantly different than WT vector with ATc 10 ng/mL, so data from these samples 
were combined for further analysis. Transcript reads for each gene were normalized to 
the total number of reads and gene length (expressed as reads per kilobase of 
transcript per million mapped reads [RPKM]). Fold changes greater than 2 relative to 
WT vector with a False Discovery Rate (FDR) p < 0.05 were considered to be 
statistically significant. 
 
Quantification of switch orientation by quantitative PCR 
After growth in TY overnight, genomic DNA was purified by 
phenol:chloroform:isopropanol extraction and washed with ethanol. qPCR was 
performed as previously described with 100 ng of DNA per 20 µL reaction and 100 nM 
primers [334]. Data were analyzed using the ΔΔCt method, with rpoA as the reference 
gene and the indicated control condition [138]. Primers are listed in Table 4.2. 
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Quantitative reverse-transcriptase PCR (qRT-PCR) 
Strains were grown overnight in TY-Tm medium. Cultures were diluted 1:30 in 
BHIS-Tm broth. After two hours of growth, ATc was added to induce gene expression 
(vector and pCmrR, 10 ng/mL; WT with pCmrT, 2 ng/mL). Samples were collected at 
mid-exponential phase and saved in 1:1 ethanol:acetone at -80 ºC. 
RNA was isolated and purified as previously described using phenol-chloroform 
extraction [184, 237]. The samples were treated with TURBO DNA-free™ Kit (Life 
Technologies). cDNA was synthesized using the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems) using the manufacturer’s protocols. Real-time 
PCR was performed using SensiFAST SYBR & Fluorescein Kit (Bioline) as previously 
described [334]. Data were analyzed using the ΔΔCt method and the indicated control 
condition, with rpoC as the reference gene [138]. Primers are listed in Table 4.2. 
 
Microscopy 
To image whole colonies, strains were grown for 24 hours on BHIS-Tm agar for 
24 hours with ATc included at the indicated concentration. Images were taken using a 
Keyence BZ-X810 microscope at 2x magnification. For Gram staining, strains were 
grown on BHIS-Tm agar with ATc for 48 hours. Colonies were heat fixed on glass slides 
and Gram stained (BD Kit 212524). Slides were imaged at 60x magnification using a 
Keyence BZ-X810 microscope. 
 
Surface and swimming motility assays 
Motility assays were done as previously described [103, 113, 334]. For surface 
motility, 5 µL of overnight culture was spotted onto BHIS-Tm 1% glucose-1.8% agar. 
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For swimming motility, 1 µL was inoculated into 0.5x BHIS-Tm 0.3% agar. ATc was 
included at the indicated concentrations. After 48 hours (swimming) or 72 hours 
(surface), the diameters of the motile spots were measured at the widest point and 
perpendicular to the first measurement, and the measurements were averaged to reflect 
overall diameter.  
 
RESULTS 
CmrR and CmrT regulate many genes of diverse functions 
 To identify regulatory targets of CmrRST, we used RNA-seq to characterize the 
transcriptomes of the response regulators CmrR and CmrT. In C. difficile R20291, cmrR 
and cmrT genes were overexpressed individually from plasmids with ATc induction. 
Because overexpression of cmrT was previously found to be toxic, a lower 
concentration of ATc (2 ng/mL) was used for the R20291 pCmrT samples compared to 
the concentration of ATc (10 ng/mL) used for R20291 pCmrR samples (n = 3 each) 
[334]. Accordingly, we included vector-control cultures treated with either 2 or 10 ng/uL 
ATc (n = 2 each). For the vector-control samples, the difference in ATc concentration 
did not significantly affect the transcriptomes of R20291 vector samples based on PCA 
analysis. Therefore, the vector-control data sets were combined to serve as the 
reference condition (n = 4). Gene transcripts that showed more than a two-fold change 
in reads per kilobase of transcript per million mapped reads (RPKM) and False 
Discovery Rate (FDR) p <0.05 were considered significant. Table 4.3 contains a 
complete list of genes that were differentially expressed in strains overexpressing cmrR 
or cmrT relative to vector.  
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 A total of 105 genes were differentially regulated by CmrR, with 43 negatively 
regulated and 62 positively regulated. CmrT differentially regulated 40 genes, 20 of 
which were positively regulated. Consistent with previous work, cmrS and cmrT were 
significantly upregulated about 7-fold by CmrR, indicating that CmrR positively 
autoregulates cmrRST expression. Therefore, we would expect genes regulated by 
CmrT to also be regulated by CmrR as well. Twenty-six genes were differentially 
regulated by both CmrR and CmrT. Due to CmrR autoregulation of cmrRST, we cannot 
distinguish between direct targets of both CmrR and CmrT versus genes that are 
regulated indirectly by CmrR through CmrT. Of the 14 regulated only by CmrT, 12 
genes were within 0.6-fold of the two-fold cutoff; therefore, these genes may not have 
met significance due to the lower CmrT abundance in pCmrR samples compared to 
pCmrT.  
 The largest category of genes regulated by CmrR and CmrT include those from 
the flagellar operons, nearly all of which are about two-fold upregulated. CmrR and 
CmrT were previously shown to inhibit flagellar swimming motility, therefore inhibition of 
swimming motility is not due to altered flagellar gene transcription. The next largest 
functional category of genes includes those that encode cell surface proteins. The gene 
with the highest fold change in R20291 pCmrR was cwp28 (37.2-fold, 
CDR20291_1911), which encodes a cell wall protein of unknown function. Genes 
encoding cell wall proteins Cwp10, Cwp11 and Cwp12 were also differentially regulated, 
though their function is also unknown. Additionally, CDR20291_2503-2508, which may 
constitute an operon containing three genes with functions in cell division regulation as 
well as a gene annotated as encoding a membrane protein, is significantly 
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downregulated. CmrR also differentially fapR (-2.7-fold, CDR20291_1015) encoding a 
fatty acid/phospholipid biosynthesis regulator with functions in the regulation of 
membrane lipids in other bacteria [361]. These results may indicate that CmrRST has a 
role in remodeling the cell surface, which perhaps relates to its effects on cell elongation 
and chaining. CmrR and CmrT also significantly altered expression of several genes 
involved in transport and metabolism, including genes encoding a putative 
osmoprotectant transporter (>-6.9-fold, CDR20291_3074-3075). CmrR significantly 
downregulated an operon involved in riboflavin biosynthesis (-5.3 to -7.9-fold, 
CDR20291_1595-1598) as well as a riboflavin transporter (-3.7-fold, CDR20291_0146). 
These targets suggest that CmrRST impacts metabolic pathways within the bacterium 
as well. 
Cross-talk between phase variable genes 
 The C. difficile R20291 genome contains seven invertible DNA elements, flanked 
by inverted repeats, that are known or putative targets of site-specific recombination. 
Three of these elements, including the cmr switch, have been demonstrated to regulate 
the expression of neighboring genes in a phase variable manner [103, 179, 334]. Our 
RNA-seq results indicate that two genes known to be phase variable (flgB and cwpV) 
and two putative phase variable genes (CDR20291_0685 and CDR20291_1514) were 
differentially expressed in R20291 pCmrR and pCmrT compared to R20291 with vector. 
These transcriptional differences may be due to disparities in the orientation of the 
invertible element between conditions, transcriptional regulation of the genes by CmrR 
and CmrT, or both. To distinguish between these possibilities, we quantitatively 
determined the orientation of these invertible elements in R20291 with vector, pCmrR, 
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or pCmrT without induction by qPCR. The invertible element upstream of 
CDR20291_0685 in R20291 pCmrR showed a significant difference in orientation from 
R20291 vector and pCmrT; while R20291 vector and pCmrT possessed the switch in 
the orientation matching the sequence in the R20291 reference genome, the sequence 
was inverted in R20291 pCmrR (Figure 4.1). These results correlate with the RNA-seq 
data showing differential expression of these genes in pCmrR compared to pCmrT and 
the vector control. Differences in CDR20291_0685 transcript abundance is likely 
attributable to differences in the orientation of invertible elements and not direct 
regulation by CmrR and CmrT. Similarly, the invertible element upstream of 
CDR20291_1514 showed a bias toward the reference genome orientation in pCmrR 
and pCmrT, but the opposite bias in the vector control (Figure 4.1). Accordingly, 
CDR20291_1514 transcript abundance differed in the vector control compared to 
pCmrT and pCmrT.  In contrast, no significant difference in switch orientation bias was 
observed for the flg and cwpV switches, suggesting that CmrR and CmrT are direct or 
indirect regulators of cwpV and flagellar gene transcription. 
Regulation of swimming motility and colony morphology by CDR20291_1689-
1690 
 Having identified regulatory targets of CmrR and CmrT, we sought to identify 
which genes are responsible for phenotypes known to be regulated by CmrRST. 
CDR20291_1689 and CDR20291_1690 were both positively regulated by CmrR and 
CmrT (pCmrR, 27.5- and 2.5-fold, respectively; pCmrT, 19.1- and 2.4-fold, respectively), 
and CDR20291_1689 was one of the most highly upregulated genes that was identified 
(Figure 4.2A). This result was validated by qRT-PCR. Overexpression of either cmrR or 
145 
cmrT increased the abundance of CDR20291_1689 transcript more than 40-fold (Figure 
4.2B). CDR20291_1690 transcript also increased more than 3-fold but did not reach 
statistical significance.  
 cmrRST expression results in a rough colony morphology, increased surface 
motility, decreasing swimming motility, and cell chaining and elongation [334]. To 
assess the contribution of CDR20291_1689-1690 to these phenotypes, both genes 
were overexpressed in tandem in R20291, under the control of an ATc-inducible 
promoter. Increasing levels of induction showed a progressive change in colony 
morphology resembling, but not identical, to the rough colony morphology (Figure 
4.3A)[334]. Similar to rough colonies or those formed with the overexpression of CmrT, 
R20291 p1689-1690 formed colonies that were irregular and exhibited tendrils; in 
contrast, these colonies still have a rounded and smooth texture [334]. We also Gram 
stained bacteria overexpressing CDR20291_1689-1690 as well as vector and pCmrT 
controls to determine whether these genes contribute to cell elongation or chaining. 
CDR20291_1689-1690 overexpression did not alter cell morphology (Figure 4.3B).  
CmrRST positively regulates surface motility and negatively regulates swimming 
motility [334]. Therefore, we also examined the ability of CDR20291_1689-1690 to 
regulate motility. Overexpression of CDR20291_1689-1690 did not significantly 
increase surface motility relative to vector control (Figure 4.4A). However, 
CDR20291_1689-1690 overexpression significantly reduced swimming motility about 
two-fold (Figure 4.4B). In contrast, overexpression of cmrT inhibits swimming entirely. 
These results suggest that CDR20291_1689-1690 contribute to, but do not fully underly, 
the CmrRST-mediated inhibition of swimming motility. 
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Contribution of CmrR and CmrT to regulation 
 CmrR regulates the expression of cmrT (Table 4.3). Therefore, our RNA-seq 
results cannot distinguish whether gene targets are regulated directly by CmrR or if they 
are regulated indirectly by CmrR through CmrT. To evaluate the contribution of CmrR to 
regulation of gene expression, we overexpressed cmrR and cmrT individually in a 
ΔcmrRΔcmrT and used qRT-PCR to assess differential regulation of genes identified in 
our RNA-seq analysis to be regulation by both CmrR and CmrT (CDR20291_1689, 
1690, 1911, 1913, 1914, 3074, 3075) or just by CmrR (CDR20291_1595 and 2122), 
focusing on those with the highest fold changes in transcript abundance. 
Overexpression of cmrR in a ΔcmrRΔcmrT background did not significantly affect the 
expression of any of the investigated genes, including in CDR20291_1595 and 2122 
(Figure 4.5A). cmrT overexpression did affect CDR20291_1595 expression, in contrast 
to our RNA-seq analysis. CDR20291_2122 expression was not affected by 
overexpression by either cmrR or cmrT, and may instead be regulated by differences in 
the expression of phase variable genes as described above (Figure 4.1). cmrT 
overexpression resulted in the differential regulation of all tested genes identified by 
RNA-seq to be regulated by CmrR and CmrT, including CDR20291_1689-1690 (Figure 
4.5A).  
CmrR and CmrT both promote the rough colony morphology and surface motility 
when overexpressed [334]. However, only a cmrT mutant is deficient in these 
phenotypes as compared to WT [334]. To determine the respective contributions of 
CmrR and CmrT to colony morphology, we overexpressed cmrR in ΔcmrT and 
ΔcmrRΔcmrT backgrounds and examined colony morphology and surface motility. 
Consistent with prior work showing a requirement for CmrT in rough colony 
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development, the ΔcmrT and ΔcmrRΔcmrT strains exclusively formed smooth colonies 
(Figure 4.5B). Overexpression of cmrT in these strains as well as in WT restored the 
rough colony morphology. In contrast, while overexpression of cmrR causes rough 
colony formation in WT, cmrR does not restore the rough colony morphology in ΔcmrT 
and ΔcmrRΔcmrT. The same patterns arose when examining surface motility. 
Overexpression of cmrT significantly increased surface motility in all strain backgrounds 
(Figure 4.5C). However, while cmrR overexpression increased surface motility in WT, it 
was unable to promote surface motility to ΔcmrT or ΔcmrRΔcmrT strains. These data 
indicate that CmrT is essential for the rough colony morphology and surface motility, 
and CmrR cannot compensate for the loss of cmrT. Together, our results suggest that 




 In this study, we characterized the CmrRST regulon. CmrRST regulates more 
than a hundred genes of diverse functions, indicating the significance of this TCS to C. 
difficile physiology. Because CmrRST is phase variable, its regulon is also subject to 
regulation by phase variation. Therefore, defining the transcriptional impact of CmrRST 
is important to understand the extent to which phase variation affects C. difficile 
physiology and pathogenesis as well as the scope of phenotypic heterogeneity within 
the bacterial population. 
 RNA-seq analysis indicates that CmrRST has wide ranging transcriptional 
effects. However, our analysis is complicated by several factors. First, CmrR regulates 
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cmrRST expression. Therefore, our experimental design cannot distinguish between 
targets of CmrR regulation versus those regulated by CmrT. Additionally, we found 
evidence of phase variation in other loci; the strains, and in some cases replicates of the 
same strain, differed in bias of some invertible DNA elements orientation within the 
populations. Differences in population-wide invertible element orientation is likely a 
result of stochastic differences between colonies saved as bacterial stocks and then 
propagated, or may have arisen during culturing for experimentation. For these genes, 
the observed differential expression may be due to phase variation rather than 
transcriptional regulation by CmrR or CmrT. Importantly, phase variation is a 
complication not just in this study but in all such studies of C. difficile and underscores 
the importance of accounting for phase variation in experiments. 
CDR20291_1689 is one of the most highly upregulated genes by both CmrR and 
CmrT (27.9- and 19.1-fold, respectively). Overexpression of this gene and its neighbor 
CDR20291_1690, which together may constitute an operon, affected some but not all 
phenotypes known to be affected by CmrRST. A strain overexpressing 
CDR20291_1689-1690 exhibited altered colony morphology and decreased swimming 
motility relative to a vector control but showed no difference in cell morphology or 
surface motility. These results indicate that CmrRST regulation of colony morphology 
and motility is the result of multiple independent factors and that these are discrete 
phenotypes that are not mediated by a single factor. Additionally, this result 
demonstrates that cell elongation and chaining are not required for the observed 
reduction in swimming motility. Further work will identify the factors that contribute to 
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CmrRST regulation of motility, cell morphology, and colony morphology as well as the 
interdependency of these behaviors. 
CDR20291_1689 and CDR20291_1690 are highly conserved and found in all C. 
difficile genomes available through NCBI. Both genes are predicted to encode small 
proteins (81 and 87 amino acids, respectively). No homology to proteins with a defined 
function was detectable using BLASTp, and prediction of protein structure using Phyre 
was uninformative. These small proteins may act as post-translational regulators of 
other proteins, and it remains possible that the loci do not encode proteins. Future 
studies will characterize these gene products and their mechanisms of action in the 
regulation of swimming motility and colony morphology. 
CmrR is an autoregulator of cmrRST expression. We found that eight of nine 
tested genes, including those with the highest fold changes found through RNA-seq, 
were regulated by CmrR through CmrT. Our data also indicate that CmrR is unable to 
restore colony morphology and surface motility phenotypes in a cmrT mutant. This data 
does not preclude the possibility that CmrR also regulates that production of factors that 
contribute to the rough morphology and surface motility. In previous work, a cmrR 
mutant, but not a cmrT mutant, was shown to have increased biofilm formation and was 
attenuated in a hamster model of infection. This indicates that CmrR may regulate 
important factors. However, our data do suggest that one mechanism by which CmrR 
positively regulates colony morphology and surface motility is through increasing cmrT 
expression. 
In summary, this study begins to characterize the regulon of the putative TCS 
CmrRST. Many questions remain, including the conditions that favor cmrRST 
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expression as well as the function and significance of the CmrR and CmrT regulated 
genes. Our results suggest that many genes may be regulated in a phase variable 
manner through CmrRST, leading to phase variation-mediated global regulatory 
changes and broad phenotypic heterogeneity. Phase variation of CmrRST likely has a 
vast impact C. difficile physiology, and elucidating the underlying mechanisms is 
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Figure 4.1. Orientation of invertible DNA elements varies between strain 
populations. WT vector, pCmrR and pCmrT were grown overnight in broth without 
induction. qPCR was performed using gDNA and orientation specific primers to quantify 
percent invertible element orientation. Reference orientation refers to the orientation 
found in the published R20291 genome (FN545816.1). Show are individual values with 
mean of from 7-8 biological replicates over two independent experiments. ****, p < 






Figure 4.2. CmrR and CmrT regulate CDR20291_1689-1690. A) Diagram of 
CDR20291_1689-1690 locus. B) qRT-PCR measurement of CDR20291_1689 and 
CDR20291_1690 transcript abundance in WT with pCmrR, pCmrT, and vector control. 
Strains were grown with ATc induction (10 ng/mL for vector and pCmrR, 2 ng/mL for 
pCmrT) prior to RNA isolation. Shown are means and standard deviations of 4-6 
biological replicates from two independent experiments. **** p < 0.0001, one-way 





Figure 4.3. CDR20291_1689-1690 regulates colony morphology. A) WT vector and 
pCDR20291_1689-1690 were grown on BHIS-Tm with the indicate concentrations of 
ATc. Representative images of colony morphology after 24 hours of growth. B) WT 
vector, pCmrT and CDR20291_1689-1690 were grown on BHIS-Tm with ATc (vector 
and CDR20291_1689-1690, 50 ng/mL; pCmrT, 2 ng/mL). Colonies were Gram stained 





Figure 4.4. CDR20291_1689-1690 inhibits swimming motility but not surface 
motility. Motility of WT vector, pCmrT and CDR20291_1689-1690 grown with the 
indicated concentration of ATc. n.d., no data; pCmrT growth is inhibited with more than 
2 ng/mL ATc. Shown are means with standard deviations of eight biological replicates 
from two independent experiments A) Surface motility was quantified by measuring the 
diameter of growth after 72 hours. D) Swimming motility was quantified by measuring 
the diameter of growth in 0.5x BHIS 0.3% agar after 48 hours. ** p < 0.01, *** p < 0.001, 




Figure 4.5. Gene regulation by CmrR occurs through CmrT. A) qRT-PCR analysis 
of transcript abundance for cmrRST targets in ΔcmrRΔcmrT strains overexpressing 
cmrR, cmrT, or vector control. Shown are means and standard deviations of 4-5 
biological replicates. * p < 0.05, ** p < 0.01, **** p < 0.0001, Holm-Sidak t-test for 
multiple comparisons. B) Representative images of colony morphology of WT, ΔcmrT, 
and ΔcmrRΔcmrT, each carrying pCmrR, pCmrT or vector control. Colonies were grown 
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on BHIS-agar with ATc induction (10 ng/mL for vector, pCmrR; 2 ng/mL for pCmrT). C) 
Surface motility after 72 hours of growth. Shown are means and standard deviations of 
eight biological replicates from two independent experiments. ***p < 0.001, ****p < 




Table 4.1. Strains and plasmids used in this study. 
Lab Notation Strain/Plasmid Name Description Reference 
AC472 Escherichia coli DH5α F- φ80lacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1 hsdR17(rκ 
-, mκ+) phoA supE44 thi-1 gyrA96 
relA1 λ- tonA 
Invitrogen 
[313] 
RT270 Escherichia coli 
HB101(pRK24) 
E. coli used in conjugations with C. 
difficile, ApR, CmR 
[314] 
RT273 C. difficile R20291 Ribotype 027 strain (Genbank 
Accession # FN545816) 
[99] 
RT1615 R20291 vector R20291 with pRT1611 [103] 
RT2085 R20291 pCmrR R20291 with pCmrR (pRT2073) [334] 
RT2107 R20291 pCmrT R20291 with pCmrT (pRT2106) [334] 
RT2518 R20291 p1689-1690 R20291 with p1689-1690 (RT2520) This work 
RT2307 R20291 ΔcmrRΔcmrT 
vector 
R20291 with deletions of cmrR and 
cmrT, contains plasmid RT1611 
This work 
RT2308 R20291 ΔcmrRΔcmrT 
pCmrR 
R20291 ΔcmrRΔcmrT with pCmrR 
(RT2073) 
This work 
RT2309 R20291 ΔcmrRΔcmrT 
pCmrT 
R20291 ΔcmrRΔcmrT with pCmrT 
(RT2106) 
This work 
RT709 pRPF185 Contains ATc-inducible Ptet promoter 
with gusA 
[320] 
RT1611 pRT1611 Derivative of pRPF185 with gusA 
removed 
[103] 
RT2073 pCmrR pRPF185 with gusA replaced by 
cmrR 
[334] 
RT2106 pCmrT pRPF185 with gusA replaced by 
cmrT 
[334] 







Table 4.2. Primers used in this study. 
Primer 
Name 
Lab Notation Primer Sequence (5’ to 3’) 
R2175 qPCR_FlgSwit-ON GTTTTCTTACCAAAGTGATACATTATTATATTAATG 
R2176 qPCR_FlgSwit-OFF CATTAATATAATAATGTATCACTTTGGTAAGAAAAC 
R2177 qPCR_FlgSwit-REV GCTATTGTCTGACTTCTTAAATTAGTTGCAT 
R2213 LCF801 GGTAAGTTTGATTTTTATGTTAATGAATTG 
R2214 LCF714 CAGTTTGTGCACTAGCTATGCCTGC 
R2215 LCF796 CGCAATTATTTGTTTTTCATATGGATAAAATTGG 













R2273 RpoAqF TCATTACCAGGTGTAGCAGTGAATGC 
R2274 RpoAqR GATAGAGCATGGTCCTTGAGCTTCT 
R2755 CDR_1689-1690F cgtagcgttaacagatctgagctcGAGATTGGAGGAATTGCTTTG 
R2756 CDR_1689-1690R gttttattaaaacttataggatccTCCAATATTCTAAAATTAATTTTG 
R2805 CDR20291_1689qF GAAGGGTATATATTAACATGTAAAATATCTG 
R2806 CDR20291_1689qR GCAACAACTTCTCCATCCCATAC 
R2807 CDR20291_1690qF GTAGAGGTAAATTTAGAGAAACAAGCC 
R2808 CDR20291_1690qR CTTGATTTACTACTAGATACCATGTTCC 
R2816 CDR20291_1911qF CAATTAGTAGATGCAATATCATCTGTAG 
R2817 CDR20291_1911qR GCACTTAATCCATCTGCAATAGAG 
R2818 CDR20291_1913qF GGGATAGCTATATCTTTTCTACTTATAATCAG 
R2819 CDR20291_1913qR CCTACTTTTATGTCTACTTTTAGATTTAATAG 
R2820 CDR20291_1914qF TTGGCAAATCTAGCATCAATTTTAAAAC 
R2821 CDR20291_1914qR CTCTCAACTTCTGCCCATATTCC 
R2822 CDR20291_3074qF GGTCTGATTTTGCCAGATGGAGG 
R2823 CDR20291_3074qR CAGTCATATGAGGAAAAAGAACACTTCC 
R2824 CDR20291_3075qF CTATAATAATTGCGATTGTTTTGGGTGG 
R2825 CDR20291_3075qR CAGAAATCCTAGCATAGAAATAGATGG 
R2828 CDR20291_1595qF CTTTTATCAGGAGCTGAAGACTGTC 
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R2829 CDR20291_1595qR ATAGCATCATACCTACCACTTTTAGCC 
R2830 CDR20291_2122qF ATATGGTTGGAGTATCGCCTTGG 





Table 4.3. Genes differentially regulated by CmrR and/or CmrT 






CDR20291_3126 cmrT response regulator 6.892 14.498 
CDR20291_3127 cmrS histidine kinase 7.053 1.402 











CDR20291_0227 putative transglycosylase 2.551 1.668 
CDR20291_0228 conserved hypothetical 2.288 1.736 
CDR20291_0229 fliN_1 flagellar motor switch protein 2.338 1.662 
CDR20291_0230 flgM anti-SigD factor 2.199 1.9 
CDR20291_0231 putative flagellar 
biosynthesis protein 
2.505 1.948 
CDR20291_0232 flgK putative flagellar hook-
associated protein 
2.418 1.707 
CDR20291_0233 flgL flagellar hook associated 
protein 
2.475 1.725 
CDR20291_0234 fliW flagellar assembly factor  2.539 1.68 
CDR20291_0235 csrA carbon storage regulator 2.741 1.874 
CDR20291_0236 fliS1 flagellar protein FliS 2.537 1.791 
CDR20291_0237 fliS2 flagellar protein FliS 2.485 1.757 
CDR20291_0238 fliD flagellar cap protein 2.487 1.687 
CDR20291_0239 conserved hypothetical 
protein 
2.532 1.768 
CDR20291_0240 fliC flagellin 2.631 2.21 
CDR20291_0241 putative glycosyltransferase 3.076 2.043 
CDR20291_0242 glycosyl transferase family 2 2.913 1.941 
CDR20291_0243 glycosyl transferase family 2 3.114 1.875 






CDR20291_0246 putative ornithine 
cyclodeaminase 
2.156 1.343 




CDR20291_0248 flgB flagellar basal body rod 
protein 
2.312 1.553 
CDR20291_0249 flgC flagellar basal body rod 
protein 
2.349 1.538 
CDR20291_0250 fliE flagellar hook-basal body 
complex protein 
2.143 1.545 
CDR20291_0251 fliF flagellar M-ring protein 2.112 1.611 
CDR20291_0252 fliG flagellar motor switch protein 1.896 1.79 
CDR20291_0253 fliH flagellar assembly protein 2.203 1.911 
CDR20291_0254 fliI flagellum-specific ATP 
synthase 
2.014 1.892 
CDR20291_0255 fliJ flagellar protein 2.298 1.993 
CDR20291_0256 fliK putative flagellar hook length 
control protein 
2.219 2.089 
CDR20291_0257 flgD putative basal body rod 
modification protein 
2.157 1.946 
CDR20291_0258 flgE flagellar hook protein 1.966 1.947 
CDR20291_0259 putative flagellar protein 1.773 1.728 
CDR20291_0260 motA flagellar motor protein, 
chemotaxis protein 
1.915 2 
CDR20291_0261 motB flagellar motor protein, 
chemotaxis protein 
2.016 1.995 
CDR20291_0262 fliL flagellar basal body 
associated protein 
2.248 2.137 
CDR20291_0263 putative flagellar protein 1.877 2.136 
CDR20291_0264 fliP flagellar biosynthesis protein 1.849 2.093 
CDR20291_0265 fliQ flagellar export protein 2.143 2.034 
CDR20291_0266 flhB flagellar export protein 1.8 1.998 
CDR20291_0267 flhA flagellar export protein 1.795 1.909 
CDR20291_0268 flhF flagellar biosynthesis protein 1.808 1.914 
CDR20291_0269 fleN flagellar number regulator 1.859 1.852 
CDR20291_0270 sigD flagellar sigma factor 
(SigD/FliA) 
1.931 1.879 
CDR20291_0271 putative exported protein 1.86 1.833 
CDR20291_0272 flgG flagellar basal body rod 
protein 
1.871 1.86 
CDR20291_0273 putative flagellar basal body 
rod protein 
2.143 2.146 
CDR20291_0274 fliM putative flagellar motor 
switch protein 
2.368 2.273 
CDR20291_0275 fliN_2 putative flagellar motor 
switch protein 
2.324 2.244 
CDR20291_0276 conserved hypothetical 
protein 
2.665 2.244 
Cell wall and membrane 
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CDR20291_0008 processive 1,2-diacylglycerol 
beta-glucosyltransferase 
-2.231 1.095 
CDR20291_0440 cwpV cell wall protein -6.406 -7.821 




CDR20291_1911 cwp28 cell surface protein 37.172 11.158 
CDR20291_1913 putative membrane protein 5.024 4.201 
CDR20291_1914 hypothetical protein 18.311 10.767 
CDR20291_2099 putative cell surface protein -2.47 1.212 
CDR20291_2505 putative membrane protein -2.112 -1.478 
CDR20291_2677 putative cell wall teichoic 
acid glycosylation protein 
-2.797 -1.545 
CDR20291_2679 hypothetical protein -2.457 -1.864 
CDR20291_2680 cwp2 cell surface protein (S-layer 
protein precursor) 
-2.25 -1.541 
CDR20291_2683 cwp12 cell surface protein  2.39 1.863 
CDR20291_2684 cwp11 cell surface protein 2.892 2.172 
CDR20291_2685 cwp10 cell surface protein -2.087 -1.723 
Energy and metabolism 
CDR20291_0176 anaerobic carbon-monoxide 
dehydrogenase iron sulfur 
subunit 
-2.093 -2.815 
CDR20291_0177 putative oxidoreductase, 
NAD/FAD binding subunit 
-2.111 -3.317 
CDR20291_0517 putative membrane protein -1.104 -2.012 
CDR20291_0970 gloA glyoxylase I -2.745 -1.584 
CDR20291_0972 putative membrane protein -2.429 -1.417 
CDR20291_1016 plsX fatty acid/phospholipid 
synthesis protein 
-2.102 1.214 
CDR20291_1477 hom2 homoserine dehydrogenase 2.308 1.342 
CDR20291_1493 cysA serine acetyltransferase 2.901 1.49 
CDR20291_1595 ribH riboflavin synthase beta 
chain 
-5.286 1.589 
CDR20291_1596 ribA riboflavin biosynthesis 
protein 
-6.636 1.433 
CDR20291_1597 ribB riboflavin synthase alpha 
chain 
-7.918 1.333 
CDR20291_1598 ribD riboflavin biosynthesis 
protein 
-7.112 1.368 
CDR20291_1829 pduU ethanolamine utilization 
protein 
-4.218 -1.661 
CDR20291_2074 hcp hydroxylamine reductase 1.231 -5.357 
CDR20291_2075 Iron-sulfur binding protein 1.164 -5.247 
CDR20291_2507 putative alanine racemase -2.379 -1.614 
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CDR20291_2732 putative amidohydrolase 1.658 2.057 
CDR20291_2829 nrdF ribonucleoside-diphosphate 
reductase beta-chain 
-1.654 -2.222 
CDR20291_2838 uxaA altronate dehydratase large 
subunit 
2.126 1.386 
CDR20291_2839 altronate dehydratase small 
subunit 
3.502 1.365 
CDR20291_2934 bglA1 1-phospho-beta-glucosidase -2.007 -1.681 
CDR20291_3142 proC2 pyrroline-5-carboxylate 
reductase 
2.174 1.109 
CDR20291_3143 pflD putative formate 
acetyltransferase 
2.45 1.025 
CDR20291_3144 pflE putative pyruvate formate-
lyase 3 activating enzyme 
2.428 -1.034 
CDR20291_3226 cls cardiolipin synthase 2.135 1.745 
Transporters 
CDR20291_0146 riboflavin transport -3.665 1.031 
CDR20291_0516 putative cation transporting 
ATPase 
-1.374 -2.306 
CDR20291_0946 zupT zinc transporter -1.446 -2.221 
CDR20291_1328 feoB1 ferrous iron transport protein 
B 
-1.349 -2.009 




CDR20291_1718 P-type Ca2+ transporter 
ATPase 
-2.059 -2.164 
CDR20291_2535 sbp sulfate ABC transporter 
binding protein 
-2.497 -1.789 
CDR20291_2840 kdgT2 putative carbohydrate 
permease  
2.719 1.491 
CDR20291_2935 PTS beta-glucoside specific 
IIA component 
-2.045 -1.24 
CDR20291_3074 putative osmoprotectant acid 
ABC transporter ATP 
binding protein 
-8.448 -7.299 
CDR20291_3075 osmoprotectant transport 
system substrate binding 
protein 
-8.316 -6.946 
CDR20291_3236 sn-glycerol 3-phosphate 
transport system substrate-
binding protein  
-2.535 -1.509 
Regulators 
CDR20291_0205 putative signaling protein, 
GGDEF-EAL 
-2.346 -1.181 








CDR20291_1229 GntR family transcriptional 
regulator 
-2.09 -1.715 
CDR20291_1514  putative signaling protein, 
GGDEF-EAL 
-8.57 -13.188 
CDR20291_2040 putative signaling protein, 
GGDEF-EAL 
8.02 2.992 
CDR20291_2122 sinR’ putative regulatory protein 3.586 1.234 
CDR20291_2503 cell division initiation protein -2.073 -1.452 
CDR20291_2504 putative RNA binding cell 
division protein 
-2.002 -1.578 
CDR20291_2506 sepF cell division inhibitor -2.455 -1.661 




CDR20291_0522 cotJB1 spore coat protein -2.917 -3.948 
CDR20291_0684 putative reductase -2.165 -1.77 
CDR20291_1329 putative exported protein -2.196 -2.298 
CDR20291_1689 hypothetical protein 27.52 19.109 
CDR20291_1690 conserved hypothetical 
protein 
2.518 2.382 
CDR20291_1929 hypothetical protein -3.89 -1.828 
CDR20291_2116 putative GTP binding protein -2.695 -1.533 
CDR20291_2508 putative exported protein -2.103 -1.627 
CDR20291_2828 conserved hypothetical 
protein 
-1.852 -2.163 
CDR20291_3190 conserved hypothetical 
protein 
-1.909 -2.368 




Grey text, less than 2-fold change 
Green text, >2-fold up-regulated by CmrR/CmrT 
Red text, >2-fold down-regulated by CmrR/CmrT 




CHAPTER 5. DISCUSSION 
This project began with a simple observation: Clostridioides difficile forms two 
distinct colony morphologies. Further investigation into this observation revealed the 
regulatory mechanisms underlying these colony morphologies as well as their 
significance to C. difficile physiology. In Chapter 2, we describe our discovery that these 
colony morphologies, called rough and smooth, gain their morphology from the phase 
variable expression of three genes, cmrRST, encoding a putative two-component 
system (TCS) with two response regulators and a histidine kinase. The response 
regulators CmrR and CmrT positively regulate type IV pili (TFP)-independent surface 
motility, which has not previously been described in C. difficile. Additionally, CmrR and 
CmrT influence swimming motility, cell morphology, and biofilm formation. Using an 
animal model, we found that CmrRST has a role in virulence and that phase variation 
occurs in vivo. In Chapter 3, we characterized the regulation of cmrRST. In addition to 
regulation by site-specific recombination of an invertible DNA element, termed the cmr 
switch, cmrRST is transcriptionally regulated by c-di-GMP through a riboswitch. 
Regulation by this riboswitch occurs whether the cmr switch is ON or OFF, and the two 
regulatory mechanisms occur independently of each other. We also found that CmrR, 
but not CmrT, regulates cmrRST expression. In Chapter 4, we defined the CmrRST 
regulon through RNA-seq. We identified multiple gene targets of CmrT including one 
that contributes to the CmrRST-mediated regulation of swimming motility and colony 
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morphology. Together, our data indicate that cmrRST expression is subject to a 
complex network of regulation with extensive and important impacts on multiple aspects 
of C. difficile physiology (Fig 5.1). 
 
GENE REGULATION BY CmrR AND CmrT 
 TCS response regulators and sensor kinases typically exist as cognate pairs; 
thus, the presence of two response regulator encoding genes with a single kinase gene 
within one operon is unusual [362]. CmrR and CmrT are similar in structure, with both 
containing a receiver (REC) domain and a winged helix-turn-helix domain indicating an 
ability to bind DNA and regulate gene expression. CmrR and the family-defining 
response regulator OmpR share significant homology. However, key residues within the 
receiver domain of CmrT, including the conserved residue at the phosphorylation site, 
are divergent from the OmpR consensus sequence. OmpR-family response regulators 
are typically phosphorylated at a conserved aspartate residue [285]. CmrR contains this 
residue, D52, suggesting that CmrR is regulated though phosphorylation, presumably 
by CmrS. Consistent with the role of this conserved residue in signaling, we found that a 
D52A mutation decreased CmrR activity. In contrast, CmrT has a glutamate at this 
position (E53). Glutamate substitutions at this site can function as a phosphomimic, 
removing the requirement for phosphorylation and resulting in a constitutively active 
response regulator [286, 287]. Therefore, while CmrR may require phosphorylation for 
full activity, CmrT may instead be constitutively active. 
 Our data show that CmrR and CmrT are not redundant. Overexpression of cmrR 
or cmrT result in similar phenotypic changes. However, CmrR is not able to regulate 
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these phenotypes in the absence of CmrT. Similarly, we identified genes that were 
differentially regulated with the overexpression of cmrR and cmrT. Further analysis of a 
few of these targets found that CmrR was unable to regulate expression upon deletion 
of cmrT, suggesting that CmrT is the primary regulator of genes involved in CmrRST-
regulated phenotypes. CmrR, on the other hand, autoregulates cmrRST expression. 
Based on these data, we hypothesize that the primary role of CmrR is to promote 
transcription of cmrT and that CmrT is a constitutively active transcriptional regulator 
that, once produced, regulates genes outside the cmrRST operon. Whether CmrR has 
any direct targets other than cmrRST is unclear; RNA-seq revealed several genes that 
were differentially regulated by overexpression of cmrR but not cmrT, but we were 
unable to validate these results for the two targets that were tested. Further analysis of 
our RNA-seq data set as well as the mechanisms underlying CmrRST-dependent 
phenotypes may reveal additional roles for CmrR. 
 
SIGNALS FOR THE REGULATION OF cmrRST EXPRESSION 
 cmrRST expression is subject to regulation through three mechanisms: c-di-GMP 
signaling through a riboswitch, phase variation through site-specific DNA recombination, 
and autoregulation by the TCS (Fig. 5.1). In Chapter 3, we characterized how c-di-GMP, 
phase variation, and CmrR interact to control cmrRST expression. We found that 
orientation of the cmr switch is independent of regulation by c-di-GMP or CmrR. C-di-
GMP promotes cmrRST expression from a promoter upstream of the cmr switch, 
regardless of its orientation. Similarly, CmrR promotes expression from both 
orientations of the cmr switch, though the degree (fold-change) of activation is highest 
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from the OFF orientation. These overlapping regulatory strategies suggest that cmrRST 
expression can be activated in response to multiple signals and that coordinated 
activation of cmrRST is critical. Understanding the signals that regulate cmrRST 
expression may elucidate the conditions under which CmrRST provides a benefit to 
bacterial fitness.  
 C-di-GMP-modulating diguanylate cyclases (DGCs) and phosphodiesterase 
(PDEs) are often activated in response to environmental signals through sensor 
domains; therefore, these environmental signals would indirectly contribute to regulation 
to cmrRST [213-216]. C. difficile has a large c-di-GMP network, with 37 genes in strain 
630 encoding predicted DGCs and PDEs, consisting of nearly 1% of its total genome 
[238, 239]. Based on two separate studies expressing these genes in heterologous 
bacteria, 28 DGCs and PDEs have been demonstrated to be enzymatically active [238, 
239]. The majority of these DGCs and PDEs remain uncharacterized; their expression 
patterns as well as activating signals are unknown. However, most of these enzymes 
contain sensor domains that may be tied to their activity. Six DGC/PDE proteins contain 
one or more PAS domains [238]. PAS domains are sensor domains that sense a wide 
range of signals including ligand binding and can contribute to activation and 
dimerization or proteins [363]. One DGC contains a REC domain, indicating that the 
activity of this enzyme may be regulated by phosphorylation [345]. Two PDEs contain 
Cache domains, which are often extracellular domains that contribute to regulation of 
protein activity in response to small molecule binding [364]. One PDE contains a PTS 
EIIC domain, indicating that it may bind a carbohydrate [365]. Finally, a DGC and a PDE 
each contain solute-binding protein (SBP) family 3 domains, which participate in signal 
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transduction through the binding of small molecules including polar amino acids [366]. 
Together, the number of DGCs and PDEs and the diversity of their accessory domains 
suggest that c-di-GMP signaling in C. difficile is subject to regulation by many signals, 
potentially affecting cmrRST.  
The significance of sensory domains can be illustrated through the regulation of 
the C. difficile PDE PdcA, which contains a PAS domain and a degenerate GGDEF 
domain [120]. Removal of the PAS and GGDEF domains decreased enzyme activity. 
PdcA activity is regulated by GTP, the intracellular level of which is affected by nutrient 
availability and growth phase. Additionally, pdcA expression is regulated by CodY, a 
global transcription factor that represses gene transcription during growth in nutrient-rich 
conditions such as exponential phase. While the signals that regulate the activity and 
expression of other C. difficile DGC and PDE are unknown, Purcell et al. showed that c-
di-GMP increases with surface growth versus liquid [113]. These examples lead us to 
propose that other DGC and PDE are subject to similar regulation, potentially tying 
cmrRST expression to the same environmental signals. One open question is which c-
di-GMP enzymes can regulate cmrRST expression and whether any are dedicated to 
this regulation. 
Rather than a sense-and-respond mechanism, phase variation relies on 
environmental selective pressures on the population as a whole. Accordingly, 
environmental pressures determine whether cmr ON or OFF cells become the 
predominant subpopulation. We found that motile spots on a hard agar surface 
originating from a cmr OFF inoculum develop cmr ON cells on the edges while 
remaining cmr OFF in the center. One explanation for this is that this growth condition 
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applies selective pressure, perhaps nutrient availability, for the ON orientation. 
Inversely, in soft agar, a cmr ON inoculum develops into a predominantly cmr OFF 
population that is able to swim. These data indicate that the orientation of the cmr 
switch that allows for the appropriate motility and optimal nutrient acquisition 
mechanisms the greatest fitness benefit in the given environment. While selective 
pressures in vitro may be simple, they are undoubtedly more complex and multivariate 
in vivo. In an acute model of infection, hamsters were inoculated with cmr ON bacteria, 
and analysis of DNA recovered from ceca at the end point of infection revealed that the 
cmr switch was predominantly OFF. This result indicates that there is selective pressure 
against cmr ON cells during infection, at least in this animal model and at the end point 
of disease. That the cmrRST locus is highly conserved and considered part of the C. 
difficile core genome implies a selective advantage to maintenance of the locus for 
survival in the large bowel, the only environment in which C. difficile is known to grow 
naturally. Future studies may define the environmental factors that contribute to this 
selective pressure and provide clues as to the function of CmrRST in infection. 
 CmrR regulates the expression of cmrRST. While many response regulators can 
bind DNA without phosphorylation, phosphorylation can increase activity and binding 
affinity [367, 368]. As a response regulator, CmrR may be activated by the sensor 
kinase CmrS. Key domains for kinase activity and phosphotransfer are well conserved 
in CmrS, suggesting that it is an active histidine kinase [369]. Additionally, CmrS 
contains a transmembrane domain typical of sensor kinase with extracellular sensory 
domains. However, the putative sensory domain does not share significant homology 
with any characterized proteins; histidine kinase sensory domains are extremely diverse 
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and the activating signal is difficult to predict through sequence alone [369, 370]. 
Additionally, TCS can be regulated by multiple factors; one study estimated that 15-25% 
of cognate response regulator/sensor kinase pairs undergo regulatory crosstalk with 
other TCS [362].  The B. subtilis response regulator Spo0F is phosphorylated by five 
distinct kinases [371], and CmrR similarly may be activated by multiple kinases. CmrS 
activity also may be regulated by other membrane proteins. For example, the sensor 
kinase GacS is regulated by interactions with two other sensor kinases, each of which is 
regulated by additional protein interactions as well as environmental signals, illustrating 
how complex sensor kinase activation can be [350]. Together, these studies indicate 
interactions between TCS components can be subject to multiple interactions and 
signals. Further work characterizing the phosphorylation requirement of CmrR, the 
conditions under which CmrR is active, and the signals to which CmrS responds will 
provide important details about the regulation of CmrRST.  
 Because CmrR is an autoregulator, it may initiate a positive feedback loop. This 
mechanism would require low amounts of CmrR and possibly CmrS to be present in the 
cell to initiate autoactivation. For example, in S. enterica, the TCS-encoding genes 
phoPQ are expressed from a constitutive promoter, leading to low levels of PhoP and 
PhoQ [338, 372, 373]. If this TCS is activated by changes in Mg2+, PhoP promotes 
phoPQ expression in a positive feedback loop. We identified a transcriptional start site, 
designated TSS4, between the cmr switch and the start of cmrR, and transcriptional 
reporter experiments indicate the TSS4 promoter has weak activity. TSS4 thus may 
mark the location of a constitutive promoter, allowing low levels of cmrRST transcription 
which can be amplified upon activation of CmrS/R. Alternatively, cmrR expression could 
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originate from the promoter upstream of the c-di-GMP riboswitch under permissive 
conditions, similarly perpetuating cmrRST expression in a positive feedback loop. 
 These overlapping mechanisms of regulation raise questions about the relative 
contributions of these regulatory mechanisms to cmrRST expression and under what 
conditions they are relevant (Fig. 5.1). The cmr switch likely inverts stochastically at a 
low rate per generation, with cmr ON and OFF subpopulations coexisting as a bet-
hedging strategy against sudden environmental changes that provide a fitness benefit to 
one subpopulation over the other. In contrast to this passive form of regulation, c-di-
GMP signaling and CmrR regulation serve as sense-and-respond mechanisms that 
allow each bacterium to act individually in response to its environment. Notably, the 
phenotypic heterogeneity provided by phase variation provides an existent advantage to 
subpopulations, which the c-di-GMP and CmrR autoregulatory mechanisms follow some 
lag as the bacteria modify gene expression. That multiple discrete, independent 
mechanisms impact cmrRST transcription implies the need of C. difficile to failsafe 
expression of this signaling system and its regulatory targets. Further experiments will 
investigate the conditions under which each of these transcriptional regulatory 
mechanisms benefits C. difficile fitness. 
 
REGULATION OF MOTILITY, CELL MORPHOLOGY, AND COLONY MORPHOLOGY 
BY CmrRST 
 CmrRST negatively regulates swimming motility, but the underlying mechanism 
is unknown. qRT-PCR analysis as well as RNA-seq indicated that overexpression of 
cmrR and cmrT did not decrease transcript abundance of flagellar genes. Additionally, 
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scanning electron microscopy (SEM) revealed structures resembling flagella on the 
surface of cmr ON cells [334]. These data suggest that CmrRST may regulate 
swimming through the post-translational regulation of flagella. There are several 
mechanisms through which post-translational regulation of flagella could occur. C. 
difficile flagella are glycosylated, and loss of glycosylation has been shown to inhibit 
swimming motility [98, 100]. While genes encoding flagellar glycosyltransferases are not 
downregulated by CmrR or CmrT, their activity could be. Alternatively, many bacteria 
demonstrate regulation of flagellar motor or stator activity [374]. For example, YcgR is a 
c-di-GMP binding protein produced by E. coli and S. Typhimurium that inhibits 
swimming motility by directly binding MotA, a component of the flagellar motor, and 
decoupling it from other components of the motor [223, 375]. Flagella can also be 
sterically hindered by extracellular factors such as exopolysaccharides. Cellulose 
production was found to contribute to swimming inhibition in addition to YcgR in S. 
Typhimurium [376]. Overexpression of CDR20291_1689 partially reduced swimming 
motility, which may indicate that multiple factors contribute to CmrRST-mediated 
inhibition of motility. This will be addressed in future studies. 
 Type IV pili (TFP)-mediated surface motility has been well demonstrated in C. 
difficile [113, 114, 237]. However, CmrRST positively regulates surface motility in a 
TFP-deficient strain. Additionally, CmrRST does not transcriptionally regulate TFP 
genes. Together, these results indicate that C. difficile is capable of an additional TFP-
independent surface motility that has not been previously identified. Given that CmrRST 
negatively regulates flagella-mediated swimming motility, this novel mechanism of 
surface motility is likely independent of flagella as well. Several mechanisms of pili- and 
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flagella-independent motility are exhibited by other bacteria [377-379]. During sliding 
motility, bacteria migrate through the pushing force of cell division [377]. This can 
require additional factors. Several bacteria, including Pseudomonas species and 
Serratia marcescens, produce surfactants that facilitate movement [377]. Sliding motility 
in Bacillus subtilis requires the production of exopolysaccharide (EPS) as well as 
surfactant [304]. Cell-to-cell contact can also contribute to sliding motility. B. subtilis 
forms bundles of cells connected pole-to-pole that, through cell division, expand in a 
loop facilitated by surfactant that results in migration [304]. Mycobacteria such as M. 
smegmatis also exhibit sliding motility. These bacteria produce glycopeptidolipids in the 
cell envelope that allow sliding also facilitated by cell contact and the formation of 
pseudofilaments [380]. C. difficile may undergo motility through similar mechanisms. 
 CmrRST positively regulates cell length and the formation of cell chains, 
consisting of cells joined pole-to-pole. The mechanisms underlying these phenotypes 
are unclear but may reflect altered cell division. Alterations in the cell cycle and the 
regulators of cell division can increase cell length [381]. Additionally, cell chaining can 
be a results of incomplete daughter cell separation during division [311, 382, 383]. RNA-
seq analysis of CmrRST targets identified several genes whose products are annotated 
as inhibitors of cell division (CDR20291_2503-2508). Further study will determine the 
contribution of these genes to cell morphology. Alternatively, cell chaining can be the 
result of extracellular factors that bind cells pole-to-pole. In E. coli, the phase variable 
factor Ag43 contributes to cell chaining in biofilms [291]. CmrRST regulates the 
expression of several genes encoding cell wall proteins that may function in cell 
adhesion. 
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 One unanswered question is whether the changes in surface motility, swimming 
motility, and cell morphology are interdependent. As described above, cell chaining is 
important to surface motility for many bacteria. The arrangement of cells during B. 
subtilis sliding motility resembles that of cells during C. difficile CmrRST-mediated 
surface motility [304]. Cell length and chaining could also affect the ability of the 
bacterium to swim by affecting its physical properties and slowing its ability to move 
through viscous substances [290]. Alternatively, production of an EPS or other matrix 
component could explain the regulation of both surface and swimming motility. 
Overexpression of CDR20291_1689 partially inhibited swimming motility and altered 
colony morphology but did not affect surface motility. However, differences between 
these results versus those from the overexpression of cmrT indicate that 
CDR20291_1689 is not fully responsible for CmrRST-mediated regulation of these 
phenotypes, and therefore it remains possible that surface motility, swimming motility 
and cell morphology are interconnected. Further analysis of CmrRST targets will allow 
us to disentangle these phenotypes. 
 
IMPLICATIONS OF CmrRST PHASE VARIATION FOR PATHOGENESIS 
An important part of understanding the role of CmrRST in infection is to 
understand the contributions of cell morphology and motility to pathogenesis. Cell 
morphology can be a key virulence determinant for bacterial pathogens. Cell 
morphology physically affects the way a bacterium interacts with its environment, 
neighboring bacteria, and the host [384]. The increased surface area of elongated or 
chained cells can affect targeting by the immune system. Several studies have found 
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that filamentous cells are resistant to phagocytosis by macrophages [385, 386]. In 
contrast, Salamaga et al. showed that Enterococcus faecalis strains that form long cell 
chains were severely attenuated in an animal model and were more susceptible to 
phagocytosis [383]. Filamentous cells can be more susceptible to targeting by the 
complement system due to increased surface area. Increased chain length in 
Streptococcus pneumoniae was shown to increase opsonization and phagocytosis by 
neutrophils [387]. Furthermore, short-chain S. pneumoniae were more virulent than 
long-chain cells in a model of systemic infection. Together these studies indicate that 
cell morphology plays an important role in bacterial interactions with immune cells. Cell 
chaining and length can also affect the interaction of bacteria with surfaces including 
host cells. S. pneumoniae chains were shown to increase adherence to human 
epithelial cells, and strains with increased chain length outcompeted short-chain strains 
in a model of respiratory colonization [388]. Prashar et al. demonstrated that 
filamentation of Legionella pneumophila modifies its interaction with host epithelial cells 
in order to promote invasion, after which it differentiates into short rods [389]. These 
studies underscore that the consequences of cell morphology can be context 
dependent. Many pathogens exhibit heterogeneity of cell morphology in order to 
balance benefits and costs in response to host stresses. Therefore, these studies 
highlight why the phase variation of cell morphology as demonstrated in C. difficile could 
allow the bacterium to bet-hedge in order to increase fitness. 
Motility is also a key virulence determinant and an essential aspect of 
pathogenesis for many bacteria, and therefore many are capable of multiple types of 
motility specialized for planktonic and surface-associated states [390-392]. The 
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transition between these states and these motility patterns is key to bacterial fitness. For 
example, Proteus mirabilis is capable of both swimming motility and swarming motility, a 
flagellum- and surfactant-dependent form of surface motility [393]. P. mirabilis reversibly 
differentiates into swarmer cells in response to inhibition of flagellar rotation, surface 
contact, and cell-to-cell contact, initiating changes not only in motility but in the 
regulation of virulence factors [393, 394]. Swarmer cells have been shown to allow P. 
mirabilis to migrate across catheters to establish urinary tract infections [395, 396]. 
Taylor et al. demonstrated the importance of having multiple motility strategies in 
Pseudomonas aeruginosa [397]. This study used different surface conditions to evolve 
isogenic strains that exhibited increased surface or swimming motility, then showed that 
these strains exhibited trade-offs in motility and virulence. The ability to switch between 
motility types has been shown to be an important aspect of P. aeruginosa colonization. 
Laventie et al. demonstrated that surface contact of the bacterium increased c-di-GMP, 
promoting TFP-mediated surface attachment and motility [193]. Through an asymmetric 
distribution of c-di-GMP following cell division, surface associated populations release 
swimming cells that can travel farther distances to establish new sites of colonization. 
Therefore, both surface-associated and swimming cells are coordinated to maximize 
bacterial colonization. These examples demonstrate the ability to adapt with different 
motility strategies, and not just motility itself, can contribute to bacterial pathogenesis.  
Characterization of the role of CmrRST in virulence will be central to future work. 
In a hamster model of acute infection, a cmrR mutant strain was highly attenuated, 
suggesting an important role for CmrRST in virulence. The cmrR mutant was not 
recovered from the feces at any point during infection, which may indicate that CmrRST 
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contributes to colonization. Additionally, we found evidence that phase variation of this 
system occurs in vivo. We inoculated hamsters with bacterial populations in which the 
cmr switch was predominantly ON and OFF, individually. Regardless of the starting 
orientation, DNA from the hamster cecum at the time of sacrifice showed that the cmr 
switch was predominantly in the OFF orientation, indicating selective pressure against 
cmr ON bacteria in the late stages of infection. These cecal samples do suggest that a 
minority cmr ON population remains. Many open questions remain regarding the role of 
CmrRST in infection. Together, our data suggest that CmrRST may be important for 
colonization and the early stages of infection and detrimental to overall fitness during 
late infection. Future studies will assess the spatial and temporal dynamics of cmr 
phase variation over the course of infection. Competition experiments with phase locked 
and unlocked strains may provide details about the significance of phase variation over 
time. Additionally, cmr switch orientation may affect the spatial organization of bacteria 
and whether they are motile or surface associated. Finally, understanding the signals 
regulating cmrRST expression and activity may provide important information about the 
significance c-di-GMP signaling and CmrR autoregulation during infection.   
Based on all our findings, I propose the following model: C. difficile populations 
consist of cmr ON and cmr OFF subpopulations (Fig. 5.1). During infection, cmr ON 
subpopulations form bacterial chains that are associated with the surface of the host 
epithelia or perhaps mucus layer. CmrRST-mediated surface motility allows migration 
across surfaces, potentially aiding access to nutrients. CmrR may become activated by 
CmrS, promoting cmrRST expression and surface migration in response to nutrient 
cues. Regulation by c-di-GMP, which increases with surface contact, may reinforce 
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cmrRST expression in surface associated cells and activate cmrRST expression in 
phase OFF cells that become surface associated. The cmr OFF cells are capable of 
swimming motility which may allow rapid movement to more distant areas, propagating 
the colonization of new sites. The fitness benefits of cmr ON surface associated cells 
versus cmr OFF planktonic cells likely changes over the course of infection as the 
epithelial surface is disrupted by toxins and the host immune response develops. 
Elongated cmr ON cell chains may be more susceptible to targeting by immune cells, 
consistent with our data showing bacterial populations to be predominantly phase OFF 
at the endpoint of infection. Many open questions remain, and much work will be 
needed to address multiple parts of this proposed model. Continued investigation of 
CmrRST will provide important insights into C. difficile pathogenesis including the 
identification of important environmental signals to which the bacteria respond, 
characterization of behaviors significant through the course of infection, and 
understanding of the fitness benefits of phase variation and phenotypic heterogeneity in 
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Figure 5.1. Model of cmrRST regulation and the role of CmrRST in infection. PDE, 
phosphodiesterase; DGC, diguanylate cyclase; R, CmrR; S, CmrS; T, CmrT; P, 
phosphorylation; Lightning bolt represents an activating signal.  1) With the cmr switch 
in the OFF orientation and basal c-di-GMP levels, cmrRST is not expressed. cmrRST 
expression can be activated through three mechanisms: 2) increased c-di-GMP levels 
through activity of DGC; 3) inversion of the cmr switch to the ON orientation; 4) 
activation of CmrR by CmrS. 5) During infection, C. difficile may consist of cmr OFF, 
swimming cells and cmr ON, surface associated cells.  
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